Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.7785987720639096,-2.2566419104116138,0.0,0.0,0.0,9/22,13.51%,ALDH1A2;PTGDS;NR2F2;ABCA4;RBP4;RXRA;RBP1;RARA;CYP26B1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.5417752615008286,-1.9795001273412887,0.0,0.02805890680132688,0.043,23/60,10.93%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;PDGFRB;EPHB1;NTRK2;NRP1;AXL;RYK;EPHA7;ROR1;EFEMP1;KIT;CRIM1;DDR1;PDGFRA;EPHB4;NRP2;EPHB2;EPHA3;IGF2R
prerank,platelet-derived growth factor binding (GO:0048407),-0.823903868589431,-1.962220683321501,0.0,0.02688978568460493,0.063,7/11,6.19%,COL1A2;COL1A1;PDGFRB;COL3A1;COL5A1;COL6A1;PDGFRA
prerank,cation channel activity (GO:0005261),-0.4923313006194618,-1.956258267613759,0.0,0.021628740659356136,0.067,42/94,28.99%,TRPM3;SLC24A3;HCN1;NALCN;MCU;CACNA1D;PKD1;UNC80;ANXA2;TRPM6;TRPC5;SEC61A1;PIEZO2;KCNK5;TRPC1;KCNA1;SLC24A2;ANO1;KCNK10;TMEM63A;ABCC9;TMCO1;ANO6;TMEM63B;TMEM38A;KCNQ4;ANO10;KCNA2;GRIN1;TRPC6;MCOLN1;ANXA6;PANX1;CALHM5;KCNK9;CHRNA7;TRPV2;SLC24A4;KCNK1;TRPC3;TMEM63C;CACNA1E
prerank,retinoic acid binding (GO:0001972),-0.8159563969961414,-1.9508732428049391,0.0,0.01823828942086247,0.071,4/12,13.51%,NR2F2;RXRA;RARA;CYP26B1
prerank,voltage-gated cation channel activity (GO:0022843),-0.4769585709957965,-1.9173704938451726,0.0,0.025720664567882974,0.118,40/97,28.99%,CACNA2D3;KCNQ3;KCNB2;CACNA1C;HCN1;KCNH7;KCNQ5;KCNMA1;CACNA1D;CACNB4;GRIN2B;KCNC2;KCND2;CACNA1B;KCNH5;KCNA1;CACNG7;CACNG4;KCNS3;OPRM1;KCNQ4;CACNG2;NCS1;KCNA6;KCNA2;GRIN2D;GRIN1;CACNA2D1;KCNC1;CACNG3;CACNG8;CACNB1;KCNC3;HCN2;KCNQ1;CACNA2D2;KCNQ2;KCNK1;LRRC38;CACNA1E
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.5593071981381483,-1.8007873875170848,0.002380952380952381,0.10789317734319742,0.442,13/32,28.09%,KCNQ3;KCNB2;KCNQ5;KCNC2;KCNA1;KCNS3;KCNQ4;KCNA6;KCNA2;KCNC1;KCNC3;KCNQ1;KCNQ2
prerank,nucleotidyltransferase activity (GO:0016779),0.6899401491537912,1.7676751564714916,0.005434782608695652,1.0,0.677,9/19,15.07%,THG1L;MOCS3;NUDT5;TENT4A;TERT;CRPPA;TUT7;PAPSS1;TUT4
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.48218413821252937,-1.765858218565704,0.0,0.13707945093564902,0.582,21/60,12.18%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;PDGFRB;EPHB1;NTRK2;TGFBR2;AXL;RYK;EPHA7;ROR1;KIT;DDR1;PDGFRA;EPHB4;ACVR1;EPHB2;EPHA3;ACVR1B
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.6887833122770286,1.7423104818874537,0.007407407407407408,0.5362605828620285,0.789,7/16,6.45%,PTPRR;PTPRG;PTPRC;PTPRM;PTPRB;PTPRE;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.6887833122770286,1.7423104818874537,0.007407407407407408,0.5362605828620285,0.789,7/16,6.45%,PTPRR;PTPRG;PTPRC;PTPRM;PTPRB;PTPRE;PTPRT
prerank,solute:sodium symporter activity (GO:0015370),0.6054192670208802,1.7250990690898937,0.005190311418685121,0.4943652248259325,0.852,3/27,0.83%,SLC5A7;SLC4A4;SLC4A5
prerank,voltage-gated potassium channel activity (GO:0005249),-0.4380271957613288,-1.7166465490849085,0.0031645569620253164,0.2094025822395321,0.762,28/80,29.46%,KCNK2;KCNQ3;KCNB2;HCN1;KCNH7;KCNQ5;KCNMA1;KCNC2;KCND2;KCNH5;KCNJ2;KCNA1;KCNJ6;KCNJ13;KCNS3;KCNQ4;KCNJ10;KCNA6;KCNA2;KCNT1;KCNC1;KCNC3;HCN2;KCNQ1;KCNQ2;KCNK1;LRRC38;KCNJ12
prerank,wide pore channel activity (GO:0022829),-0.5675500313206988,-1.711535271168063,0.0022935779816513763,0.19781529294935452,0.775,5/23,11.17%,GJB6;GJC1;GJD3;GJA1;GJB2
prerank,gap junction channel activity (GO:0005243),-0.5739679981004211,-1.704636568288368,0.0023094688221709007,0.1921609980939356,0.789,5/22,11.17%,GJB6;GJC1;GJD3;GJA1;GJB2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.7232081443381031,1.6947782964485503,0.009560229445506692,0.5445514537154875,0.924,9/12,16.46%,CNOT2;CNOT7;PAN3;PAN2;CNOT6;CNOT1;CNOT6L;NOCT;PARN
prerank,glycine binding (GO:0016594),-0.7192557602714656,-1.6893122765608726,0.00625,0.20878554609459554,0.844,5/11,7.73%,GRIN2B;GLRB;SRR;GLRA3;GLRA1
prerank,metalloendopeptidase activity (GO:0004222),-0.431933736122521,-1.6771342694566507,0.0,0.21664713616793738,0.874,28/76,20.62%,TRABD2B;NRDC;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;MMP16;ADAMTS6;ADAMTSL5;ADAMTS17;MMP14;ADAMTS9;ADAM19;ADAMTS5;NLN;ADAMTS1;ADAMTSL4;ADAMTS3;AFG3L2;ADAMTS10;MBTPS2;PITRM1;ADAMTS15;ADAMTS16;SPG7;MMP2;ADAM33;ADAMTS20
prerank,organic cation transmembrane transporter activity (GO:0015101),0.6704662276575855,1.66133993842808,0.01981981981981982,0.6369564434049257,0.975,4/16,7.94%,SLC5A7;SLC7A8;SLC44A1;SLC25A26
prerank,MAP-kinase scaffold activity (GO:0005078),-0.6902310267282302,-1.6601970913033264,0.004329004329004329,0.23390773199558512,0.91,4/11,8.30%,AKAP13;KSR1;IQGAP1;MAP2K2
prerank,potassium channel regulator activity (GO:0015459),-0.45906161252843947,-1.6469307942875742,0.011267605633802818,0.24559337591939168,0.933,15/49,13.20%,DPP6;KCNIP4;KCNIP1;WNK1;FLNA;KCNIP3;ENSA;AKAP9;ARPP19;WNK4;SGK1;DPP10;ABCC9;DLG1;WNK3
prerank,calcium channel activity (GO:0005262),-0.4207191067933693,-1.645051540900174,0.0,0.23506641453090774,0.936,36/84,28.99%,CACNA2D3;SLC24A3;CACNA1C;STIM2;MCU;CACNA1D;CACNB4;PKD1;ANXA2;TRPC5;P2RX4;SEC61A1;CACNA1B;TRPC1;SLC24A2;CACNG7;TMCO1;CACNG4;OPRM1;CACNG2;NCS1;GRIN1;CACNA2D1;TRPC6;MCOLN1;ANXA6;PANX1;CACNG3;CACNG8;CACNB1;CHRNA7;TRPV2;SLC24A4;CACNA2D2;TRPC3;CACNA1E
prerank,solute:anion antiporter activity (GO:0140323),-0.6421033398725251,-1.6404114990176564,0.019522776572668113,0.23299896137964576,0.94,6/14,20.04%,SLC7A11;SLC26A7;SLC26A2;SLC26A11;SLC4A2;SLC4A3
prerank,R-SMAD binding (GO:0070412),-0.5945072909692704,-1.6335723981005383,0.017582417582417582,0.23466858859535653,0.95,7/18,12.13%,DDX5;LDLRAD4;SMAD3;SMAD4;SMAD6;RANBP3;PPM1A
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5948064104414398,-1.6330481630480147,0.011111111111111112,0.22360979674566206,0.953,7/18,16.88%,PDLIM5;ANXA2;ANXA1;BAIAP2L1;PDLIM1;S100A11;CDC42EP1
prerank,alanine transmembrane transporter activity (GO:0022858),0.7022373543704397,1.6163205160406644,0.025193798449612403,0.8197630056626778,0.997,4/12,5.53%,SLC7A8;SLC36A4;SLC3A2;SLC6A6
prerank,metallopeptidase activity (GO:0008237),-0.38626146760363445,-1.6159851793927467,0.0,0.24785367674505412,0.971,37/113,20.76%,TRABD2B;NRDC;ADAMTS12;ADAMTSL3;ADAMTS2;ADAM12;THSD4;ADAM23;MMP16;PAPPA;ADAMTS6;ADAMTSL5;ADAMTS17;MMP14;ADAMTS9;RNPEP;ADAM19;ADAMTS5;ANPEP;NLN;ADAMTS1;ADAMTSL4;ADAMTS3;AFG3L2;ADAMTS10;MBTPS2;LAP3;ACE;PITRM1;ADAMTS15;ADAMTS16;SPG7;MMP2;COPS5;ADAM33;ADAMTS20;MYSM1
prerank,monocarboxylic acid binding (GO:0033293),-0.5936523891689918,-1.60847452911737,0.027777777777777776,0.25214045417303466,0.979,6/18,13.51%,NR2F2;PSAP;NAPEPLD;RXRA;RARA;CYP26B1
prerank,poly(A) binding (GO:0008143),-0.5514055994276028,-1.593844470790821,0.02733485193621868,0.2722457945893894,0.984,7/21,7.46%,RBMS1;TIA1;KHDRBS1;KHDRBS2;HNRNPDL;ELAVL4;DDX1
prerank,leak channel activity (GO:0022840),-0.582257432161946,-1.5917093373896207,0.027649769585253458,0.26600046973069486,0.984,4/18,10.34%,KCNK2;NALCN;KCNK5;KCNK10
prerank,adenylate cyclase binding (GO:0008179),-0.676903915338207,-1.5904191629617757,0.02569593147751606,0.25818091327609805,0.984,4/10,2.65%,ADCY5;AKAP6;AKAP12;ADCY2
prerank,poly-purine tract binding (GO:0070717),-0.517130863377432,-1.5860421134860245,0.01639344262295082,0.25650517300879655,0.985,11/27,16.15%,RBMS1;TIA1;KHDRBS1;KHDRBS2;HNRNPDL;ELAVL4;DDX1;ATXN1;DAZAP1;PABPC4;RBMS3
prerank,estrogen receptor binding (GO:0030331),0.5490393156142035,1.585916102753313,0.02564102564102564,0.9313999597077337,1.0,11/32,10.52%,DCAF1;ARID5A;LEF1;DDX54;RERG;SRARP;CCDC62;PHB2;WBP2;ESR1;TACC1
prerank,acid-thiol ligase activity (GO:0016878),-0.6280728229894905,-1.5790993506457298,0.03765690376569038,0.2608938738161836,0.986,6/13,27.60%,ACSL1;ACSS3;ACSS2;AASDH;AACS;ACSS1
prerank,phosphatase binding (GO:0019902),-0.3905488329080609,-1.577372911183829,0.003215434083601286,0.2544353956243777,0.986,45/105,21.97%,MAGI2;EGFR;SMAD3;IQGAP1;AP3B1;JAK1;MAPK14;DLG4;SYTL2;CTNNB1;WNK1;PXN;VCP;MYO16;CRY2;ELL;STAT6;CDKN1B;DLG3;MAP3K5;TP53;CRY1;IKBKE;KIF3A;SIRPA;VRK3;DLG1;RACK1;PTK2;MTMR9;PPME1;MTMR4;NFATC2;TRAF2;FBXL2;TSC2;SNX3;CNST;SHOC2;MET;PIK3R1;PPP6R3;ITGA1;SH3RF2;PDLIM4
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.5441716669996056,-1.5761419067941396,0.03278688524590164,0.24802069404744298,0.988,8/21,9.54%,ARFGEF2;AKAP6;WASF2;PRRC1;WASF1;AKAP9;EZR;PRKACA
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.45991639547964963,-1.5655383779377698,0.012468827930174564,0.26139935589052227,0.992,16/42,17.33%,LRRC4C;CNTN4;PDLIM5;CNTN6;NTNG1;ANXA2;DSCAM;JAM3;PALLD;ANXA1;BAIAP2L1;SIRPA;PDLIM1;S100A11;CDC42EP1;NEXN
prerank,ion channel activity (GO:0005216),-0.4042956505018241,-1.5517894537210137,0.006349206349206349,0.28273245672725905,0.993,33/80,28.80%,TRPM3;GABRB1;NALCN;GRIA4;GRIA2;GRID2;GRIN2B;UNC80;TRPM6;PIEZO2;GRID1;TRPC1;TMEM63A;ABCC9;GRIK4;TMEM63B;TMEM120B;GRIK1;GRIK3;MCUB;GRIN2D;GRIN1;TMEM120A;TRPC6;MCOLN1;ANXA6;CALHM5;CHRNA7;TRPV2;LRRC8A;GRIA1;TMC4;TMC6
prerank,CoA-ligase activity (GO:0016405),-0.5998921461214995,-1.5401949781149535,0.03225806451612903,0.2990310107899474,0.997,3/14,6.30%,ACSL1;ACSS3;ACSS2
prerank,ATPase activator activity (GO:0001671),-0.5410132368790412,-1.5215301126056593,0.039473684210526314,0.3345513145569664,0.998,7/20,9.45%,TOR1AIP2;ATP1B1;DNAJC24;ATP1B3;DNAJC19;TOR1AIP1;ATP1B2
prerank,deoxyribonuclease activity (GO:0004536),0.6172337878542091,1.5144882411829106,0.055762081784386616,1.0,1.0,5/14,5.73%,ZRANB3;NME1;MAP1S;ERCC4;APLF
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6576241842070465,-1.5135507384720868,0.04056795131845842,0.3449615852582321,0.999,3/10,7.64%,SLC6A13;SLC6A1;SLC6A12
prerank,voltage-gated calcium channel activity (GO:0005245),-0.46164201709919045,-1.511876533313751,0.03513513513513514,0.3391826675101573,1.0,15/37,24.83%,CACNA2D3;CACNA1C;CACNA1D;CACNB4;CACNA1B;CACNG7;CACNA1G;CACNG4;OPRM1;CACNG2;NCS1;CACNA2D1;CACNG3;CACNG8;CACNB1
prerank,potassium:proton antiporter activity (GO:0015386),0.6637176089304241,1.5017770593893343,0.06321839080459771,1.0,1.0,3/10,6.96%,SLC9A7;SLC9A6;SLC9A8
prerank,RNA polymerase II complex binding (GO:0000993),-0.45926633540132755,-1.4986142648380454,0.040865384615384616,0.3626279669466722,1.0,16/32,27.56%,ELP4;WAC;RPRD1B;ERCC5;CDC73;ELP2;BRD4;WDR43;PAF1;SMYD2;RTRAF;PCIF1;GTF2B;ZNF326;SUPT4H1;SCAF1
prerank,damaged DNA binding (GO:0003684),0.478261948714505,1.4983324509153528,0.03872053872053872,1.0,1.0,14/44,13.19%,ERCC3;RAD18;PNKP;ERCC4;RAD1;XRCC1;EP300;TDG;DCLRE1B;CREBBP;APTX;RPS3;NBN;MPG
prerank,GTP binding (GO:0005525),0.3912282876654473,1.4919119355745354,0.00648508430609598,1.0,1.0,35/172,12.98%,PCK1;THG1L;RAC2;ARF5;RALB;EEF1A1;RAP2A;ARL5C;ARL4D;RERG;NRAS;TUBB;NME1;ATL1;GBP3;RRAD;RAB7A;RAB11B;RALA;GBP4;RAB6A;RAB14;RANBP17;ARL5B;ARF1;RHOQ;MFHAS1;RHOG;DRG2;GNAI1;RAB22A;LANCL2;RAP2C;RIT1;RRAGC
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.47779660703404747,-1.4905221253819765,0.04697986577181208,0.3744435132167812,1.0,13/27,27.17%,SLC22A8;SLC26A7;SLC39A14;SLC26A2;ANKH;ANO1;SLC39A8;SLC22A6;SLC26A11;SLC5A5;SLC25A30;SLC25A11;LRRC8A
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.4493506862196916,-1.4703497665884977,0.028708133971291867,0.4209151998879227,1.0,14/34,18.34%,IQGAP1;OGT;ADAP2;ZFYVE16;CYTH3;PLEKHB2;GAB2;HIP1R;FCHSD2;DAPP1;COMMD1;IQGAP2;MYO1B;ARAP3
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.6122523342677942,-1.4636539279475418,0.06832298136645963,0.4297750757760255,1.0,2/11,1.57%,ITPR1;RYR3
prerank,translation elongation factor activity (GO:0003746),0.6091243861435461,1.4636107892983359,0.06618962432915922,1.0,1.0,6/14,13.37%,EIF5AL1;EIF5A;EEF1A1;TSFM;GTPBP2;EEF1B2
prerank,potassium channel activity (GO:0005267),-0.364819073417196,-1.4563786713426745,0.006711409395973154,0.43943965256479783,1.0,23/89,20.97%,KCNK2;KCNQ3;KCNB2;HCN1;KCNH7;KCNQ5;KCNMA1;KCNC2;KCND2;KCNH5;KCNK5;KCNA1;KCNK10;ABCC9;GRIK4;TMEM38A;KCNS3;KCNQ4;KCNA6;KCNA2;GRIK1;GRIK3;KCNT1
prerank,general transcription initiation factor binding (GO:0140296),0.5197259099163364,1.4559969385399918,0.054945054945054944,1.0,1.0,12/25,15.69%,RUVBL2;PSMC1;DRAP1;RUVBL1;RELA;PSMC2;ESR1;GTF2A2;TBP;THRA;DR1;TAF1
prerank,hexosaminidase activity (GO:0015929),-0.5995024487161235,-1.4524874697237689,0.07883817427385892,0.4390634353849296,1.0,7/12,29.58%,CEMIP;CEMIP2;HEXA;HEXB;HEXD;HYAL1;NAGA
prerank,tRNA binding (GO:0000049),0.4643256785460828,1.4479079869506215,0.05,1.0,1.0,11/43,16.27%,THG1L;EEF1A1;EIF2A;FARS2;YARS2;ELP1;TRMT10B;TERT;PTCD1;SSB;NSUN6
prerank,zinc ion binding (GO:0008270),0.36084889119305535,1.4478507935760214,0.0011947431302270011,1.0,1.0,61/293,15.30%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;LVRN;TRIM28;ARIH1;SOD1;TAB2;SHANK3;MYRIP;DUSP12;TRIM8;BIRC2;NUDT12;PHF5A;CA2;SIRT3;MME;MMP12;QPCTL;HPF1;KDM2A;CHMP1A;ZNF205;BMI1;TET3;ZNF3;TAB3;WDFY1;ESCO1;MDM2;MYCBP2;ZDHHC15;NQO2;RBSN;ACER3;TNKS;PAM;CHD3;HHIP;RNF11;CZIB;USP33;CSRP1;ZKSCAN5;PGGT1B;KDM5C;PHF8;GCH1;GRIN2A;MT2A;QPCT;CRIP2;S100A13;CLIP1;PTGR2
prerank,cAMP response element binding (GO:0035497),-0.6124561164139788,-1.4435453140098047,0.08108108108108109,0.45436038716701477,1.0,7/10,29.17%,CREB5;ATF7;CREB3L2;E4F1;JUN;CREB3L1;HMGA2
prerank,cysteine-type peptidase activity (GO:0008234),-0.371998082149822,-1.4434533788055517,0.014925373134328358,0.4438206448813054,1.0,40/73,28.45%,USP40;USP29;CAPN2;MALT1;USP13;PDIA3;USP11;LGMN;OTULIN;CTSO;USP38;USP50;USP34;USP20;USP7;CASP7;USP10;USP1;USP16;CTSZ;USP42;OTULINL;USP5;CASP2;GGH;USP35;USP49;USP2;USP46;CASP9;CASP3;USP24;ATG4D;OTUD7B;CTSK;SFRP1;CTSF;CTSB;CTSC;UCHL1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5079207104767614,-1.4433455714084453,0.06666666666666667,0.4340158229356405,1.0,4/19,4.75%,ITPR1;GRIN2B;RYR3;P2RX4
prerank,neurexin family protein binding (GO:0042043),-0.6190354396788263,-1.4412746065989983,0.06336633663366337,0.4306351349707431,1.0,6/10,25.99%,SYTL2;NLGN2;NLGN1;SYTL5;NLGN3;SYTL4
prerank,phospholipase inhibitor activity (GO:0004859),-0.6259661823942693,-1.4410530654073133,0.07172995780590717,0.4216110551591969,1.0,4/10,12.41%,ANXA2;ANXA4;ANXA1;ANXA5
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.43657405998627513,-1.4350875445517495,0.05152224824355972,0.4300078298656246,1.0,15/33,26.46%,ELP4;WAC;RPRD1B;ERCC5;CDC73;ELP2;WDR43;PAF1;SMYD2;RTRAF;SPTY2D1;GTF2B;ERBB2;ZNF326;SUPT4H1
prerank,chloride channel regulator activity (GO:0017081),-0.563281047699875,-1.434919686064254,0.0784313725490196,0.42120697594580503,1.0,8/14,26.56%,WNK1;STX8;WNK4;SGK1;WNK3;STX1A;VAMP8;CHRNA7
prerank,outward rectifier potassium channel activity (GO:0015271),-0.6045186229790969,-1.4337406926238883,0.08669354838709678,0.4155982003047228,1.0,2/11,2.09%,KCNK2;KCND2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.568534748512091,-1.4326326244377348,0.08024691358024691,0.41014677543776284,1.0,10/13,24.45%,GLRB;GABRA2;GLRA3;GABRG2;GLRA1;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,metal ion binding (GO:0046872),0.35015461249834545,1.4325303744102198,0.0022222222222222222,1.0,1.0,79/477,13.17%,PCK1;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;THG1L;SPOCK2;EFHD2;LCP1;MAP2K7;GCLC;SNRK;CSGALNACT1;EML1;RAP2A;SLC25A24;OXSR1;CABYR;ASTN2;CETN3;PPP3CB;ADGRL3;NUCB2;LTBP4;MEX3B;NUDT5;NME1;NUDT12;ATP2A2;CDH2;ITSN1;ESYT2;MMP12;EFHD1;SDF4;APOE;RASGRP3;CIB1;TDG;RET;SELP;MCTP2;SIK3;CALM3;CDH12;UBA2;RCN2;AIF1L;DXO;EXD2;NIM1K;S100A16;TRPM4;PAPOLA;SRPK2;NLK;MCTP1;PGP;GNAI1;ACER3;PAM;PPP3CA;PRNP;PPP3R1;AGRN;MICU3;ADPRH;LETM1;IDS;SLC25A12;CDH5;MAPK12;HSPE1;RRAGC;GSS
prerank,ligand-gated anion channel activity (GO:0099095),-0.532082286111621,-1.4324641160207272,0.06521739130434782,0.4024582532203652,1.0,11/17,24.45%,GABRB1;GLRB;GABRA2;GLRA3;GABRG2;GLRA1;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.636491768150105,1.432331990054075,0.09487666034155598,1.0,1.0,4/10,18.77%,NAA25;NAA80;NAA15;NAA50
prerank,protein tyrosine kinase activity (GO:0004713),-0.349305353100687,-1.4321375134656233,0.016891891891891893,0.39546094871706705,1.0,25/108,11.07%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;PDGFRB;EPHB1;NTRK2;JAK1;AXL;RYK;FER;EPHA7;ROR1;KIT;TEC;DDR1;PDGFRA;HIPK3;FRK;EPHB4;EPHB2;CSK;EPHA3;HIPK1
prerank,potassium ion leak channel activity (GO:0022841),-0.549690043390417,-1.4279605531478878,0.07349665924276169,0.39808574024382515,1.0,3/15,10.34%,KCNK2;KCNK5;KCNK10
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5688103422871442,-1.42680009499917,0.09183673469387756,0.39359675633339275,1.0,4/13,4.74%,BMP6;BMP5;BMP7;BMP4
prerank,tropomyosin binding (GO:0005523),-0.5449926487480096,-1.4262756633727391,0.07306889352818371,0.38784510527698285,1.0,2/16,2.45%,CALD1;TMOD2
prerank,phospholipase C activity (GO:0004629),-0.4773576951402061,-1.4238824273587245,0.0688836104513064,0.38553363079974673,1.0,10/25,19.67%,PLCE1;PDIA3;EDNRA;PLCD3;CHRM3;PLCB3;PLCH1;PLCL1;PLCD1;BDKRB2
prerank,glutathione transferase activity (GO:0004364),-0.47075622944181617,-1.4208506837207517,0.06683168316831684,0.38568470554145307,1.0,14/23,40.23%,GSTT1;GSTZ1;GSTT2;PTGES;GSTA4;GSTM1;HPGDS;MGST1;GSTA3;GSTM2;MGST3;LANCL1;GSTM5;GSTO1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5753216251794406,1.417432930958193,0.10486891385767791,1.0,1.0,1/14,0.03%,CAPN8
prerank,protease binding (GO:0002020),-0.3511997292217011,-1.4170814022531875,0.02564102564102564,0.38743032936422767,1.0,27/99,12.39%,COL1A2;SLC2A13;TIMP3;COL1A1;CFLAR;TIMP2;NTRK2;COL3A1;PSAP;ANXA2;STIM1;ATP9A;F3;VCP;DPP4;LDLR;ADAMTSL4;CCBE1;BIN1;FAP;DVL3;GSK3B;UBC;FN1;TP53;SRI;ECM1
prerank,acetylcholine receptor activity (GO:0015464),0.530626621467105,1.4137122534104178,0.07625649913344887,1.0,1.0,1/22,0.03%,HRH4
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5929616300727443,1.4110993997250123,0.09351145038167939,1.0,1.0,3/13,9.94%,EBP;ECH1;IDI1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5869046971728832,-1.4081600791320548,0.08478260869565217,0.402480023061849,1.0,8/11,32.78%,ITPR1;TRPC5;TRPC1;ITPR2;RPH3A;TRPC6;TRPC3;TRPC7
prerank,BMP receptor binding (GO:0070700),-0.5688132979641662,-1.4052671380831177,0.10578842315369262,0.40253434517101294,1.0,4/12,4.74%,BMP6;BMP5;BMP7;BMP4
prerank,pyrophosphatase activity (GO:0016462),0.44471747140868295,1.4019054691005393,0.071875,1.0,1.0,9/50,10.80%,NUDT14;BNIPL;NUDT11;FITM2;NUDT5;PLPP1;DXO;PRUNE1;DDX3X
prerank,transmitter-gated ion channel activity (GO:0022824),-0.45745005971003355,-1.401183389257753,0.07058823529411765,0.4057824542622447,1.0,17/29,24.45%,GABRB1;GRIA4;GRIA2;GRID2;GABRA2;GLRA3;GRID1;GABRG2;GRIK4;GABRA5;GABRG3;GABRA4;GRIK1;GRIK3;GRIN2D;GABRG1;GABRA1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4564036392209379,1.3979740935411344,0.07450331125827815,1.0,1.0,14/37,17.80%,FARS2;GARS1;YARS2;IARS1;LARS2;HARS1;NARS2;RARS2;EARS2;WARS2;LARS1;HARS2;WARS1;IARS2
prerank,guanyl ribonucleotide binding (GO:0032561),0.3603839143728069,1.3930501257412897,0.021383647798742137,1.0,1.0,37/196,12.98%,PCK1;THG1L;RAC2;ARF5;RALB;EEF1A1;RAP2A;ARL5C;ARL4D;RERG;RAB5C;NRAS;TUBB;NME1;ATL1;GBP3;RRAD;RAB7A;RAB11B;RALA;GBP4;RAB6A;RAB14;RANBP17;ARL5B;ARF1;RHOQ;MFHAS1;RHOG;DRG2;GNAI1;RAB5B;RAB22A;LANCL2;RAP2C;RIT1;RRAGC
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.5755945962738631,-1.3926302235596122,0.09147609147609148,0.42195689353689386,1.0,1/11,0.75%,HCN1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.4797321566753315,1.3926121901628348,0.08665511265164645,1.0,1.0,15/34,16.46%,REXO2;CNOT2;USB1;CNOT7;EXOSC9;XRN2;EXD2;PAN3;PAN2;CNOT6;CNOT1;CNOT6L;NOCT;ERI2;PARN
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5977504969867723,1.390984679451345,0.1111111111111111,1.0,1.0,1/12,0.99%,GPR52
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4947049796414252,1.3885318852387583,0.08084358523725835,1.0,1.0,7/27,13.47%,POLR2J;POLR2B;POLR1D;POLR1C;TERT;POLR3F;POLR3B
prerank,sodium:proton antiporter activity (GO:0015385),0.5954186539908801,1.3874660987909218,0.10800744878957169,1.0,1.0,3/11,6.96%,SLC9A7;SLC9A6;SLC9A8
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5067240793635542,-1.3826980790803491,0.1022964509394572,0.4331686524845053,1.0,6/17,10.80%,EPHA6;EPHB1;EPHA7;EPHB4;EPHB2;EPHA3
prerank,ephrin receptor activity (GO:0005003),-0.5067240793635542,-1.3826980790803491,0.1022964509394572,0.4331686524845053,1.0,6/17,10.80%,EPHA6;EPHB1;EPHA7;EPHB4;EPHB2;EPHA3
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.48710354583687004,1.3762447445045733,0.09433962264150944,1.0,1.0,4/27,2.49%,POLR2J;POLR2B;POLR1D;POLR1C
prerank,TBP-class protein binding (GO:0017025),0.5112472019346047,1.3736690763849433,0.09363295880149813,1.0,1.0,10/21,15.69%,RUVBL2;PSMC1;DRAP1;RUVBL1;PSMC2;ESR1;GTF2A2;THRA;DR1;TAF1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.33879714741038236,-1.372576502256974,0.0231023102310231,0.452778687485474,1.0,34/100,21.98%,PLA2G4A;IQGAP1;OGT;ADAP2;MAPT;WIPI1;SNX21;GAP43;PLEKHA8;CLVS2;ZFYVE16;CYTH3;OSBP;OSBPL5;PLEKHB2;GAB2;HIP1R;RNF34;FCHSD2;DAPP1;COMMD1;IQGAP2;MYO1B;ARAP3;SNX3;ARFIP2;BBS5;SAP30L;SNX11;GSDMD;OSBPL8;ATG2A;SH3PXD2B;RPH3A
prerank,O-acyltransferase activity (GO:0008374),0.4734352865341047,1.3692112611718976,0.08117443868739206,1.0,1.0,6/30,7.72%,GPAM;LPCAT2;SOAT1;LPCAT3;GPAT4;MBOAT1
prerank,adrenergic receptor binding (GO:0031690),-0.5070645546121004,-1.3689930131116907,0.09803921568627451,0.4560111949577183,1.0,3/16,6.20%,MAGI2;DLG4;ARRDC3
prerank,insulin-like growth factor binding (GO:0005520),-0.5087501694195053,-1.3672611848403942,0.08668076109936575,0.4537429909823157,1.0,6/15,16.10%,IGFBP5;IGFBP2;IGFBP6;IGF2R;IGFBP4;ITGB4
prerank,sterol transfer activity (GO:0120015),-0.5017698825131665,-1.366833270610733,0.10022779043280182,0.4481223790826341,1.0,7/17,18.72%,GRAMD1B;GRAMD1C;OSBP;ABCA1;STARD5;GRAMD1A;MTTP
prerank,solute:proton symporter activity (GO:0015295),-0.510725537469593,-1.3645264210285122,0.10480349344978165,0.4476186510861185,1.0,10/16,36.94%,SLC2A13;SLC25A3;CTNS;SLC39A8;SLC15A4;SLC11A2;SLC2A10;SLC36A1;SLC17A5;SLC2A9
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.6065768641625372,-1.3644113037675174,0.11016949152542373,0.44135169345468755,1.0,4/10,6.12%,CACNA1C;CACNA1D;CACNB4;CACNA1B
prerank,semaphorin receptor activity (GO:0017154),-0.5574090467933422,-1.3632986911284322,0.12804878048780488,0.4380863841659548,1.0,6/11,15.77%,PLXNA2;NRP1;NRP2;PLXND1;PLXNB2;PLXNC1
prerank,GABA receptor activity (GO:0016917),-0.4839612423392635,-1.3629990958258498,0.11564625850340136,0.43262421267092793,1.0,10/21,24.45%,GABRB1;GABRA2;GABRG2;GABBR2;GABRA5;GABRG3;GABRA4;GPR156;GABRG1;GABRA1
prerank,anion:anion antiporter activity (GO:0015301),-0.49738444657132275,-1.3623284807679052,0.11037527593818984,0.4280931822396886,1.0,8/17,31.46%,SLC26A7;SLC26A2;SLC26A11;SLC4A2;SLC19A1;SLC4A3;SLC25A11;SLC25A5
prerank,peptidase inhibitor activity (GO:0030414),-0.42404522668909983,-1.3621686288174688,0.05542168674698795,0.4224691224384714,1.0,8/33,18.38%,TIMP2;TFPI;GPC3;PSMF1;ITIH2;RENBP;CAST;SERPIND1
prerank,GDP binding (GO:0019003),0.41152754261097774,1.3604486987576638,0.06006006006006006,1.0,1.0,20/63,17.51%,RALB;RAP2A;RERG;RAB5C;NRAS;RAB7A;RAB11B;RALA;RAB14;GNAI1;RAB5B;RAB22A;RAP2C;RIT1;RRAGC;MIEF1;ARF6;MRAS;RAB28;RAB27A
prerank,serotonin receptor activity (GO:0099589),0.5023452173608264,1.3590838477356044,0.0933572710951526,0.9919056767872323,1.0,3/22,6.74%,HRH4;HTR1F;HTR2A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5023452173608264,1.3590838477356044,0.0933572710951526,0.9919056767872323,1.0,3/22,6.74%,HRH4;HTR1F;HTR2A
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5023452173608264,1.3590838477356044,0.0933572710951526,0.9919056767872323,1.0,3/22,6.74%,HRH4;HTR1F;HTR2A
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.571126345767264,1.3588866576788838,0.12660550458715597,0.9653817501147893,1.0,4/12,12.24%,SLC9A7;SLC9A6;SLC9A8;LETM1
prerank,dynactin binding (GO:0034452),-0.5609163521819096,-1.3577369459242437,0.11946902654867257,0.4278825297862252,1.0,6/12,21.12%,BICD1;MAPT;HTT;GSK3B;BICDL1;SNX6
prerank,death receptor activity (GO:0005035),0.5888067872964445,1.3546193963125226,0.10707070707070707,0.9611736736121911,1.0,6/11,20.73%,TNFRSF10B;TNFRSF1B;TNFRSF19;TNFRSF1A;TNFRSF11A;FAS
prerank,ligand-gated ion channel activity (GO:0015276),-0.43135097838185305,-1.351499797999493,0.09296482412060302,0.4371733562462291,1.0,5/30,1.54%,GABRB1;GRIA4;GRIA2;GRID2;GRIN2B
prerank,transition metal ion binding (GO:0046914),0.32970922929184865,1.3507264509647579,0.014689265536723164,0.9567228603267811,1.0,78/397,15.49%,PCK1;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;LVRN;RNF7;TRIM28;ARIH1;GYG1;SOD1;TAB2;SHANK3;MYRIP;DUSP12;TRIM8;BIRC2;NUDT12;PHF5A;CA2;SIRT3;MME;MMP12;QPCTL;FBXL5;HPF1;KDM3A;KDM2A;CHMP1A;ZNF205;PIM1;ISCU;BMI1;TET3;ZNF3;TAB3;WDFY1;SOD2;ESCO1;MDM2;MYCBP2;ZDHHC15;EXD2;PARK7;PAPOLA;NQO2;RBSN;NOS3;ACER3;TNKS;PAM;PRNP;CUTC;MGAT5;CHD3;HHIP;RNF11;CZIB;USP33;CSRP1;ZKSCAN5;PGGT1B;KDM5C;PHF8;GCH1;GRIN2A;MT2A;QPCT;IMPA1;CRIP2;S100A13;CLIP1;PTGR2;DYRK2
prerank,ligand-gated channel activity (GO:0022834),-0.43256969138993584,-1.3490478828733905,0.10379746835443038,0.4377743255220178,1.0,5/29,1.54%,GABRB1;GRIA4;GRIA2;GRID2;GRIN2B
prerank,rRNA binding (GO:0019843),0.4413683783150194,1.3480954989019411,0.07923930269413629,0.9456251581988021,1.0,11/42,11.52%,RPL23;FASTKD2;MRPL18;RPS14;RPL5;EMG1;RPLP0;NGRN;MDM2;RPS9;RPS3
prerank,glucuronosyltransferase activity (GO:0015020),0.5244181660957756,1.3467838939441499,0.12341197822141561,0.9299225970822503,1.0,3/19,9.20%,CSGALNACT1;EXT2;B3GAT2
prerank,chloride channel activity (GO:0005254),-0.36745082972665255,-1.3467541387065778,0.0603448275862069,0.43740313156527316,1.0,22/59,27.19%,GABRB1;GLRB;GABRA2;ANO3;CLIC4;SLC26A7;GLRA3;GABRG2;GLRA1;CLCN6;ANO1;CLCN2;ANO6;GABRA5;GABRG3;GABRA4;GABRG1;TTYH3;GABRA1;TTYH1;FXYD1;SLC1A4
prerank,ephrin receptor binding (GO:0046875),0.5104423063290652,1.342363204840423,0.1316270566727605,0.9293132589480412,1.0,6/21,9.31%,PIK3CG;CBL;SRC;FYN;EFNA1;LYN
prerank,cell adhesion mediator activity (GO:0098631),-0.4558002886920039,-1.3420149853087506,0.11363636363636363,0.443246790560277,1.0,7/24,6.72%,LRRC4C;CNTN4;CNTN6;NTNG1;DSCAM;JAM3;PALLD
prerank,poly(U) RNA binding (GO:0008266),-0.4703705774289014,-1.3385105556206591,0.12837837837837837,0.44697424162472355,1.0,7/20,16.15%,RBMS1;HNRNPH1;KHDRBS1;ATXN1;DAZAP1;PABPC4;RBMS3
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.46595166790083564,1.3366387852113681,0.09931506849315068,0.9359149982930773,1.0,10/32,17.97%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC6A6;SFXN1;SLC38A5;SLC25A38;SLC7A5;SLC43A2
prerank,kinesin binding (GO:0019894),0.4633416435115547,1.3351233370839697,0.12758620689655173,0.9217594122037116,1.0,8/27,14.63%,CLSTN1;ACTB;KIFAP3;KIF1B;AP1G1;NEK6;AP1AR;ARHGEF10
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.40726645777044,-1.3326657941680653,0.07862407862407862,0.4555626571446682,1.0,17/35,18.88%,MPPED2;PLCXD3;PLCE1;ENPP1;PDIA3;NAPEPLD;TDP2;ENPP6;SMPD3;PLCB3;PDE11A;PLCL1;GPLD1;PLD3;APEX2;ENPP3;GDPD3
prerank,lipase activator activity (GO:0060229),0.5830218380048356,1.3318931858577332,0.14754098360655737,0.9167065159563182,1.0,2/10,4.94%,SRC;FYN
prerank,water transmembrane transporter activity (GO:0005372),-0.561860501323998,-1.3268195784137984,0.13617021276595745,0.4634194036369353,1.0,3/11,24.93%,PDPN;AQP4;AQP11
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.3315831246393008,-1.3261730498911357,0.05723905723905724,0.4594503412971335,1.0,31/91,22.43%,SVIL;GSN;ADAP2;TULP3;SNAP91;ANXA2;SYTL2;MAPT;FRMPD4;WIPI1;SNX21;GSDME;KCNJ2;CLVS2;ACTN2;HIP1R;SYT7;COMMD1;MYO1B;EXOC1;PLCD1;TWF2;SNX3;SNX18;GSDMD;FZD7;VILL;SH3PXD2B;PFN2;RPH3A;AMER1
prerank,retinoid X receptor binding (GO:0046965),0.5695697917947451,1.3228924802416802,0.14575645756457564,0.9404160367587765,1.0,3/11,10.52%,ARID5A;NR4A2;TACC1
prerank,galactosyltransferase activity (GO:0008378),-0.5527238267024495,-1.3224711984641273,0.146,0.4629719622218936,1.0,8/11,33.67%,A4GALT;B4GALT1;B4GALT6;B4GALT4;B4GALT7;B4GALT3;B4GALT2;B4GALT5
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.3458545354620017,-1.3222436317162602,0.06818181818181818,0.4578640163905012,1.0,26/72,22.43%,SVIL;GSN;ADAP2;TULP3;SNAP91;ANXA2;SYTL2;FRMPD4;SNX21;GSDME;KCNJ2;ACTN2;HIP1R;SYT7;COMMD1;MYO1B;EXOC1;PLCD1;TWF2;SNX18;GSDMD;FZD7;VILL;PFN2;RPH3A;AMER1
prerank,metal ion:proton antiporter activity (GO:0051139),0.5531359547576556,1.317253269183042,0.1654275092936803,0.9472185731538568,1.0,4/13,12.24%,SLC9A7;SLC9A6;SLC9A8;LETM1
prerank,magnesium ion binding (GO:0000287),0.3586377471662781,1.3095777748868902,0.06784260515603799,0.9646722866049332,1.0,26/135,13.66%,PCK1;THG1L;MAP2K7;GCLC;SNRK;RAP2A;OXSR1;NUDT5;NME1;NUDT12;TDG;SIK3;UBA2;DXO;EXD2;NIM1K;PAPOLA;SRPK2;NLK;PGP;GNAI1;ADPRH;MAPK12;RRAGC;GSS;NEK6
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3313854895345324,1.304832287149056,0.03717026378896882,0.967837896104917,1.0,49/248,13.12%,RAC2;DYNC1I1;RALB;DNM3;ABCB10;EEF1A1;RAP2A;PIN1;RUVBL2;GNAQ;RERG;RAB5C;NRAS;ATL1;GBP3;RAB7A;RAB43;RAB11B;RALA;VWA8;GBP4;GNB1;RAB6B;HBS1L;IFT22;RAB6A;RAB14;RUVBL1;GNA12;DNAJC27;GNA11;KIF15;RAB1A;KIF2A;RHOQ;DDX3X;EFTUD2;RHOG;DRG2;GNAI1;RAB5B;RAB22A;RAP2C;EFL1;TBC1D24;CHD3;RIT1;RRAGC;MYO1E
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.40742719008968536,1.3036513076620238,0.11028315946348734,0.9535401489169272,1.0,18/49,18.05%,ZRANB3;ABRAXAS1;RAD18;TNFAIP3;TAB2;UBL7;TAB3;SPRTN;RAD23A;UBQLN1;TNIP2;BRCC3;MINDY2;UBQLN4;UFD1;UBQLN2;RAD23B;AGAP3
prerank,phospholipase activator activity (GO:0016004),0.5757093855360806,1.2989327105826396,0.1659919028340081,0.957295701011729,1.0,2/10,4.94%,SRC;FYN
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5524729002230031,-1.2942434884010796,0.15942028985507245,0.525100433801106,1.0,8/10,38.80%,PML;FAN1;DNAJB2;ANKRD13D;ANKRD13B;LAPTM5;FAAP20;IDE
prerank,adenylyltransferase activity (GO:0070566),0.4817200041128878,1.2918693562746715,0.1412639405204461,0.9720241892337561,1.0,10/21,21.52%,GPHN;FLAD1;TENT4A;PAPOLA;NMNAT1;SELENOO;PAPOLG;COASY;TENT2;MTPAP
prerank,AMP binding (GO:0016208),-0.5466807733027946,-1.288776032845327,0.16075156576200417,0.533486278878135,1.0,4/11,6.30%,PRKAG2;MPPED2;PRKAG1;ACSS2
prerank,semaphorin receptor binding (GO:0030215),0.47324848581830536,1.2887391712304674,0.14664310954063603,0.9686647781714189,1.0,6/23,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,syntaxin-1 binding (GO:0017075),-0.4359673242821752,-1.288610451053109,0.14446952595936793,0.5278649032868398,1.0,13/22,35.93%,SNAP25;STXBP5;UNC13C;STXBP1;SNPH;UNC13B;VAMP2;DAPK1;CPLX1;SYP;SYNPR;UNC13A;CPLX2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.4315956117013098,-1.2866272685335092,0.14676616915422885,0.5273001945760719,1.0,12/25,30.08%,MICAL2;CYP27A1;MICAL3;MSMO1;CYP26B1;FMO2;FMO5;MTRR;MICAL1;SQLE;POR;NOS1
prerank,symporter activity (GO:0015293),0.5696673619705838,1.2845316052902158,0.17286245353159851,0.9704412744853628,1.0,1/10,0.82%,SLC4A4
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5501584355339324,1.2835853824071237,0.18582375478927204,0.9569291778794364,1.0,4/11,15.70%,RDH13;RDH11;RDH14;AKR1A1
prerank,GABA-A receptor activity (GO:0004890),-0.47712198937317757,-1.2812040232439021,0.16470588235294117,0.5355231524202683,1.0,8/18,24.45%,GABRB1;GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,GABA receptor binding (GO:0050811),-0.5431965850869513,-1.2810101324606333,0.16356107660455488,0.5299885826793219,1.0,3/11,6.93%,ARFGEF2;PLCL2;TRAK1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3107980912633482,1.2788075896752698,0.02783964365256125,0.9614523619889371,1.0,92/431,15.88%,PCK1;THG1L;RAC2;ARF5;SNRK;PPIP5K2;RALB;EEF1A1;RAP2A;HSPA8;OXSR1;HSPA4L;ARL5C;ARL4D;NEK11;PNKP;RPS6KA4;RERG;PYGL;RPS6KA5;NRAS;TUBB;NME1;ATL1;GBP3;RRAD;RAB7A;MLKL;RAB11B;RALA;TDG;PEX1;MTHFS;YARS2;GBP4;PRPS1L1;PRPS1;ABCF1;SIK3;CDK11B;LONP1;PIM1;HARS1;UBA2;RAB6A;SYN3;RAB14;PEAK1;MINK1;RANBP17;ACVRL1;LATS2;ARL5B;ARF1;RHOQ;NIM1K;MFHAS1;PAPOLA;SRPK2;NLK;P2RX7;RHOG;DRG2;OLA1;PNPLA8;GNAI1;RAB22A;LANCL2;PRKCI;RAP2C;MYO9B;MAP4K4;ABCF2;RIT1;RRAGC;NDUFA13;GSS;PPP5C;TLK2;NEK6;PTPA;GCH1;TWF1;ABCF3;RRM1;DYRK2;ARF6;CDKL5;TOP1;MYH9;MRAS;TUBA1B
prerank,chloride channel inhibitor activity (GO:0019869),-0.5559573125562747,-1.2786054583383601,0.1726315789473684,0.5299972904190191,1.0,6/10,23.91%,WNK1;STX8;WNK4;WNK3;STX1A;VAMP8
prerank,calcium-release channel activity (GO:0015278),-0.4713472956664684,-1.2746626182465777,0.1492204899777283,0.5344027208859599,1.0,5/17,22.76%,ITPR1;RYR3;TPCN1;ITPR2;MCOLN1
prerank,FAD binding (GO:0071949),-0.4267413808987215,-1.2729600065513713,0.1480637813211845,0.5330563732511935,1.0,13/24,27.36%,MICAL2;DDO;MICAL3;CRY2;MTHFR;CRY1;SQOR;PRODH;QSOX1;KDM1B;MTRR;MICAL1;SQLE
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5266522426381071,-1.2712058069544168,0.18604651162790697,0.5318879208150461,1.0,8/12,19.93%,TGFBR3;TGFBR1;TGFBR2;ACVR1;LTBP1;BMPR1B;BMPR1A;BMPR2
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.46360007182758434,-1.269848054590043,0.16033755274261605,0.5299810620171677,1.0,5/18,8.66%,TGFBR3;SMAD3;TGFBR1;TGFBR2;SMAD6
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.35120314070181335,-1.2692247350802122,0.09037900874635568,0.5260436108000498,1.0,10/55,9.99%,SLC24A3;ITPR1;MCU;CACNA1D;PKD1;ANXA2;TRPC5;SEC61A1;TRPC1;SLC24A2
prerank,ATPase binding (GO:0051117),-0.33365819124424,-1.2682659042288023,0.0981012658227848,0.5231636205405474,1.0,19/71,12.07%,ANK2;SLC2A13;EGFR;SNTA1;TMTC4;TOR1AIP2;ATP1B1;ATP6V1E1;ATP1B3;PTPN3;TRPC1;TOR1AIP1;EZR;ZNHIT6;ATP1B2;CLPP;TCIRG1;ATP6V0A4;ABCA1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.49065261278450356,-1.2657402732001786,0.17660044150110377,0.5245536275741254,1.0,5/14,3.54%,SPOCK3;TIMP3;SPOCK1;TIMP2;COL4A3
prerank,cGMP binding (GO:0030553),-0.5255122407453943,-1.2641557252737512,0.16810344827586207,0.5233411253399,1.0,4/11,26.26%,PDE5A;PDE11A;RAPGEF2;PDE2A
prerank,ubiquitin-specific protease binding (GO:1990381),0.4956940308262708,1.2639104065346403,0.19607843137254902,1.0,1.0,5/19,10.24%,DERL2;SPATA2;RAD23A;PARK7;RHBDD2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3589501731060772,-1.2629355723548452,0.11206896551724138,0.5211123553564763,1.0,16/48,24.85%,TRPM3;NALCN;UNC80;SLC41A1;TRPM6;PIEZO2;SLC12A2;TRPC1;ABCC9;SLC12A6;SLC12A4;TRPC6;MCOLN1;DMAC2L;SLC12A7;CALHM5
prerank,MAP kinase kinase activity (GO:0004708),0.5081574894797798,1.261022004463545,0.2015065913370998,1.0,1.0,4/15,6.54%,MAP2K7;MAP2K5;MAP3K9;PAK3
prerank,N-acyltransferase activity (GO:0016410),0.44092296428377553,1.260922163089366,0.15593220338983052,0.9963491699335651,1.0,7/32,12.78%,CERS1;CERS4;PLAAT3;EP300;SIRT1;ESCO1;NAA80
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.32526814455059905,-1.2605122700413016,0.08024691358024691,0.5215784989938069,1.0,42/78,29.73%,CFLAR;USP40;USP29;CAPN2;MALT1;USP13;PDIA3;USP11;LGMN;CASP12;CTSO;USP38;USP34;USP20;USP7;CASP7;USP10;USP1;USP16;CTSZ;USP42;USP5;CAPN15;CASP2;USP35;USP49;CAPN1;USP2;USP46;CASP9;CASP3;USP24;CTSK;CAPN10;SFRP1;CAPN5;CTSF;CTSB;CTSC;UCHL1;GPAA1;CTSS
prerank,phospholipase binding (GO:0043274),0.529541707417861,1.2591421837510215,0.19962335216572505,0.9879381377960531,1.0,3/13,6.70%,SRC;FYN;SYK
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.4445066103516375,-1.2580265750222117,0.18820861678004536,0.5227919926941669,1.0,4/19,6.32%,GRM5;EFNA5;ABI1;ERCC6
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5601263722097896,1.2572718954622615,0.19678714859437751,0.9809981835722207,1.0,7/10,19.28%,TNFAIP3;YOD1;DESI2;OTUD5;OTUD4;ATXN3;STAMBP
prerank,Wnt-activated receptor activity (GO:0042813),-0.47803515261186186,-1.2569684572927375,0.22520661157024793,0.5202021434890012,1.0,6/15,10.31%,PKD1;FZD6;RYK;ROR1;LRP5;FZD2
prerank,GTPase activity (GO:0003924),0.32579213849534105,1.254393144091746,0.07320099255583126,0.9784210828598939,1.0,39/192,12.98%,RAC2;RALB;DNM3;EEF1A1;RAP2A;GNAQ;RERG;RAB5C;NRAS;ATL1;GBP3;RAB7A;RAB43;RAB11B;RALA;GBP4;GNB1;RAB6B;HBS1L;IFT22;RAB6A;RAB14;GNA12;DNAJC27;GNA11;RAB1A;RHOQ;DDX3X;EFTUD2;RHOG;DRG2;GNAI1;RAB5B;RAB22A;RAP2C;EFL1;TBC1D24;RIT1;RRAGC
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.39824985028966486,-1.254381172226719,0.16744186046511628,0.5214055349595926,1.0,12/27,23.50%,ITPR1;SLC41A1;MRS2;SLC12A2;KCNA1;SLC9B2;MAGT1;ITPR2;SLC11A2;CNNM2;ATP2B3;SLC4A8
prerank,aspartic-type peptidase activity (GO:0070001),-0.520349472646163,-1.254182893893173,0.1975560081466395,0.5170076267880996,1.0,4/10,13.99%,BACE2;BACE1;CTSD;DDI2
prerank,regulatory RNA binding (GO:0061980),-0.37486357731734254,-1.2517822826329976,0.1525,0.5179316841523228,1.0,11/38,14.65%,ZC3H7A;PUM1;ZC3H7B;PUM2;HNRNPA2B1;AGO3;HNRNPA1;RBM4;DDX21;DICER1;ZNF346
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5395256460848167,-1.250164172948796,0.16865079365079366,0.5171995145797539,1.0,7/10,33.67%,B4GALT1;B4GALT6;B3GALT5;B3GALT1;B4GALT7;B3GALT2;B4GALT5
prerank,insulin-like growth factor I binding (GO:0031994),-0.4915163857370074,-1.2500985104523785,0.1843817787418655,0.5126487844870513,1.0,5/13,16.10%,IGFBP5;IGFBP2;IGFBP6;IGFBP4;ITGB4
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3682464776911777,1.24983543001014,0.13153961136023917,0.983609115562563,1.0,17/69,16.50%,CERS1;ZDHHC17;CERS4;ZDHHC13;PLAAT3;SOAT1;EP300;LPCAT3;ZDHHC14;ESCO1;ZDHHC15;CREBBP;ZDHHC9;ZDHHC7;NAA15;MBOAT7;ELP3
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5167421220008871,-1.2496306968352633,0.2085889570552147,0.5090396245734605,1.0,8/12,24.45%,GABRB1;GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.5154284075851008,1.2495400260887908,0.21568627450980393,0.9692282829871092,1.0,2/14,0.92%,ALDH1L1;AASS
prerank,nuclear receptor binding (GO:0016922),0.3422871471460185,1.2482872735331387,0.12536023054755044,0.9605062084486004,1.0,29/111,14.55%,DCAF1;ARID5A;NR4A2;GAS2L1;LEF1;DDX54;RERG;SRARP;CCDC62;PHB2;KDM3A;EP300;MED12;ACTN4;SIRT1;GTF2H1;PKN1;PARK7;RNF6;BUD31;WBP2;ESR1;TACC1;MED4;JMJD1C;YWHAH;NCOA7;CNOT1;BAZ2A
prerank,anion channel activity (GO:0005253),-0.3319860467870064,-1.2478952920769297,0.11864406779661017,0.508907793735278,1.0,12/61,7.73%,GABRB1;GLRB;GABRA2;ANO3;CLIC4;LRRC8D;SLC26A7;LRRC8B;VDAC1;GLRA3;GABRG2;GLRA1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.42693676840135186,-1.2469560389398973,0.16666666666666666,0.5065032917301082,1.0,8/23,19.67%,PLCE1;EDNRA;PLCD3;CHRM3;PLCB3;PLCH1;PLCD1;BDKRB2
prerank,chemorepellent activity (GO:0045499),0.44518461725018404,1.2438656450964718,0.1945392491467577,0.9660696406088592,1.0,6/25,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.545989639902011,1.2438404390289919,0.20610687022900764,0.9515658593174525,1.0,4/11,11.12%,PRMT3;FBXO11;PRMT9;CARM1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.5430849131810583,1.2433561744148587,0.21223709369024857,0.9395749847950599,1.0,4/11,18.77%,NAA25;NAA80;NAA15;NAA50
prerank,cation transmembrane transporter activity (GO:0008324),0.40141229709199305,1.2418590273328876,0.15625,0.93263217612056,1.0,12/48,17.21%,SLC7A8;SLC1A1;SLC36A4;SLC39A1;SLC3A2;SLC6A6;SLC25A2;SFXN1;SLC38A5;SLC66A1;SLC25A38;SLC7A5
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.45835769717738517,-1.2405488995298515,0.1961206896551724,0.5177431988240373,1.0,9/18,19.93%,TGFBR3;TGFBR1;TGFBR2;ACVR1;LTBP1;ACVR1B;BMPR1B;BMPR1A;BMPR2
prerank,endopeptidase activity (GO:0004175),-0.2725827803579975,-1.2399401547220052,0.05660377358490566,0.5145581382216782,1.0,78/257,22.88%,TRABD2B;NRDC;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;USP40;USP29;PCSK2;PCSK5;MMP16;ADAMTS6;ADAMTSL5;MALT1;ADAMTS17;MMP14;USP13;BACE2;ADAMTS9;F3;RHBDL3;ADAM19;ADAMTS5;PDIA3;USP11;RHBDD1;HTRA3;DPP4;NLN;TPP2;ADAMTS1;PSMA2;ADAMTSL4;BACE1;PSMA6;FAP;LGMN;CLPP;PREP;PSMA1;ADAMTS3;CTSO;USP38;PIK3IP1;USP34;AFG3L2;PCSK6;USP20;PSMA5;DDI2;ADAMTS10;USP7;MBTPS2;CASP7;USP10;USP1;USP16;CTSZ;USP42;PSMB3;ACE;PITRM1;USP5;ADAMTS15;ADAMTS16;SPG7;MMP2;ADAM33;CASP2;ADAMTS20;RHBDF1;USP35;USP49;KLK2;USP2;USP46;CASP9;CASP3
prerank,miRNA binding (GO:0035198),-0.39693509530621596,-1.2395356553201098,0.16904761904761906,0.5111520587689088,1.0,10/30,14.65%,ZC3H7A;PUM1;ZC3H7B;PUM2;HNRNPA2B1;AGO3;HNRNPA1;RBM4;DDX21;ZNF346
prerank,mRNA 3'-UTR binding (GO:0003730),-0.31978837317665076,-1.237403784359179,0.10126582278481013,0.5118107260891307,1.0,26/79,20.36%,CELF2;DDX5;RBMS1;CPEB4;CPEB1;CPEB2;ELAVL2;PUM1;ELAVL4;YBX3;PUM2;HNRNPA2B1;SECISBP2;ELAVL3;TP53;RBM4;RPS7;DAZAP1;CSDC2;PABPC4;RBMS3;RNPS1;CIRBP;HNRNPA0;RNF40;IGF2BP2
prerank,cholesterol transfer activity (GO:0120020),-0.46827525974788897,-1.2359680424036115,0.17523364485981308,0.5104927041645143,1.0,6/16,18.72%,GRAMD1B;GRAMD1C;ABCA1;STARD5;GRAMD1A;MTTP
prerank,motor activity (GO:0003774),0.3755068083422942,1.2354904692531028,0.1435114503816794,0.9463046088214141,1.0,15/60,15.74%,DYNC1I1;KIF18A;PIN1;DNAH3;KIF1B;KIF15;STARD9;KIF2A;KIF13A;MYO1E;KIF3B;KIF6;APPBP2;DYNC1I2;MYH9
prerank,pre-mRNA binding (GO:0036002),-0.3930439114926839,-1.2332489505867623,0.15261958997722094,0.5131242603828122,1.0,9/28,16.92%,CELF2;DDX5;CELF4;SRSF6;RNPC3;HNRNPA1;RBM4;SLU7;RBM7
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.33728534045135566,-1.2325724490536683,0.13157894736842105,0.510281736224837,1.0,16/55,19.20%,SLC16A12;SLC6A13;SLC13A3;SLC7A2;PDPN;SLC16A7;SLC7A14;SLC6A12;SLC22A4;SLC25A32;SLC38A11;SLC16A11;SLC19A1;SLC16A2;SLC38A7;SLC16A9
prerank,U6 snRNA binding (GO:0017070),0.5013130373351731,1.2319058124312026,0.21083172147001933,0.9486369070140132,1.0,2/14,1.26%,EIF5A;RBM22
prerank,protein tyrosine phosphatase activity (GO:0004725),0.35406957009421297,1.2230230362420116,0.15294117647058825,0.973947506416,1.0,15/71,11.62%,PTPRR;PTPN18;PTPRG;PTPRJ;PTPRC;PTPRM;PTPRB;PTPRE;PTP4A2;PTPN12;PTPRT;EYA3;DUSP11;PGP;HACD2
prerank,phosphatidate phosphatase activity (GO:0008195),-0.4791682079368633,-1.2208882836991664,0.21902654867256638,0.5341115084923446,1.0,9/13,30.95%,PLPPR1;PLPP3;PLPPR5;LPIN1;PLPPR4;LPIN2;PLPP5;LPIN3;PLPPR2
prerank,poly-pyrimidine tract binding (GO:0008187),-0.40972616057830413,-1.2201531990902523,0.18620689655172415,0.5313850329020732,1.0,7/23,16.15%,RBMS1;HNRNPH1;KHDRBS1;ATXN1;DAZAP1;PABPC4;RBMS3
prerank,exonuclease activity (GO:0004527),0.3954426802058663,1.2156910893636923,0.179080824088748,0.9948555019963234,1.0,12/46,13.15%,AEN;REXO2;RAD1;APLF;DCLRE1B;CNOT7;EXOSC9;XRN2;DXO;EXD2;CNOT6;EXOSC1
prerank,filamin binding (GO:0031005),-0.5107146074981547,-1.2148081790998835,0.2266949152542373,0.5396701723420495,1.0,8/11,38.50%,DPYSL3;SYNPO2;CEACAM1;FBLIM1;CRMP1;MICALL2;RFLNA;RFLNB
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4655930223044188,-1.2134540063122439,0.210752688172043,0.5383994401704058,1.0,5/15,23.50%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A8
prerank,muscle alpha-actinin binding (GO:0051371),-0.45606621136300296,-1.2119694845837266,0.2405857740585774,0.537444026852109,1.0,7/15,21.97%,PDLIM5;PDLIM7;PALLD;SYNPO2;PDLIM1;PDLIM2;PDLIM4
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3612015937458717,-1.209078417809501,0.1806615776081425,0.5396531077243101,1.0,12/37,18.44%,SLCO3A1;SLC22A8;SLC16A7;CYB5A;UQCRH;SLC22A4;COX8A;UQCRC1;NDUFA4;SLC22A6;COX7A2L;COX6A1
prerank,tRNA methyltransferase activity (GO:0008175),0.48291370698933045,1.2082500045546418,0.21165048543689322,1.0,1.0,4/16,11.84%,BCDIN3D;THUMPD2;METTL2B;METTL2A
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.39794858185394577,-1.20509182267705,0.19950124688279303,0.5455586779071323,1.0,12/26,23.56%,SLC16A12;SLC6A13;SLC6A1;SLC16A7;SLC6A12;SLC27A1;SLC16A11;SLC16A2;SLC5A6;SLC16A9;SLC16A4;SLC6A11
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.40701743396344475,-1.2044744678497337,0.18876404494382024,0.5426484942003968,1.0,8/25,18.34%,ADAP2;PLEKHA2;GAB2;HIP1R;FCHSD2;DAPP1;COMMD1;ARAP3
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.46261608941266896,-1.2027028589557383,0.2340909090909091,0.5427575741796036,1.0,1/15,1.27%,PLA2G4A
prerank,phosphatidylinositol kinase activity (GO:0052742),0.487571908867903,1.200426737747359,0.2388888888888889,1.0,1.0,6/15,14.60%,PIK3CG;PIK3C2G;PIKFYVE;PI4KA;PIK3CD;PIK3C2A
prerank,WW domain binding (GO:0050699),0.4263111211773216,1.1973067219897782,0.23809523809523808,1.0,1.0,2/26,4.98%,PRRG4;TCEAL9
prerank,alpha-actinin binding (GO:0051393),-0.40016991611703745,-1.1954673245233376,0.1952941176470588,0.5559901610710839,1.0,8/24,13.62%,CACNA1C;PDLIM5;CACNA1D;PDLIM7;PALLD;SYNPO2;RARA;PDLIM1
prerank,carboxypeptidase activity (GO:0004180),-0.36026963841476883,-1.1936062845782223,0.17632850241545894,0.5561300704295289,1.0,9/35,16.79%,AEBP1;AGBL4;PEPD;AGBL3;SCPEP1;CPM;CTSA;NAALAD2;CTSZ
prerank,clathrin adaptor activity (GO:0035615),-0.4453892620822356,-1.1929687539433411,0.24066390041493776,0.5535608622891262,1.0,7/15,13.04%,DAB2;AP2B1;AP2A2;STON2;AP2A1;STON1;HIP1R
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.4478858335816936,-1.1908157925710543,0.25379609544468545,0.5544579207525557,1.0,9/17,30.02%,DPYD;TECR;BLVRA;BLVRB;LBR;SRD5A3;DECR2;PECR;DHCR24
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5279602415761384,-1.1899965229258305,0.2520491803278688,0.5525602962797918,1.0,7/10,24.45%,GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,transcription coregulator binding (GO:0001221),0.3704988206581475,1.1898610816335158,0.21150592216582065,1.0,1.0,16/50,13.66%,EZH2;RPL23;EED;HDAC3;UBE2I;CNOT2;PPARD;RELA;LMO2;ESR1;TERT;THRB;CTBP1;HDGF;CTBP2;NEK6
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.503800368944903,1.1895021956670904,0.2543689320388349,1.0,1.0,6/13,17.83%,PRKAR1A;GSK3A;PJA2;PKIA;RYR2;PRKAR2A
prerank,epidermal growth factor receptor binding (GO:0005154),-0.4023358645296853,-1.18869911712155,0.22453703703703703,0.5517284728650632,1.0,8/25,12.24%,ERBB4;SNX2;SNX4;FER;EFEMP1;CNOT9;PLSCR1;GRB2
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.34797209427080766,-1.188563219162565,0.18203309692671396,0.5479426380111108,1.0,2/38,0.17%,MAGI2;SORBS1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.42622283424927576,1.1878488489477874,0.225130890052356,1.0,1.0,4/27,6.96%,SLC9A7;SLC3A2;SLC9A6;SLC9A8
prerank,CXCR chemokine receptor binding (GO:0045236),0.5078555653175315,1.1859734605482484,0.2555147058823529,1.0,1.0,1/11,2.58%,CXCL12
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.33565834792830634,-1.1857228126240846,0.1745152354570637,0.551028432702107,1.0,15/49,14.55%,ANXA3;PLA2G4A;CPNE8;PCLO;ANXA2;ANXA4;SYT9;ESYT1;ANXA1;ANXA5;SYT12;SYT11;SYT4;CPNE2;SYT7
prerank,Tat protein binding (GO:0030957),0.530260073576849,1.1846804483500608,0.27586206896551724,1.0,1.0,6/10,19.08%,ACTB;MDFIC;GABARAPL1;SMARCA4;NPM1;SMARCB1
prerank,death receptor binding (GO:0005123),-0.45175140968544925,-1.1837666135239857,0.22755741127348644,0.5514469220255873,1.0,5/15,17.90%,EDA;CASP8AP2;MADD;NGF;TMBIM1
prerank,neuropeptide binding (GO:0042923),-0.4256874247536371,-1.1799242060117974,0.24504950495049505,0.5563821793287439,1.0,4/18,22.54%,SORL1;GPR37;OPRM1;GPR149
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.41323534246675003,1.1784897673625983,0.2281303602058319,1.0,1.0,6/28,10.32%,MAP2K7;RPS6KA1;MAP2K5;MAP3K9;PAK3;PRKAA2
prerank,transcription corepressor binding (GO:0001222),0.4148048658088235,1.1780057524599301,0.24408014571949,1.0,1.0,10/27,15.78%,EZH2;EED;HDAC3;CNOT2;ESR1;CTBP1;HDGF;CTBP2;NEK6;WIZ
prerank,cyclic nucleotide binding (GO:0030551),-0.4012498085358833,-1.1704647592630357,0.22706422018348624,0.5757159029562107,1.0,6/21,16.22%,HCN1;PDE5A;PDE11A;PDE4B;SLC19A1;RAPGEF2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3991037644663775,1.1696319467170697,0.24787775891341257,1.0,1.0,12/33,16.46%,REXO2;USB1;CNOT7;EXOSC9;XRN2;EXD2;PAN2;CNOT6;CNOT6L;NOCT;ERI2;PARN
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5187190327943384,1.1677131652986183,0.26666666666666666,1.0,1.0,3/11,6.61%,PFN1;BAG1;GRPEL2
prerank,adenyl nucleotide binding (GO:0030554),0.5187190327943384,1.1677131652986183,0.26666666666666666,1.0,1.0,3/11,6.61%,PFN1;BAG1;GRPEL2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4044912853085631,1.1655687566530455,0.24528301886792453,1.0,1.0,5/29,5.65%,PRKAR1A;RPTOR;SPRED1;CIB1;CDKN1A
prerank,RNA binding (GO:0003723),0.2707574995663014,1.162643542544639,0.041666666666666664,1.0,1.0,368/1321,19.41%,THG1L;LRRFIP1;SORBS2;MAZ;CMSS1;SNRPD2;ZC3H12D;RPS19BP1;NCBP1;RPL30;EIF5A;ILF3;THUMPD1;UTP20;RSRC2;SYNE1;KHDRBS3;RBM22;FAU;RALYL;TRIM28;RSL24D1;EEF1A1;RPP25L;UTP18;HSPA8;POLR2B;MRPL23;RPL17;RPL23;PATL2;EIF2S1;EIF2A;FASTKD2;RPL31;PRPF31;PRPF3;RPL3;SNRPD1;RPS21;HNRNPH2;DDX54;MANF;DDX10;LARP4B;PCBP1;NAP1L4;FLNB;MEX3B;FARS2;UBA1;PPIB;IFIT1;NUDT5;NME1;PHF5A;ZFP36L1;HNRNPAB;SLC3A2;GOT2;SF1;QKI;PRPF40A;PFN1;EIF3B;RBBP6;SMG1;HNRNPK;YY1;PPIG;METAP2;RPL35A;SEC23IP;PSMC1;SAMSN1;FAM50A;MYO5A;UBE2I;CPSF4;MYEF2;RPS14;FXR1;NFX1;RTCA;RPL8;CHTOP;YARS2;RPL5;SRSF10;ABCF1;SSBP1;RO60;POLR1G;MRPS12;RPS12;CDK11B;RBM20;SLC4A1AP;SFPQ;LONP1;RPS26;ACTN4;RPL37A;HNRNPC;TXN;ZNF638;GEMIN5;MAP4;CS;SMNDC1;FAM120C;PUS10;ADAR;YTHDC1;IMMT;PYM1;ELP1;ZFR;TRMT10B;FYTTD1;RPL4;RARS2;SRSF4;RBM34;EMG1;TRIM25;MRPL20;SECISBP2L;EIF4H;SNU13;XPO5;POP5;RPLP0;NOVA2;SARNP;DHX32;EXOSC9;NGRN;SF3A1;XRN2;ARF1;PCID2;BCLAF1;DXO;FBRSL1;PATL1;PARK7;SUCLG1;AKAP8L;SYF2;TARDBP;ZMAT3;TSFM;RPS28;U2AF1;CPSF6;TAF15;RPS24;RRP7A;DUSP11;S100A16;ASCC3;FAM133B;GLRX3;EIF4G2;CCAR2;RBM45;BCCIP;NCBP3;TERT;SRPK2;RPS9;RPS23;RPL24;DDX3X;ADARB2;RPL34;NGDN;CISD2;EFTUD2;FAM32A;ERH;TDRD3;NANOS3;MATR3;APTX;DRG2;AGO4;HELZ;EIF4B;RPS11;RPS3;PA2G4;ANKHD1;ZBED4;PTBP1;DDX27;HDGF;PCBP3;MRPS15;ACO1;NUFIP2;ILF2;MRPS24;CRKL;FKBP4;G3BP2;ARCN1;ZC3H14;RBM10;API5;SRFBP1;STRAP;NDUFV3;CHD3;HELB;HSPE1;TUT7;RRP8;RNMT;EXOSC1;PPHLN1;UTP11;DDX55;HEATR6;CSRP1;ANKRD17;RPS15A;RBM26;RPL23A;PTCD1;RPL21;SRP9;RPL35;YBX1;SRSF7;PURG;HEATR1;CNOT1;TASOR;CAPRIN1;BAZ2A;SCAF8;DCP1A;ATP5F1C;UCHL5;SNRPA;FUS;TFAM;SSB;PTCD2;PCDHGA9;TUT4;MRPS28;MRPS35;LARP1B;EIF5;TCF20;RBM4B;SF3B6;MOV10;PPP1R8;HNRNPL;NOCT;NKAP;TCERG1;TRA2B;TOP1;ADARB1;ANG;MYH9;SLBP;TUBA1B;TCP1;PRKRIP1;TDRD7;UPF3B;EIF1AX;DKC1;U2AF2;RSL1D1;PURB;ZCCHC17;OTUD4;NSUN6;NAA15;ENDOV;HARS2;PARN;ACAA2;WDR33;N4BP1;LARP4;PRKDC;KPNB1;SPATS2;LSM1;CALR;RPL19;STAU2;SERPINH1;NONO;URB1;NPM1;RPL38;EIF2S2;SNRPA1;HNRNPF;CKAP4;UBAP2;RANGAP1;EIF3A;RPL36;RCC1L;YTHDC2;DCAF13;SMG6;STAT3;RPSA;ZC3H13;DHX8;DDX23;TSNAX;RPL26;LUC7L2;RPS8;SMG5;HEXIM1;SAFB;MYO18A;RPL15;RPL10;NUP42;HDAC2;RDX;CCDC47;PDIA4;USP36;DDX60;RPL32;ZYX;SNRPD3;MRPS9;RC3H1;RPS2;ZNF106;NSUN2;NSRP1;EIF4G1;CLUH;TRIM56;PRRC2C;PRRC2B;MRPL13;TFRC;DHX36;TOP3B;TFB1M;YWHAE;RPL27A;HNRNPM;TRNT1;EIF3E;NOP58;LARP1;NVL;DCP1B;MTIF2
prerank,GTPase inhibitor activity (GO:0005095),-0.44770724703978126,-1.1622196069246367,0.2719836400817996,0.5925509544824578,1.0,7/13,29.16%,CPEB2;IQGAP1;IQGAP2;CDC42SE1;ARL2;RHOH;RTKN
prerank,store-operated calcium channel activity (GO:0015279),-0.49908231849407503,-1.1619542820144473,0.2727272727272727,0.5889280608184452,1.0,3/10,8.60%,STIM2;TRPC5;TRPC1
prerank,actin binding (GO:0003779),-0.2661499944180639,-1.157630653810724,0.09829059829059829,0.5953562725026219,1.0,29/170,8.83%,SORBS1;CALD1;MAP1B;PAWR;KCNMA1;PDLIM5;GSN;SYNE2;PARVA;MICAL2;PLEKHH2;LIMA1;PACRG;MOBP;MAPT;TPM1;MACF1;MTSS1;PDLIM7;MICAL3;FMN2;VCL;ARPC1A;COBL;TLN2;P4HB;PHACTR3;EZR;SMTN
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.48264269256654374,1.1574120851827572,0.2796296296296296,1.0,1.0,6/13,17.17%,PIK3CG;PIK3C2G;PIKFYVE;PIK3CD;PIK3C2A;PIP4K2A
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3615615088691078,-1.1566879679122437,0.22164948453608246,0.5934277657040017,1.0,17/31,28.65%,HCN1;SLC12A2;KCNK5;KCNA1;KCNK10;ABCC9;SLC12A6;TMEM38A;SLC12A4;KCNQ4;SLC12A9;KCNA2;SLC12A7;KCNK9;SLC12A8;SLC12A5;KCNK1
prerank,microtubule motor activity (GO:0003777),0.3567929283627828,1.152860332596472,0.2406832298136646,1.0,1.0,12/51,14.75%,DYNC1I1;KIF18A;DNAH3;KIF1B;KIF15;STARD9;KIF2A;KIF13A;KIF3B;KIF6;APPBP2;DYNC1I2
prerank,PDZ domain binding (GO:0030165),-0.312085075318631,-1.1495067171650022,0.21148036253776434,0.6077304132196482,1.0,14/61,10.31%,TGFBR3;GRID2;PLEKHA2;SDC2;CXADR;ARHGAP29;DLG4;SRR;CRIM1;CIT;MAP2K2;NLGN1;SLC22A4;FZD2
prerank,frizzled binding (GO:0005109),-0.3584523835780916,-1.145721767896004,0.257985257985258,0.6125545139891524,1.0,13/34,28.40%,WNT5B;RYK;RNF43;WNT4;DVL3;ZNRF3;WNT9A;LRP6;DVL1;FZD7;SFRP1;FZD1;MYOC
prerank,ubiquitin protein ligase binding (GO:0031625),0.28905638038616377,1.1446828728041454,0.17028985507246377,1.0,1.0,62/254,17.17%,PRKAR1A;RAD18;PRR5L;TRIB3;RALB;TRIM28;ARIH1;SLF1;MAP1LC3B;HSPA8;RPL23;CCT2;SPOP;RFFL;TUBB;YOD1;TNFRSF1B;WFS1;RALA;CDKN1A;TPI1;RPL5;BAG1;TRAF5;SMAD7;AXIN1;MAGEC2;NDUFS2;TRAF3;RELA;MDM2;AUP1;FBXO7;MFHAS1;NAE1;ERLIN2;GPI;NLK;SPOPL;PA2G4;ELOB;CUL3;MID1;CHEK2;NEK6;PSMD1;FAF1;APC;NFKBIA;RNF20;FANCL;UBE2G1;GABARAPL1;TUBA1B;TCP1;LAPTM4B;DNM1L;ABI2;SLF2;BECN1;CALR;ATXN3
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4062774397168142,1.1440308308797504,0.29442508710801396,1.0,1.0,3/26,3.56%,CSGALNACT1;CHSY3;EXTL2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.35198884444623657,-1.1405469915748554,0.2608695652173913,0.6212467727132862,1.0,14/33,27.32%,ELP4;WAC;RPRD1B;ERCC5;CDC73;ELP2;WDR43;PAF1;SMYD2;RTRAF;GTF2B;ZNF326;SUPT4H1;LLPH
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.4671385680750169,1.1385093011616816,0.3188405797101449,1.0,1.0,7/14,17.17%,YOD1;DESI2;USP15;OTUD5;MINDY2;USP9X;ATXN3
prerank,endopeptidase inhibitor activity (GO:0004866),-0.2855235164755016,-1.1362840051308782,0.22186495176848875,0.6269452026815884,1.0,12/82,11.69%,SPOCK3;TIMP3;SPOCK1;TIMP2;TFPI;ANXA2;COL4A3;ROCK1;BIN1;PSMF1;ITIH2;RENBP
prerank,tubulin binding (GO:0015631),0.2834806685869618,1.1326810647736796,0.1933570581257414,1.0,1.0,57/295,14.17%,REEP1;ABRAXAS1;DYNC1I1;EML1;KIF18A;DNM3;TTLL1;GAS2L1;MAP1LC3B;ALMS1;CETN3;TTLL12;EML6;CLASP2;TUBGCP5;MAP1S;SGIP1;KIF1B;CCT5;FYN;DST;KRIT1;DIP2B;CRIPT;FGF13;ARHGEF7;CCDC88C;DNAL1;UXT;CLIP2;AGTPBP1;MAP4;DAG1;TRPV4;RAB11FIP5;TBCEL;REEP3;KIF15;STARD9;PRUNE1;KIF2A;PAK1;KIF13A;DDX3X;RMDN3;RPS3;PRNP;MAP4K4;AGBL5;MID1;KIF3B;KIF6;RABGAP1;TTLL7;APC;SPEF1;EFHC2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.38830966819433804,-1.132658760229169,0.2645631067961165,0.6315003735371193,1.0,5/21,32.47%,GRM5;CHRFAM7A;CHRNA7;GRIA1;CHRNB1
prerank,microtubule binding (GO:0008017),0.29015496799931156,1.130935625008864,0.19676214196762143,1.0,1.0,39/222,13.23%,REEP1;ABRAXAS1;DYNC1I1;EML1;KIF18A;DNM3;GAS2L1;MAP1LC3B;ALMS1;CETN3;HAUS4;EML6;CLASP2;TUBGCP5;MAP1S;SGIP1;KIF1B;DST;KRIT1;CRIPT;FGF13;CCDC88C;UXT;CLIP2;CAMSAP2;MAP4;TRPV4;REEP3;KIF15;STARD9;KIF2A;KIF13A;RMDN3;RPS3;PRNP;MAP4K4;MID1;KIF3B;KIF6
prerank,beta-tubulin binding (GO:0048487),-0.35802711990708125,-1.1265819214118578,0.2857142857142857,0.6419896834864403,1.0,11/31,13.07%,EML4;GJB6;SMC3;PACRG;LRPPRC;PEX14;HTT;IFT74;ARL8A;TAOK1;PDCD5
prerank,DNA polymerase activity (GO:0034061),0.41185366896803377,1.1251701705313455,0.3029197080291971,1.0,1.0,5/22,10.58%,POLK;POLE;POLD3;POLA1;TERT
prerank,amyloid-beta binding (GO:0001540),-0.29218401197577415,-1.124722620191325,0.2140468227424749,0.6421299652964733,1.0,19/79,13.51%,LRP1;GRIA4;GRIA2;GRIN2B;COL25A1;FZD6;PGRMC1;SORL1;CACNA1B;TM2D1;HSPG2;LDLR;NLGN1;BACE1;EPHB2;VBP1;APBA1;GSAP;PFDN2
prerank,tau protein binding (GO:0048156),0.3693084050207447,1.121499738317129,0.2912621359223301,1.0,1.0,8/40,6.91%,GSK3A;PIN1;ACTB;PPP2CA;APOE;FYN;EP300;PPP2CB
prerank,DNA binding (GO:0003677),0.2645493483331248,1.120068388904495,0.1434643995749203,1.0,1.0,131/694,16.20%,TBX4;LRRFIP1;IRX1;ERCC3;IMPDH1;CTCFL;RAD18;MECOM;CHCHD2;SIM1;ARID5A;ILF3;TFCP2;NR4A2;BANF1;ATF6;TRIM28;CTC1;LEF1;PNKP;KLF2;GTF3C1;PCBP1;PAX8;ZBTB33;ZMYM4;NR5A1;MAP1S;RLF;SIRT3;MMP12;ERCC4;RAD1;FLI1;SMARCA2;SOX2;MEIS1;YY1;USF2;EP300;RFX3;TBX1;TDG;CARF;GTF3C5;SSBP1;CEBPG;CALCOCO1;FOXF2;PPARD;POLE;SFPQ;PMS2;CDC45;LONP1;ZNF638;DRAP1;DCLRE1B;CLOCK;ZNF3;HEY2;ZBTB14;MLH1;PMS1;SOX13;RELA;SPRTN;CENPC;POLA1;HOXA7;PCID2;BCLAF1;RAD23A;TFAP4;MSH3;ERG;PARK7;TARDBP;ZKSCAN3;AIFM1;RYBP;ING2;HIC2;TERT;THRB;DDX3X;RBPJ;RAD51B;HP1BP3;CREBBP;APTX;APP;RPS3;TOP3A;POLR3F;HDGF;TIGD2;ILF2;E2F3;SP1;TAF4B;NBN;IRF2;CHD3;RNF11;NUP35;MPG;EPAS1;DDIT3;HES1;YBX1;GRHL1;BRIP1;TSHZ1;TFAM;INO80;EZH1;TAF6L;TOP1;FOXJ3;TAF1;ANG;ELK4;BCL6;GTF3C2;SMARCA4;TCF7L1;TCF3;TSHZ2;ZBTB18;PURB
prerank,alkali metal ion binding (GO:0031420),-0.4410715925456899,-1.119082300163213,0.3111587982832618,0.6521669354706182,1.0,3/13,7.60%,ATP1A2;HDAC4;ATP1A1
prerank,SUMO transferase activity (GO:0019789),0.4472841709991543,1.118711909672975,0.3192660550458716,1.0,1.0,5/16,11.39%,TRIM28;UBE2I;MDM2;PIAS2;PIAS1
prerank,3'-5' DNA helicase activity (GO:0043138),0.43953361800948626,1.1181463745047622,0.3182608695652174,1.0,1.0,6/16,21.38%,ERCC3;ASCC3;FBH1;NAV2;MCM2;DHX9
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2816165090580323,1.1145706762400425,0.21733821733821734,1.0,1.0,36/254,12.67%,SOX30;ATF3;CTCFL;MECOM;ONECUT1;TFCP2;NR4A2;ATF6;LEF1;ELK3;GABPA;SMAD1;PRDM15;RLF;PRDM4;MYBL2;MEIS1;YY1;VEZF1;CEBPG;FOXF2;CLOCK;RELA;HOXA7;MDM2;TFAP4;ERG;KLF6;ESR1;RBPJ;NFIC;E2F3;SP1;MZF1;SMARCD1;IRF2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.32818613429636984,1.1115594184022164,0.2714285714285714,1.0,1.0,15/75,15.79%,IMPDH1;ABCC4;SPR;ME3;HMGCR;KDSR;KCNAB1;HSD17B11;NSDHL;RDH11;HSD17B4;RDH10;BDH2;AKR1A1;HPGD
prerank,metalloexopeptidase activity (GO:0008235),-0.3100965917507218,-1.1113353449078607,0.2736842105263158,0.6678081758907413,1.0,10/51,8.27%,CPQ;AEBP1;MMP16;AGBL4;MMP14;PEPD;RNPEP;TRHDE;ANPEP;AGBL3
prerank,calcium channel inhibitor activity (GO:0019855),0.4794870384230457,1.110684068183092,0.34824902723735407,1.0,1.0,1/11,0.30%,PHPT1
prerank,ATP binding (GO:0005524),0.28153205556311617,1.1106303252632783,0.24033816425120774,1.0,1.0,56/266,15.74%,THG1L;SNRK;PPIP5K2;HSPA8;OXSR1;HSPA4L;NEK11;PNKP;RPS6KA4;PYGL;RPS6KA5;NME1;MLKL;TDG;PEX1;MTHFS;YARS2;PRPS1L1;PRPS1;ABCF1;SIK3;CDK11B;LONP1;PIM1;HARS1;UBA2;SYN3;PEAK1;MINK1;ACVRL1;LATS2;NIM1K;PAPOLA;SRPK2;NLK;P2RX7;OLA1;PNPLA8;LANCL2;PRKCI;MYO9B;MAP4K4;ABCF2;NDUFA13;GSS;PPP5C;TLK2;NEK6;PTPA;TWF1;ABCF3;RRM1;DYRK2;CDKL5;TOP1;MYH9
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.43606808629563054,-1.1104407609454874,0.3088888888888889,0.6657837096279756,1.0,5/14,26.06%,SLC26A7;SLC26A2;SLC26A11;SLC25A30;SLC25A11
prerank,GTPase binding (GO:0051020),0.2862389218208425,1.1089871065563133,0.2332065906210393,1.0,1.0,58/194,17.01%,LCP1;SOD1;CHML;CHM;EVI5L;EXOC8;TBC1D30;CYRIB;MYO5A;CIB1;GNB1;IARS1;LAMTOR1;USP6NL;AP1G1;TRIP11;RABGAP1L;FGD5;RAPGEF6;XPO5;RASIP1;MYCBP2;RANBP1;PKN1;PAK1;GCC2;DOCK7;ATP6AP1;DMXL2;PICALM;MYO9B;PDE6D;ERC1;RRAGC;USP33;KIF3B;RABGAP1;AP3M1;YBX1;ANKRD27;BICD2;ATG16L1;RCC1;RUSC2;PPP6R1;TMEM127;ATG14;RAB3GAP1;WHAMM;CDKL5;BRAF;DOCK4;EXOC2;DNM1L;ABI2;BNIP3;CYFIP1;BECN1
prerank,I-SMAD binding (GO:0070411),-0.4497932312061507,-1.107753318659842,0.3264887063655031,0.6680877670334451,1.0,6/13,14.23%,SMAD3;TGFBR1;CTNNB1;SMAD4;SMAD6;SMAD5
prerank,protein serine/threonine kinase activity (GO:0004674),0.27234487139600533,1.107437822363587,0.20833333333333334,1.0,1.0,75/334,16.75%,STK32A;MAP3K11;MAPK3;SNRK;GSK3A;OXSR1;MAP3K7;CDK19;PLK2;NEK11;RPS6KA1;PRKCH;RPS6KA4;CAMK1D;HIPK2;PRKD2;RPS6KA5;STK35;MAP3K9;PKN3;SMG1;SLK;MAP3K4;MAPK8;PAK3;CSNK1G3;SIK3;SYK;CDK11B;SBK1;PIM1;TRIO;PIKFYVE;MOK;MINK1;CDK4;ACVRL1;LATS2;CDKL4;NRBP1;PKN1;PAK1;NIM1K;PRKAA2;ACVR2A;SRPK2;NLK;NEK7;PRKCI;MAST4;MAP4K4;MAPK6;IKBKB;MAPK12;CHUK;CHEK2;TLK2;NEK6;BRD2;CSNK2A2;MAP3K10;BMP2K;DYRK2;CDKL5;TOP1;CAMK2G;TAF1;ATR;BRAF;PTK2B;PIK3R4;CDK14;WNK2;RPS6KC1;PRKDC
prerank,carboxy-lyase activity (GO:0016831),0.40250508859227024,1.1070563638734783,0.32299270072992703,1.0,1.0,7/23,16.01%,MLYCD;DDC;AMD1;UXS1;ODC1;ECHDC1;CSAD
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3867040740414089,-1.1063878041402593,0.3062645011600928,0.6671126559144477,1.0,3/21,4.02%,PDE1A;PDE5A;PDE1C
prerank,protein phosphorylated amino acid binding (GO:0045309),0.35724185775778133,1.1058119951983738,0.2901639344262295,1.0,1.0,14/42,19.52%,PIN1;BCAR3;PFN1;SAMSN1;YWHAB;SYK;YES1;CRKL;LDLRAP1;SHC1;PTPN11;IRS1;YWHAE;FBXW7
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.46363833458601955,-1.1056994191036602,0.3306613226452906,0.6645284427447583,1.0,6/10,22.88%,CFLAR;CASP12;CASP7;CASP2;CASP9;CASP3
prerank,endodeoxyribonuclease activity (GO:0004520),0.41063263562698615,1.0996581326975143,0.33515482695810567,1.0,1.0,6/20,17.41%,ZRANB3;ERCC4;APLF;RPS3;ENDOV;DCLRE1C
prerank,3'-5' exonuclease activity (GO:0008408),0.3573130357658138,1.0984158678554405,0.30357142857142855,1.0,1.0,14/45,16.46%,REXO2;RAD1;APLF;USB1;CNOT7;EXOSC9;XRN2;EXD2;PAN2;CNOT6;CNOT6L;NOCT;ERI2;PARN
prerank,vitamin D receptor binding (GO:0042809),-0.43007179526228,-1.097488337887855,0.35281837160751567,0.6818074533006181,1.0,11/14,32.39%,MED13;MED1;MED17;SNW1;RXRA;THRAP3;TAF11;MED24;MED16;MED30;TAF7
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.47697521727410486,-1.0974577337369584,0.3595959595959596,0.6775168570873471,1.0,4/10,16.98%,DSE;GLCE;RENBP;DSEL
prerank,adenyl ribonucleotide binding (GO:0032559),0.27661255159171605,1.0972772369230446,0.24311377245508983,1.0,1.0,60/291,15.74%,THG1L;GCLC;SNRK;PPIP5K2;PDE4D;HSPA8;OXSR1;HSPA4L;NEK11;PNKP;RPS6KA4;HMGCR;PYGL;RPS6KA5;NME1;MLKL;TDG;PEX1;MTHFS;YARS2;PRPS1L1;PRPS1;ABCF1;SIK3;CDK11B;LONP1;PIM1;HARS1;UBA2;SYN3;PEAK1;MINK1;ACVRL1;LATS2;NIM1K;PAPOLA;SRPK2;NLK;P2RX7;OLA1;PNPLA8;LANCL2;PRKCI;MYO9B;MAP4K4;ABCF2;NDUFA13;GSS;PPP5C;TLK2;NEK6;MIEF1;PTPA;TWF1;ABCF3;RRM1;DYRK2;CDKL5;TOP1;MYH9
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.30451073820667185,-1.0963648893754478,0.2972972972972973,0.6759369929837578,1.0,15/53,16.06%,DPYD;MICAL2;AOX1;DDO;MICAL3;CRY2;XDH;DLD;MTHFR;CRY1;NOX4;KDM1A;SQOR;PRODH;QSOX1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.37286513158557005,1.0950829440215029,0.33916083916083917,1.0,1.0,12/33,16.97%,ARIH1;DCUN1D4;UBA2;AUP1;UBE3D;PARK7;RPS3;RNF180;TCERG1;RNF125;DCUN1D2;DCUN1D1
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3570684498121841,-1.0949926599081694,0.323943661971831,0.6753549454633835,1.0,5/26,11.91%,AEBP1;AGBL4;PEPD;AGBL3;CPM
prerank,chemokine binding (GO:0019956),-0.3477825495525403,-1.0939936050602486,0.31592039800995025,0.6737352715389437,1.0,24/30,63.14%,PDPN;CCR9;ACKR3;ITGA4;CX3CR1;ITGB3;HMGB1;ZFP36;ITGAV;CCR5;ACKR1;CCR2;CXCR4;PLP2;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;FGF2;ITGB1;CCR6;CXCR2
prerank,endonuclease activity (GO:0004519),0.3459850433756737,1.0929575549178816,0.34935897435897434,1.0,1.0,5/49,5.73%,ZRANB3;ZC3H12D;PNKP;ERCC4;APLF
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3545799195615918,1.08937386748037,0.31862745098039214,1.0,1.0,11/44,14.55%,MECOM;EZH2;EED;TTLL12;SMYD3;SETD5;SETD3;SETD1B;KMT5B;DOT1L;NSD2
prerank,glutamate receptor activity (GO:0008066),-0.3906297906099287,-1.0887720962303093,0.3413566739606127,0.6832532608291013,1.0,4/19,1.54%,GRIA4;GRIA2;GRID2;GRM5
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.4435488339509822,1.0870048563275214,0.34423076923076923,1.0,1.0,5/14,14.36%,MAL;BCL2L13;BAD;NOD1;APAF1
prerank,GTPase regulator activity (GO:0030695),-0.2424693991716865,-1.0851355808715681,0.19383259911894274,0.6886845057193985,1.0,57/212,16.63%,RIMS1;RANBP3L;ARHGAP42;ALDH1A1;ADGRB3;CPEB2;IQGAP1;DOCK1;TBCK;ERRFI1;ARHGAP10;NRP1;HACD3;ARHGEF10L;DEPDC5;SGSM2;WASL;ARHGAP29;RGS7;GARNL3;ARHGAP32;ARHGAP28;RAB3GAP2;ARFGAP1;BCR;ARHGAP20;ELMOD1;TBC1D22B;NPRL3;TBC1D8B;RGS12;STARD13;ELMOD2;SMAP2;STXBP5;SEC23A;GPSM1;RANBP3;RP2;GMIP;ARHGAP22;GDI1;MTSS2;SIPA1;SIRPA;TBC1D13;TBC1D10A;GNB5;RALBP1;ELMOD3;TBC1D9B;RALGDS;IQGAP2;ARHGAP26;RAPGEF2;RGS20;JUN
prerank,calcium-activated potassium channel activity (GO:0015269),0.4742052361174046,1.0846393580548073,0.3588235294117647,1.0,1.0,4/11,9.46%,KCNN2;KCNU1;KCNMB2;KCNMB3
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.43912360036177245,-1.0836816343188216,0.3640256959314775,0.6881748138957334,1.0,9/12,52.13%,B3GALT5;B3GALNT1;B3GALT1;B3GALT2;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,hormone receptor binding (GO:0051427),-0.4215573172000713,-1.0833252200532404,0.35876288659793815,0.6849267547166377,1.0,3/14,10.53%,JAK1;NCOA6;SOCS2
prerank,protein kinase C activity (GO:0004697),0.4401078360798485,1.080891310694753,0.3651685393258427,1.0,1.0,4/14,12.23%,PRKCH;SMG1;PKN1;PRKCI
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.2717092288580654,1.0803097925742675,0.2838323353293413,1.0,1.0,62/269,17.17%,PRKAR1A;RAD18;PRR5L;TRIB3;RALB;TRIM28;ARIH1;SLF1;MAP1LC3B;HSPA8;RPL23;CCT2;SPOP;RFFL;TUBB;YOD1;TNFRSF1B;WFS1;RALA;CDKN1A;TPI1;RPL5;BAG1;TRAF5;SMAD7;AXIN1;MAGEC2;NDUFS2;TRAF3;RELA;MDM2;AUP1;FBXO7;MFHAS1;NAE1;ERLIN2;GPI;NLK;SPOPL;PA2G4;ELOB;CUL3;MID1;CHEK2;NEK6;PSMD1;FAF1;APC;NFKBIA;RNF20;FANCL;UBE2G1;GABARAPL1;TUBA1B;TCP1;LAPTM4B;DNM1L;ABI2;SLF2;BECN1;CALR;ATXN3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.3222345006679207,-1.0792270783109699,0.3129973474801061,0.6917795931381682,1.0,3/38,2.62%,SPOCK1;TFPI;ANXA2
prerank,voltage-gated sodium channel activity (GO:0005248),-0.36271371884202797,-1.0758006829756481,0.34474327628361856,0.6971201588877854,1.0,5/22,13.06%,HCN1;SCN8A;SCN3A;SCN1A;CACNA1G
prerank,retinoic acid receptor binding (GO:0042974),0.42362428127936386,1.074762951047296,0.3649906890130354,1.0,1.0,5/17,14.50%,ARID5A;NR4A2;ACTN4;TACC1;CNOT1
prerank,ribosomal large subunit binding (GO:0043023),-0.4569058657309709,-1.074294724960918,0.38289205702647655,0.6967121768632862,1.0,4/11,13.86%,CPEB2;LTN1;RBM3;MRRF
prerank,Toll-like receptor binding (GO:0035325),0.4727059196448452,1.0723496109820858,0.38269230769230766,1.0,1.0,1/11,2.92%,TIRAP
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.30465073414902155,-1.070853294830496,0.3314447592067989,0.7014309157075749,1.0,8/47,5.61%,SLC7A11;SLC6A13;SLC7A2;SLC47A1;PDPN;SLC6A1;SLC7A14;SLC1A5
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3898121403596343,1.0703836384548129,0.3413793103448276,1.0,1.0,5/22,9.11%,ZRANB3;TNFAIP3;TAB2;TAB3;SPRTN
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.36315028675666416,-1.0701772379609056,0.36792452830188677,0.69917593505831,1.0,14/23,39.73%,WIPI1;CLVS2;HIP1R;COMMD1;SNX3;SH3PXD2B;HIP1;GBF1;JPH2;MAPKAP1;PLA2G4E;PHLDA3;WDR45;ATP13A2
prerank,MAP kinase phosphatase activity (GO:0033549),0.4558726775154901,1.0700952591432764,0.38140417457305503,1.0,1.0,1/12,1.27%,DUSP7
prerank,hydro-lyase activity (GO:0016836),0.3494274988273683,1.068908126258623,0.3817891373801917,1.0,1.0,11/41,16.08%,ENO4;CA2;CA4;CDYL;PARK7;HACD2;HSD17B4;ACO1;ECHDC1;NAXD;ECHS1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.36170357217084986,-1.0687949374664734,0.35645933014354064,0.6987286740003952,1.0,11/25,21.51%,PARP4;ZC3HAV1;PARP14;SIRT2;PARP6;PARP3;ART3;PARP1;SIRT5;PARP16;PARP2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4408616848124428,-1.06870998509255,0.3950617283950617,0.6948476503717477,1.0,4/12,20.03%,IGF1;SOCS2;IGF2;PIK3R1
prerank,actinin binding (GO:0042805),-0.37439726486039165,-1.0683364845196848,0.37557603686635943,0.691881798546575,1.0,7/21,12.04%,CACNA1C;PDLIM5;CACNA1D;SYNPO2;NFKB1;RARA;CSRP2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.27839049185818,1.0663328654046884,0.3240371845949535,1.0,1.0,22/173,10.43%,SOX30;LRRFIP1;ATF3;IRX1;DACH1;KLF8;GTF2IRD1;ELK3;ZBTB33;BCL6B;HEY1;YY1;NFX1;PPARD;ZNF3;HEY2;ZBTB14;SOX13;RELA;TRPS1;ZKSCAN3;HIC2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.44339055315495346,-1.063799021488841,0.38927738927738925,0.6995804508847203,1.0,8/11,36.53%,UBR5;UBE4A;UBE2K;STUB1;UBOX5;UBE4B;PRPF19;RBX1
prerank,syntaxin binding (GO:0019905),-0.28817316614764954,-1.0631543227490863,0.3056379821958457,0.6970246345201265,1.0,22/61,18.87%,SNAP25;STX16;STX8;SYT9;GOLGA2;STXBP5;TMED9;STXBP4;ABCA1;SYT12;RAB11A;UNC13C;STXBP1;SNPH;UNC13B;VAMP2;VPS54;PTPN2;SYT2;DAPK1;VAMP1;SNAP29
prerank,fibroblast growth factor binding (GO:0017134),-0.3685422436089024,-1.0616944882906918,0.4009216589861751,0.6966224875717999,1.0,4/21,10.73%,FGFR2;CEP57;THBS1;KL
prerank,nuclease activity (GO:0004518),0.3345330670792893,1.0604880548156261,0.36850393700787404,1.0,1.0,7/52,9.40%,AEN;PNKP;NME1;MAP1S;RNASE6;XRN2;RNASE12
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.3746037389305,-1.0597410423923384,0.3767123287671233,0.6976198845348838,1.0,1/20,0.02%,DLG2
prerank,microtubule minus-end binding (GO:0051011),0.4396312346792507,1.059453133630761,0.38122605363984674,1.0,1.0,3/13,7.37%,HAUS4;TUBGCP5;CAMSAP2
prerank,double-stranded RNA binding (GO:0003725),0.31558019346226246,1.058424022950404,0.3495440729483283,1.0,1.0,26/70,21.38%,LRRFIP1;ILF3;SLC3A2;FXR1;ADAR;ZFR;EIF4H;DDX3X;ADARB2;APTX;AGO4;EIF4B;ILF2;ADARB1;TUBA1B;PRKRIP1;STAU2;DDX60;RC3H1;TFRC;DHX36;DHX30;AGO1;HSP90AB1;DGCR8;DHX9
prerank,transforming growth factor beta binding (GO:0050431),-0.35596427536498965,-1.0582149795906697,0.3663594470046083,0.697337812298325,1.0,11/23,24.95%,TGFBR3;TGFBR1;TGFBR2;ACVR1;THBS1;LTBP1;CD109;TWSG1;NRROS;TGFB3;VASN
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.43896319021816665,-1.0580885964088333,0.3971774193548387,0.693702612274284,1.0,6/11,22.88%,CFLAR;CASP12;CASP7;CASP2;CASP9;CASP3
prerank,histone methyltransferase activity (GO:0042054),0.36132825767854204,1.0577769122396146,0.3644067796610169,1.0,1.0,8/32,14.58%,EZH2;EED;TTLL12;SMYD3;CARM1;KMT5B;DOT1L;NTMT1
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.430894876466138,-1.057447190221054,0.38427947598253276,0.6914469666020647,1.0,7/12,18.95%,SULF1;SULF2;ARSB;ARSG;ARSK;ARSI;GNS
prerank,kinase binding (GO:0019900),-0.21753294071488632,-1.0546986719724936,0.2,0.6945878456791429,1.0,115/434,19.24%,DLG2;ANK2;PRKAG2;BICD1;MAPK4;NBEAL1;SASH1;EGFR;GSN;SMAD3;IQGAP1;WWC2;PDGFRB;PKD1;DNAJC3;SNAP91;ERRFI1;TNS2;UFL1;CYLD;TOM1L2;DLG4;MAPT;IFNAR2;CTNNB1;WNK1;RHOA;AP2A2;MAML1;FLNA;PRKAG1;UNC5C;GHR;VDAC1;PIP5K1A;SLC12A2;CIT;PRKCD;CAB39;SKI;HTT;IRAK1;IL31RA;SRCIN1;TAX1BP1;CDKN1B;IRAK3;AP2A1;GOLGA2;CEP152;SYN1;SIK1;RND3;CNOT9;DLG3;PRKACA;RHOBTB2;CCND3;GSK3B;STRADA;CAMK2N1;EEF2;VRK2;DCX;TP53;ILK;PER1;PRKAB2;HSF1;RHOB;GRB2;RPS7;TPRKB;RPS6;RHOBTB1;GYS1;TOLLIP;PIK3IP1;DLG1;MSH2;RELB;SHC3;DNM1;POLR2A;CSPG4;PTK2;MAP3K12;CAV2;PTPN22;CCNK;TOM1L1;DCTN1;TRAF2;PTPN23;TCF7L2;PTPN2;CEP250;STX1A;GPRC5B;IRAK4;SLC12A4;NR3C1;SV2A;DVL1;MAP3K1;CDC42;MAVS;JTB;ADD2;PARP1;MSN;TRIM5;ATF5;HNRNPA0;STUB1
prerank,G protein-coupled receptor activity (GO:0004930),0.26953374854087286,1.0543587443168947,0.3482587064676617,1.0,1.0,13/239,6.34%,MTNR1A;GPR176;GPR52;ADGRE1;GPR63;NPFFR1;ADGRL4;ADGRL3;PAX8;TSHR;HCRTR1;XPR1;RXFP1
prerank,protein kinase activator activity (GO:0030295),-0.27899530823261026,-1.0542821387473333,0.34276729559748426,0.6918031986976318,1.0,15/60,14.80%,PRKAG2;GRM5;IQGAP1;ABI1;WNK1;ERCC6;CAB39;MAP2K2;STRADA;STK11;TAOK1;FAM20A;IGF2;MADD;RPLP1
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.27679867939535907,-1.0518502864381625,0.3573667711598746,0.6943230447424493,1.0,14/70,17.34%,MGAT4C;GXYLT2;OGT;B4GALT1;CHSY1;HEXA;CSGALNACT2;HEXB;XXYLT1;LARGE1;B3GALT5;B3GALNT1;B3GALT1;POGLUT3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.25780062547121724,1.051334586687808,0.32708089097303633,1.0,1.0,74/346,16.65%,FBXL6;RNF7;CBL;TRIM28;ARIH1;RNF149;TNFAIP3;RNF38;RFFL;BIRC2;RSPRY1;NEDD4L;NEURL2;VPS11;ANKRD39;NHLRC1;RBBP6;FBXL5;UBE3A;TRIM14;FBXW2;IRF2BPL;RNF130;NFX1;COP1;TRAF5;RNF187;PPP1R11;LMO7;TTC3;TRIM25;AKTIP;FBXO11;TRAF3;RBCK1;MDM2;PJA2;RFWD3;MYCBP2;UBE3D;RNF6;ZNRF1;FBXO7;UBE2M;RNF13;RNF25;CHFR;ANAPC11;DTX4;ANAPC4;RNF11;CUL3;UBE2R2;RNF146;RNF216;TSPAN17;RNF180;TRIM27;RNF20;FANCL;TRIM3;NHLRC3;UBE2G1;FBXO22;RMND5A;RNF114;TAF1;PELI1;KLHL42;RNF128;RNF125;UBE2H;KLHL13;VPS18
prerank,amino acid binding (GO:0016597),-0.328460983081696,-1.0509079751895678,0.365,0.6929118924571753,1.0,7/31,10.84%,GRIN2B;GLRB;SRR;GLRA3;CASTOR2;GLRA1;DDAH1
prerank,snRNA binding (GO:0017069),0.3404360694509651,1.0489214957325967,0.3787878787878788,1.0,1.0,14/42,18.64%,EIF5A;RBM22;PRPF31;GEMIN5;SF3B3;SNU13;COIL;EFTUD2;SNRPA;RBM41;SNRPA1;HEXIM1;SNRPB2;SNRPD3
prerank,cation:chloride symporter activity (GO:0015377),0.46488708957121205,1.0487981201052468,0.40388349514563104,1.0,1.0,1/10,0.15%,SLC12A1
prerank,ribosomal small subunit binding (GO:0043024),0.4122419172611744,1.0486632915965353,0.400359066427289,1.0,1.0,9/17,20.22%,NME1;PIM1;EIF4H;DDX3X;EIF4B;NPM1;LARP1;MTIF2;EIF1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.46360603512111315,1.047773458710459,0.4093457943925234,1.0,1.0,1/10,1.27%,DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.46360603512111315,1.047773458710459,0.4093457943925234,1.0,1.0,1/10,1.27%,DUSP7
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.3807507259650733,-1.0458436114566996,0.38694638694638694,0.7019301522092806,1.0,12/19,24.45%,GRID2;GABRA2;GRID1;GABRG2;GRIK4;GABRA5;GABRG3;GABRA4;GRIK1;GRIK3;GABRG1;GABRA1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3831193808067026,1.0442331043838116,0.40106951871657753,1.0,1.0,4/21,9.29%,POLK;POLE;POLD3;POLA1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.38522228809106784,1.0433101350905265,0.3911504424778761,1.0,1.0,2/22,3.68%,DUSP7;DUSP12
prerank,mRNA 5'-UTR binding (GO:0048027),0.3778428805711606,1.0416664273905134,0.3985890652557319,1.0,1.0,8/24,19.34%,CCT5;RPS14;RPL5;DDX3X;RSL1D1;RPL26;DHX36;LARP1
prerank,cardiolipin binding (GO:1901612),0.46605219922571106,1.0414469969791986,0.4305835010060362,1.0,1.0,2/10,5.21%,MME;UQCC3
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.4168525973244086,-1.0413541947683183,0.3930885529157667,0.7092015085507447,1.0,5/13,23.65%,FAN1;DICER1;DNASE1L1;ZGRF1;SLX4
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.3401511270087059,-1.0408864699559703,0.4054726368159204,0.706777714240233,1.0,13/28,26.56%,GRID2;GABRA2;GRID1;GABRG2;GRIK4;GABRA5;GABRG3;GABRA4;GRIK1;GRIK3;GABRG1;GABRA1;CHRNA7
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.2343587062238371,-1.0402570693562667,0.3424657534246575,0.704686190108012,1.0,54/181,21.70%,ARNT2;SMAD3;MIER1;PRRX1;HDAC4;CHD4;MAPK14;CTNNB1;RBL2;HDAC1;GTF2I;MED1;TTC8;PPARGC1A;ANXA4;WWP2;PPARA;MTA3;LDB1;SPEN;BHLHE40;SNW1;PSMA6;RXRA;GSK3B;SMARCD3;MTA1;TP53;CRY1;TBX3;DDRGK1;NCOA1;PIAS3;KDM1A;DACT1;ATN1;BBS2;COMMD7;TEAD3;TAF6;CTDP1;TCF7L2;JUN;TADA3;MTDH;BBS5;STAT1;MTA2;PIAS4;BHLHE41;HSPB1;DTX3L;ATF4;ELK1
prerank,Hsp90 protein binding (GO:0051879),-0.32191228886137446,-1.03806636528182,0.3932291666666667,0.7061242795826828,1.0,10/33,19.24%,PACRG;MAPT;SLC12A2;PPID;HSF1;USP19;NPAS2;NR3C1;TSC2;STUB1
prerank,protein phosphatase binding (GO:0019903),-0.2505184120724519,-1.0375482186972507,0.3525423728813559,0.7037676114845152,1.0,39/117,21.97%,EGFR;IQGAP1;AP3B1;JAK1;MAPK14;DLG4;MAPT;CTNNB1;PXN;VCP;MYO16;ENSA;STAT6;CDKN1B;ARPP19;MAP3K5;TP53;IKBKE;KIF3A;SIRPA;VRK3;RACK1;PTK2;MTMR9;PPME1;MTMR4;TRAF2;FBXL2;SNX3;SHOC2;MET;PPP1R16A;PIK3R1;PPP6R3;ITGA1;PPP1R3B;ADCY8;SH3RF2;PDLIM4
prerank,protein homodimerization activity (GO:0042803),0.246366235981529,1.0329920289145935,0.37987012987012986,1.0,1.0,110/589,16.21%,CIDEA;MIGA1;LRRFIP1;ATF3;CADM1;MAP3K11;SYNE1;BANF1;ABCB10;TMEM266;GLB1;GYG1;PECAM1;ABCG2;BCL2L2;GREM1;ZHX3;TRIM8;NUDT5;MAP3K9;GBP3;MME;EXT2;APOE;SLK;PHB2;TOX3;TRIM14;B2M;USF2;TPI1;SMIM1;TBX1;TDG;FXR1;KCNN2;YARS2;GBP4;PRPS1L1;PRPS1;SSBP1;PTPRT;PEX7;CHMP1A;SFPQ;ACTN4;F11R;SPPL3;HARS1;TXN;DCLRE1B;AXIN1;GALM;SNX1;RASIP1;RELA;CARNMT1;CSF1R;RAB11FIP2;RABEP1;NRBP1;FZD9;EXD2;TFAP4;MSH3;PARK7;CACYBP;S100A16;TERT;NQO2;GTF2A2;CISD2;NOD1;HSD17B4;ATG7;BNIP3L;MYO9B;SP1;IKBKB;CRPPA;MZF1;STARD3NL;CHUK;TPM2;DSCAML1;TENM4;PAPSS1;GSS;MID1;PLEK;CHEK2;DDIT3;HES1;GRHL1;TRIM27;PTPA;GCH1;MAP3K10;IMPA1;S100A13;UXS1;ODC1;TPD52L1;CAMK2G;ANG;MYH9;STARD3;KLHL7;TCF3;DNM1L
prerank,myosin binding (GO:0017022),-0.2836434829145016,-1.0319588666135684,0.407202216066482,0.7136192231090096,1.0,9/55,7.31%,CALD1;KIRREL1;GSN;RAB3C;MOBP;RHOA;SPATA6;TRAK1;RAB27B
prerank,amino acid:sodium symporter activity (GO:0005283),-0.4213548369590544,-1.031666944771465,0.4279661016949153,0.7105685547423282,1.0,5/11,13.99%,SLC1A3;SLC6A13;SLC6A1;SLC6A12;SLC6A15
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4419899561454512,-1.0308730367230836,0.44349680170575695,0.7087918553576501,1.0,3/11,28.52%,DDAH1;DDAH2;PADI2
prerank,single-stranded RNA binding (GO:0003727),0.32668634191169826,1.0286423675170744,0.4166666666666667,1.0,1.0,18/43,21.38%,ILF3;FXR1;LONP1;ZFR;EIF4H;DDX3X;ADARB2;AGO4;EIF4B;PTBP1;U2AF2;ENDOV;HNRNPF;DDX60;AGO1;AQR;CNBP;DHX9
prerank,ubiquitin binding (GO:0043130),-0.2705953783693962,-1.0264024589581775,0.42517006802721086,0.7168893189557491,1.0,30/73,20.91%,SMAD3;UBXN7;UBE2N;SIRT2;UBXN2A;USP13;ILRUN;UBXN2B;USPL1;RNF168;NPLOC4;NSFL1C;BUB3;TOLLIP;IKBKG;DDI2;RNFT1;RNF19B;TSG101;TOM1L1;UCHL3;GGA3;USP16;RNF31;OTULINL;USP5;RAE1;NEDD4;DNAJB2;HSPB1
prerank,peptide hormone receptor binding (GO:0051428),0.45150201504313847,1.0252326308347037,0.4396887159533074,1.0,1.0,1/11,3.53%,GNRH1
prerank,nuclear receptor coactivator activity (GO:0030374),0.32038820107417726,1.0250806751821138,0.39546191247974066,1.0,1.0,16/52,14.35%,CCDC62;DCAF6;CALCOCO1;MED12;ACTN4;ATXN7L3;PKN1;BUD31;CCAR2;TACC1;USP22;CARM1;MED4;SS18;CNOT6;NCOA7
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.45602604025482996,1.023713997552529,0.44787644787644787,1.0,1.0,2/11,3.76%,NUDT11;NUDT5
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.4347248783601022,1.0235671670199513,0.4598825831702544,1.0,1.0,4/13,14.06%,THUMPD2;TRMT11;TRMT10B;WDR4
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.34896797894663933,-1.0214403951482343,0.42142857142857143,0.7253070721807767,1.0,6/23,16.11%,PDE1A;PDE5A;PDE1C;PDE11A;PDE4B;ADPRM
prerank,sequence-specific DNA binding (GO:0043565),0.24510415502193894,1.020574982186942,0.41302027748132336,1.0,1.0,65/590,10.80%,SOX30;ATF3;IRX1;CTCFL;FOXQ1;CHCHD2;ARID5A;ONECUT1;FOXN2;TFCP2;NR4A2;ATF6;CTC1;LEF1;HES6;KLF2;ELK3;PAX8;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;HEY1;NR5A1;SIRT3;MMP12;IRF9;PRDM4;MYBL2;FLI1;BBX;SOX2;SMG1;YY1;GMEB2;KDM2A;ZNF740;USF2;CPSF4;RFX3;TBX1;CHTOP;CEBPG;CALCOCO1;FOXF2;PPARD;LONP1;CLOCK;TET3;HEY2;ZBTB14;ACD;SOX13;UPF2;JUND;HOXA7;TFAP4;ERG;ZKSCAN3;KLF6;ESR1;TERT;THRB;RBPJ
prerank,cadherin binding (GO:0045296),0.2526767812475706,1.0204839533935945,0.4061032863849765,1.0,1.0,98/315,19.93%,LRRFIP1;EFHD2;PSMB6;CBL;PTPRJ;NUDC;VASP;BSG;HSPA8;EIF2A;GLOD4;PTPRM;EEF1D;EHD4;PCBP1;SRC;PTPRB;FLNB;MRTFB;CDH2;SLC3A2;PROM1;ESYT2;PFN1;HNRNPK;SLK;RAB11B;EPS15L1;YWHAB;PTPRT;CDH12;RPS26;F11R;RUVBL1;TRIM25;DOCK9;ITGA6;EIF4H;TJP1;SNX1;RAB1A;RANBP1;PARK7;EIF4G2;RPL24;DDX3X;RPL34;PI4KA;OLA1;AHSA1;PICALM;CRKL;UNC45A;CDH5;ERC1;EPS8L1;RPL23A;GIPC1;APC;HCFC1;TWF1;ABCF3;ASAP1;EIF5;FXYD5;GAPVD1;MYH9;RSL1D1;PACSIN2;CDH13;PFKP;CD2AP;LDHA;BAIAP2;CAPZA1;UBAP2;RANGAP1;PTPN11;EPN2;ARGLU1;CD46;GOLGA3;RPL15;RDX;CNN3;RPS2;FNBP1L;SH3GLB1;BZW2;YWHAE;EIF3E;LARP1;ADD1;KIF5B;SEPTIN9;RPL14;PKN2;PAK2
prerank,GTPase activator activity (GO:0005096),0.2534327577679153,1.0196780729820683,0.40860215053763443,1.0,1.0,85/313,17.58%,THG1L;RGS2;TIAM1;VAV3;GNAQ;EEF1D;RGS5;EVI5L;CYTH4;CHN2;NUCB2;TBC1D30;TBC1D8;RALGAPA2;RGS8;ITSN1;TBC1D9;STXBP5L;RASGRP3;ARHGAP25;TBC1D10B;DENND5B;ARHGEF6;LAMTOR1;USP6NL;ARHGEF7;TBC1D4;CCDC88C;RALGAPB;RAPGEF3;DENND1A;RABGAP1L;RGS10;RAP1GDS1;ARHGEF18;RAPGEF5;RGS3;FGD5;EIF2B3;RAPGEF6;DOCK9;TBC1D12;MYCBP2;RANBP1;PLCB1;ACAP2;OPHN1;TBC1D25;ARHGAP39;SBF2;NF1;PREX2;ADPRH;MYO9B;SMAP1;LARS1;TBC1D14;RABGAP1;EEF1B2;EPS8L1;RGL2;ARHGAP15;ELMO1;ANKRD27;RALGAPA1;DENND4C;SYDE1;ARHGEF10;ASAP1;RCC1;DENND1B;DOCK8;RAB3GAP1;GAPVD1;DOCK4;DNM1L;RASGRF2;ARHGAP27;WDR41;ARFGAP2;ASAP2;ARHGAP9;RGL1;RANGAP1;RCC1L
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.3387540739170951,-1.0193038967445869,0.40415704387990764,0.7269475193918982,1.0,8/24,21.37%,PLA2G4A;PLEKHA8;OSBP;OSBPL5;SNX3;ARFIP2;GSDMD;OSBPL8
prerank,growth factor receptor binding (GO:0070851),-0.2535146562859777,-1.0179952719644365,0.38591549295774646,0.7264835110659024,1.0,18/95,16.35%,ERBB4;PDGFRB;SNX2;FGF1;SNX4;FER;IL6R;PIBF1;EFEMP1;PDGFRA;ITGA5;CNOT9;PLSCR1;KL;GRB2;IL6ST;ARF4;PDGFD
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.4152391646266116,1.016536201806173,0.4396887159533074,1.0,1.0,2/13,1.52%,PTPRJ;IL1R1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.3751355952672398,1.0164075898632592,0.43345323741007197,1.0,1.0,8/22,18.03%,ATP6V1D;ATP2A2;ATP6V0D1;ATP6V0E1;ATP2C1;ATP6V1B2;ATP5F1B;ATP6V1A
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3835042564027019,-1.0156998198811984,0.42701525054466233,0.7287719448398775,1.0,4/15,8.83%,WDFY3;SNAP91;EEA1;ZFYVE16
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.34040801764616035,1.0151200394426836,0.433389544688027,1.0,1.0,10/34,13.08%,NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;NDUFB7;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.34040801764616035,1.0151200394426836,0.433389544688027,1.0,1.0,10/34,13.08%,NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;NDUFB7;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,deubiquitinase activity (GO:0101005),-0.25328669337022663,-1.0142076987981588,0.4281150159744409,0.7293367233150453,1.0,35/88,23.52%,OTUD7A;USP40;USP29;CYLD;USP13;USP11;USP4;STAMBPL1;MINDY3;OTULIN;OTUD6B;USP38;USP50;USP34;USP19;USP20;UCHL3;USP7;USP10;TANK;USP1;USP16;USP42;USP5;USP45;EIF3F;COPS5;MYSM1;JOSD1;USP35;EIF3H;USP49;USP2;USP46;USP24
prerank,disordered domain specific binding (GO:0097718),0.37387786065210926,1.0141735096795235,0.4261992619926199,1.0,1.0,4/23,9.39%,BCL2L2;FYN;CALM3;MDM2
prerank,ion gated channel activity (GO:0022839),-0.34819957690988196,-1.0129101549975175,0.4492099322799097,0.7291262031809621,1.0,10/24,28.95%,ANO3;ANO1;TMEM63A;ANO6;TMEM63B;ANO10;KCNT1;TTYH3;TTYH1;TMEM63C
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.45279231221256067,1.0112182117519117,0.4722222222222222,1.0,1.0,2/10,7.85%,MECOM;SETD5
prerank,transferrin receptor binding (GO:1990459),-0.43006067019179317,-1.0097577944922522,0.4602510460251046,0.7335065886313535,1.0,3/10,3.62%,SNX2;RGMA;SNX4
prerank,chemokine receptor activity (GO:0004950),-0.33538016431825435,-1.008574115304888,0.4486607142857143,0.7329516923401332,1.0,18/24,63.14%,CCR9;ACKR3;CMKLR1;CX3CR1;CCR5;GPR35;CCR2;CXCR4;GPR75;GPR17;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;CXCR2
prerank,omega peptidase activity (GO:0008242),-0.2516609020741236,-1.008069286683672,0.428125,0.730654396124816,1.0,35/89,23.52%,OTUD7A;USP40;USP29;CYLD;USP13;USP11;USP4;STAMBPL1;MINDY3;OTULIN;OTUD6B;USP38;USP50;USP34;USP19;GGT5;USP20;UCHL3;USP7;USP10;TANK;USP1;USP16;USP42;USP5;USP45;COPS5;MYSM1;JOSD1;GGH;USP35;USP49;USP2;USP46;USP24
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.37718926833414035,-1.0079254085919134,0.46238938053097345,0.7274524993806238,1.0,10/16,53.40%,PIR;CDO1;ETHE1;ALOX12;ADI1;BCO2;HGD;ALOXE3;HAAO;ALOX5
prerank,glycerophospholipid flippase activity (GO:0140333),0.43360343813984575,1.0074975826272783,0.4446529080675422,1.0,1.0,4/11,13.90%,ATP8A1;ATP11A;ATP11C;ATP10A
prerank,ion channel inhibitor activity (GO:0008200),0.33802066868619146,1.0074014420816786,0.42495784148397975,1.0,1.0,3/35,4.22%,PHPT1;RSC1A1;NEDD4L
prerank,voltage-gated ion channel activity (GO:0005244),-0.38680019072198457,-1.0052366692339014,0.425,0.7304485345731044,1.0,3/14,5.72%,HCN1;KCND2;VDAC1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.3981138208009291,1.0037295200351832,0.46078431372549017,1.0,1.0,1/15,0.29%,CISH
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2725581216498909,1.0029672702193064,0.4532967032967033,1.0,1.0,29/134,16.56%,SLC7A8;SLC1A1;SLC36A4;ABCC4;SLC25A1;SLC25A24;ABCG2;SLC3A2;SLC52A2;SLC52A3;SLC6A6;SLC17A6;SLC1A2;SLC35A1;SLC35B1;SLC25A2;SFXN5;SFXN1;SLC25A12;SLC35A3;MPC2;SLC38A5;SLC66A1;SLCO1C1;SLC25A21;SLC25A42;SLC16A1;SLC25A38;SLC25A25
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.42366471548694173,1.0013534564599076,0.44878957169459965,1.0,1.0,4/12,14.60%,PIK3CG;PIK3C2G;PIK3CD;PIK3C2A
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.4463037491601647,1.0000140742694184,0.45746691871455575,1.0,1.0,4/10,14.60%,PIK3CG;PIK3C2G;PIK3CD;PIK3C2A
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.23941291296391215,0.9991451394151877,0.48025613660619,1.0,1.0,80/597,14.11%,SOX30;ATF3;IRX1;CTCFL;FOXQ1;ARID5A;ONECUT1;FOXN2;TFCP2;NR4A2;MTERF3;TAL1;ATF6;LEF1;HES6;KLF2;ELK3;PAX8;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;ORC3;HEY1;NR5A1;IRF9;PRDM4;MYBL2;FLI1;BBX;SMARCA2;SOX2;YY1;GMEB2;ZNF740;USF2;CPSF4;BEND3;RFX3;TBX1;CEBPG;CALCOCO1;PPARD;SFPQ;CDC45;CLOCK;ORC4;HEY2;ZBTB14;SOX13;RELA;CENPC;JUND;POLA1;HOXA7;TFAP4;ERG;KLF6;ESR1;THRB;CARM1;ORC2;NFIC;ZBED4;E2F3;SP1;MZF1;IRF2;CHD3;TBP;ZBTB45;TGIF1;HDAC5;DDIT3;THRA;HES1;YBX1;GRHL1;SP8
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.38914426550430825,-0.9980534006341916,0.45454545454545453,0.7446959331728583,1.0,10/15,35.99%,KMT2A;RBBP5;KMT2B;KMT2D;SETD4;WDR5;WDR82;PRDM9;CXXC1;SETMAR
prerank,thyroid hormone receptor binding (GO:0046966),0.3483267091932244,0.9971399894156454,0.4537205081669691,1.0,1.0,7/28,11.72%,ARID5A;GAS2L1;MED12;GTF2H1;TACC1;MED4;JMJD1C
prerank,myosin V binding (GO:0031489),0.40029438048990285,0.9968776723499583,0.4655493482309125,1.0,1.0,4/15,8.22%,RAB11B;RAB6B;RAB6A;RAB14
prerank,CCR chemokine receptor binding (GO:0048020),-0.32236919596955704,-0.9956469048999941,0.4830097087378641,0.7471535237637302,1.0,6/28,22.13%,CNIH4;CCL14;NARS1;NES;CX3CL1;CCL13
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.3664521684993767,-0.9952345153399202,0.4527027027027027,0.7445155300840803,1.0,8/17,21.80%,GRIA4;GRIA2;GRIN2B;GRIK4;GRIK1;GRIK3;GRIN2D;GRIN1
prerank,small GTPase binding (GO:0031267),0.2598184223712736,0.9934151639242719,0.4961340206185567,1.0,1.0,46/169,16.30%,SOD1;CHML;CHM;EVI5L;EXOC8;TBC1D30;CYRIB;MYO5A;CIB1;USP6NL;AP1G1;TRIP11;RABGAP1L;FGD5;RAPGEF6;XPO5;MYCBP2;RANBP1;PKN1;PAK1;GCC2;DOCK7;ATP6AP1;DMXL2;PICALM;MYO9B;PDE6D;ERC1;USP33;KIF3B;RABGAP1;AP3M1;ANKRD27;BICD2;RCC1;RUSC2;PPP6R1;TMEM127;RAB3GAP1;WHAMM;CDKL5;BRAF;DOCK4;EXOC2;DNM1L;ABI2
prerank,G protein-coupled receptor binding (GO:0001664),0.26820159031445157,0.9907366194974275,0.4759284731774415,1.0,1.0,12/132,8.84%,RTP3;REEP1;SAG;HSPA8;GNAQ;CXCL12;INSL3;CCDC88C;GNA12;CCL25;WNT5A;GNA11
prerank,kinase inhibitor activity (GO:0019210),-0.3085225872218889,-0.9899385018741599,0.4649350649350649,0.7546227146472239,1.0,17/33,32.81%,PARVA;DNAJC3;GMFB;TAOK3;CDKN1B;DUS2;LRP6;SH3BP5;SH3BP5L;RHOH;TRIB1;QARS1;SNCA;CDKN1C;NCK1;MAPK8IP1;SMCR8
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.25053488804502805,-0.9899373473517408,0.47560975609756095,0.7510120796489119,1.0,34/83,24.44%,OTUD7A;USP40;USP29;CYLD;USP13;USP11;USP4;STAMBPL1;MINDY3;OTULIN;OTUD6B;USP38;USP50;USP34;USP19;USP20;UCHL3;USP7;USP10;TANK;USP1;USP16;USP42;USP5;USP45;COPS5;MYSM1;JOSD1;USP35;USP49;USP2;USP46;USP24;OTUD7B
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.42040428723073175,-0.9898712510144846,0.4897119341563786,0.7475917144661467,1.0,5/10,19.80%,DLG4;SHISA6;IGSF11;SHANK2;SHANK1
prerank,mRNA binding (GO:0003729),0.2508108733091331,0.989748818947963,0.5091352009744214,1.0,1.0,76/249,19.40%,ZC3H12D;NCBP1;KHDRBS3;EIF2A;LARP4B;PCBP1;ZFP36L1;HNRNPAB;SF1;QKI;CCT5;HNRNPK;MYEF2;RPS14;FXR1;RPL5;RBM20;SLC4A1AP;RPS26;HNRNPC;GEMIN5;YTHDC1;FYTTD1;SRSF4;SECISBP2L;XPO5;NOVA2;DXO;MARF1;PARK7;TARDBP;CPSF6;EIF4G2;NCBP3;DDX3X;NANOS3;RPS3;PTBP1;PCBP3;ACO1;G3BP2;RPL35;RNF20;SCAF8;DCP1A;SSB;RBM4B;SF3B6;PPP1R8;HNRNPL;NOCT;TRA2B;ADARB1;SLBP;TDRD7;UPF3B;RSL1D1;PURB;PARN;N4BP1;LARP4;CALR;EIF2S2;EIF3A;RPL26;LUC7L2;RC3H1;RPS2;NSRP1;EIF4G1;CLUH;MRPL13;DHX36;HNRNPM;LARP1;DCP1B
prerank,intracellular chloride channel activity (GO:0061778),-0.3704755954240547,-0.9886820106318486,0.4722838137472284,0.7436106627354007,1.0,9/16,40.33%,ANO3;ANO1;ANO6;ANO10;TTYH3;TTYH1;ANO5;ANO8;ANO2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.3704755954240547,-0.9886820106318486,0.4722838137472284,0.7436106627354007,1.0,9/16,40.33%,ANO3;ANO1;ANO6;ANO10;TTYH3;TTYH1;ANO5;ANO8;ANO2
prerank,ribosome binding (GO:0043022),-0.2820776093965067,-0.9875342137624594,0.4425770308123249,0.743061546565577,1.0,12/46,14.35%,CPEB4;CPEB1;CPEB2;SEC61A1;EIF3C;YTHDF1;EEF2;TMCO1;SRP72;SRP19;RACK1;NOMO1
prerank,vinculin binding (GO:0017166),-0.4117450973847523,-0.9867529431895926,0.48423423423423423,0.741556042151812,1.0,3/11,5.11%,CTNNA1;TLN1;PXN
prerank,chemoattractant activity (GO:0042056),-0.327022522590696,-0.9845232797389747,0.4636363636363636,0.7435501546898906,1.0,14/26,44.03%,BMP4;SCG2;CX3CL1;VEGFA;VEGFB;PGF;FGF10;FGF7;HMGB1;HMGB2;HGF;MIF;NTF3;GDNF
prerank,pyridoxal phosphate binding (GO:0030170),-0.343729745627063,-0.9819568381868634,0.5011547344110855,0.7464730078314421,1.0,3/20,4.23%,PYGB;ABAT;SRR
prerank,triglyceride lipase activity (GO:0004806),-0.3414721805053026,-0.9813883961420751,0.5186915887850467,0.7442775883389596,1.0,7/20,38.40%,ABHD5;LIPE;PLA2G15;DDHD2;PNPLA2;LPL;PNPLA3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3745256628090962,0.9810275425125885,0.48653846153846153,1.0,1.0,1/18,0.29%,CISH
prerank,LRR domain binding (GO:0030275),0.401457701393558,0.9790102991770708,0.4854771784232365,1.0,1.0,5/14,13.40%,POLR2J;MRTFA;ZXDC;ERC1;DDIT3
prerank,C-C chemokine binding (GO:0019957),-0.3316784209930672,-0.9783421921851596,0.4801762114537445,0.7481999741157335,1.0,16/22,63.14%,CCR9;ACKR3;CX3CR1;ZFP36;CCR5;ACKR1;CCR2;CXCR4;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;CXCR2
prerank,potassium ion antiporter activity (GO:0022821),0.3991953859518243,0.9761750824902693,0.4870848708487085,1.0,1.0,3/15,6.96%,SLC9A7;SLC9A6;SLC9A8
prerank,protein tyrosine kinase binding (GO:1990782),-0.25878184666658577,-0.9758982411322872,0.5046153846153846,0.750741248965715,1.0,18/71,19.93%,GRM5;KHDRBS1;PTPN14;NEDD9;ACVR1;TP53;NOX4;PITPNM3;SIRPA;SHC3;DUSP22;RACK1;TOB1;PTPN2;SOCS5;ANGPT2;CPNE3;BMPR2
prerank,nucleosomal DNA binding (GO:0031492),0.365952665963092,0.974903739383372,0.512998266897747,1.0,1.0,8/21,19.08%,ACTL6A;ACTB;HNRNPC;RCC1;SMARCA4;RBBP4;HDAC2;SMARCB1
prerank,glutamate receptor binding (GO:0035254),-0.35854645840793137,-0.9747804368170562,0.49780701754385964,0.7498849126392493,1.0,8/17,26.62%,DLG4;SYNDIG1;SHISA6;IGSF11;SHANK2;SHANK1;CAMK2A;HIP1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.23160782232649338,0.9737313386560469,0.5688748685594112,1.0,1.0,76/732,10.86%,TBX4;SOX30;LRRFIP1;ATF3;IRX1;MAZ;ZBTB42;CTCFL;FOXQ1;DACH1;MECOM;ONECUT1;KLF8;FOXN2;TFCP2;NR4A2;TAL1;ATF6;ZFAT;LEF1;HES6;RUVBL2;GTF2IRD1;KLF2;ELK3;PAX8;ZBTB24;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;SMAD1;ZKSCAN1;PRDM15;HEY1;NR5A1;ZBTB41;IRF9;PRDM4;MYBL2;SOX2;MEIS1;YY1;GMEB2;ZNF83;ZNF740;USF2;RFX3;TBX1;ZNF260;CARF;CEBPG;CALCOCO1;FOXF2;PPARD;ZNF205;CLOCK;KDM6A;HEY2;ZBTB14;SOX13;RELA;JUND;HOXA7;TFAP4;ERG;ZKSCAN3;KLF6;WBP2;MGA;HIC2;ESR1;THRB;RBPJ;DACH2
prerank,microtubule plus-end binding (GO:0051010),0.37039129661506365,0.9732041397089257,0.5061511423550088,1.0,1.0,9/20,19.51%,KIF18A;CLASP2;DST;CLIP2;APC;CLIP1;CLASP1;PAFAH1B1;MAPRE3
prerank,phosphatidylglycerol binding (GO:1901611),0.4065067885088742,0.9727821463927876,0.502868068833652,1.0,1.0,3/13,9.93%,MME;UQCC3;PITPNA
prerank,phospholipase activity (GO:0004620),0.29251862285866365,0.9723890484791554,0.4954954954954955,1.0,1.0,10/67,14.23%,FAM83B;SMPD4;PLAAT3;PNPLA7;SEC23IP;DDHD1;PNPLA8;ABHD12;ABHD4;PNPLA6
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.4087414766892026,0.9720889242359249,0.49722735674676527,1.0,1.0,6/12,20.15%,NCBP1;GEMIN5;NCBP3;CYFIP1;LARP1;EIF4E
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.35016414555704223,-0.9714338026985703,0.5046082949308756,0.7546703259144208,1.0,8/18,28.13%,ALDH1A1;ALDH1A2;ALDH6A1;ALDH3A2;ALDH2;AKR1B10;ALDH9A1;ALDH18A1
prerank,ATPase regulator activity (GO:0060590),-0.2907534785926392,-0.9712527472628557,0.48514851485148514,0.751618486580138,1.0,11/38,17.91%,TOR1AIP2;ATP1B1;DNAJC24;ATP1B3;BAG3;DNAJC19;TOR1AIP1;ATP1B2;FNIP1;ATP5IF1;DNAJB4
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.25872791857419464,0.9712348711112213,0.5329744279946165,1.0,1.0,40/147,17.58%,THG1L;TIAM1;VAV3;EEF1D;CYTH4;NUCB2;ITSN1;DENND5B;ARHGEF6;LAMTOR1;ARHGEF7;CCDC88C;RAPGEF3;DENND1A;ARHGEF18;RAPGEF5;FGD5;EIF2B3;RAPGEF6;DOCK9;MYCBP2;SBF2;PREX2;EEF1B2;EPS8L1;RGL2;ELMO1;ANKRD27;DENND4C;ARHGEF10;RCC1;DENND1B;DOCK8;RAB3GAP1;GAPVD1;DOCK4;RASGRF2;WDR41;RGL1;RCC1L
prerank,protein kinase binding (GO:0019901),0.23477982813457365,0.9710806125560595,0.5696767001114827,1.0,1.0,76/479,14.25%,FAM83B;RAC2;FRMD5;PRKAR1A;MAP2K7;MAP3K11;PTPRR;GSK3A;CKS2;TRIB3;DUSP7;PTPRJ;EEF1A1;OXSR1;PIN1;PTPRC;MTCP1;ACTB;RPTOR;TIRAP;HDAC7;HDAC9;RFFL;PRKD2;SMAD1;NEK9;CDK5RAP1;LRBA;RBBP6;SPRED1;DCTN2;TRIM14;CDKN1A;ARHGEF7;RGCC;CALM3;FBXO5;SIRT1;CADPS;AXIN1;TRPV4;PRAM1;PLCG1;ACVRL1;RELA;RAB11FIP2;POLA1;PJA2;PKN1;FBXO7;PPP1R12A;CIR1;RNF13;ESR1;BAD;RHOG;ADIPOR1;USP37;RPS3;NBR1;TNIP2;IKBKB;KIZ;CDH5;TBC1D14;ACTA2;CTBP2;HDAC5;PLEK;CHEK2;NEK6;FAF1;MAP2K6;APC;TRIM27;GCH1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.3046535301966601,-0.970392983953097,0.5120772946859904,0.7503031367647786,1.0,13/30,26.44%,ATP7A;SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC31A1;SLC39A8;SLC11A2;SLC39A7;SLC39A6;SLC25A28;SLC30A5;TTYH1
prerank,steroid hydroxylase activity (GO:0008395),-0.35351932153532456,-0.9697283393527053,0.47884187082405344,0.7485663300161284,1.0,2/16,5.93%,CYP27A1;CYP7B1
prerank,double-stranded DNA binding (GO:0003690),0.23337882495629017,0.9676215619947256,0.5805038335158818,1.0,1.0,59/531,11.72%,SOX30;ATF3;IRX1;FOXQ1;ONECUT1;FOXN2;TFCP2;NR4A2;ATF6;LEF1;HES6;PNKP;KLF2;ELK3;PAX8;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;HEY1;NR5A1;IRF9;PRDM4;MYBL2;FLI1;BBX;YY1;GMEB2;ZNF740;USF2;CPSF4;RFX3;TBX1;TDG;CEBPG;PPARD;ZNF638;CLOCK;HEY2;ZBTB14;SPRTN;JUND;HOXA7;PCID2;TFAP4;MSH3;ERG;PARK7;TARDBP;KLF6;ESR1;THRB;RAD51B;APTX;NFIC;RPS3;POLR3F;HDGF
prerank,neuropeptide hormone activity (GO:0005184),0.35609296482412056,0.9628237910880744,0.5209790209790209,1.0,1.0,22/22,64.44%,PPY;AGRP;OXT;CORT;QRFP;HCRT;GHRH;NPPA;UCN;CALCB;GAL;CRH;VIP;NMB;PNOC;NPFF;NPY;GRP;SPX;CCK;PENK;ADCYAP1
prerank,kinase activator activity (GO:0019209),-0.30113086528433464,-0.9622660023440761,0.5340050377833753,0.7632646181223164,1.0,9/30,16.72%,PRKAG2;WNK1;MALT1;CAB39;STRADA;STK11;MADD;RPLP1;GPRC5B
prerank,protein heterodimerization activity (GO:0046982),0.24943585202619833,0.9606126537030505,0.5653896961690885,1.0,1.0,33/178,14.65%,MIGA1;ATF3;SIM1;NR4A2;ATF6;SAE1;BCL2L2;ZHX3;PPP2CA;RALGAPA2;EXT2;PHB2;USF2;FXR1;RALGAPB;UBA2;SNX1;FZD9;FBXO7;NAE1;GTF2A2;ITGA3;IKBKB;CHUK;TPM2;RRAGC;YWHAH;TENM4;EPAS1;DDIT3;RALGAPA1;CYBA;RCC1
prerank,ATP hydrolysis activity (GO:0140603),0.3128943159254025,0.9590262300068401,0.5131147540983606,1.0,1.0,10/41,18.30%,ABCB10;RUVBL2;VWA8;RUVBL1;DDX3X;CHD3;MYO1E;TOR3A;VPS4B;MYO18A
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.4029918310661537,-0.9583901099244935,0.5377777777777778,0.769059251404731,1.0,5/11,36.94%,SLC2A10;SLC5A3;SLC17A5;SLC5A11;SLC2A9
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.303914427623172,-0.9546383173853393,0.5513784461152882,0.7747822293962571,1.0,5/29,6.59%,SLC13A3;SLC26A7;SLC1A5;SLC25A13;SLC26A2
prerank,copper ion binding (GO:0005507),0.31217109899038525,0.9528262351113859,0.5245901639344263,1.0,1.0,9/42,15.71%,SNCG;RNF7;SOD1;PARK7;PAM;PRNP;CUTC;S100A13;ANG
prerank,sialyltransferase activity (GO:0008373),0.3608335078912944,0.9519293440560875,0.5276292335115864,1.0,1.0,6/20,14.61%,ST6GALNAC3;ST8SIA1;ST3GAL6;ST3GAL1;ST6GALNAC2;ST8SIA6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2935495450775275,0.9515832962294872,0.5412698412698412,1.0,1.0,10/54,13.20%,AMDHD2;ACER2;GLS2;GLS;HDAC9;HDAC3;SIRT1;NADSYN1;ACER3;HDAC5
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.2263597479792385,0.9514569829276945,0.6456361724500526,1.0,1.0,75/731,10.86%,TBX4;SOX30;LRRFIP1;ATF3;IRX1;MAZ;ZBTB42;CTCFL;FOXQ1;DACH1;MECOM;ONECUT1;KLF8;TFCP2;NR4A2;TAL1;ATF6;ZFAT;LEF1;HES6;RUVBL2;GTF2IRD1;KLF2;ELK3;PAX8;ZBTB24;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;SMAD1;ZKSCAN1;PRDM15;HEY1;NR5A1;ZBTB41;IRF9;PRDM4;MYBL2;SOX2;MEIS1;YY1;GMEB2;ZNF83;ZNF740;USF2;RFX3;TBX1;ZNF260;CARF;CEBPG;CALCOCO1;FOXF2;PPARD;ZNF205;CLOCK;KDM6A;HEY2;ZBTB14;SOX13;RELA;JUND;HOXA7;TFAP4;ERG;ZKSCAN3;KLF6;WBP2;MGA;HIC2;ESR1;THRB;RBPJ;DACH2
prerank,mannose binding (GO:0005537),0.39860847435488,0.9495303561701705,0.5287769784172662,1.0,1.0,1/12,4.27%,LMAN2
prerank,C-C chemokine receptor activity (GO:0016493),-0.32814916310668996,-0.9466862536957887,0.5146726862302483,0.7903207471798444,1.0,15/21,63.14%,CCR9;ACKR3;CX3CR1;CCR5;CCR2;CXCR4;GPR75;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;CXCR2
prerank,peptidase activator activity (GO:0016504),-0.32356060068464276,-0.9455020728201249,0.5103926096997691,0.789529443051601,1.0,15/22,34.71%,CASP8AP2;VCP;PCOLCE2;PSME4;PCOLCE;EBAG9;TANK;PINK1;APH1B;CLPX;PSME2;PSME3;CAV1;PSME1;PSENEN
prerank,DNA replication origin binding (GO:0003688),0.3512415607374102,0.9454712769255488,0.5446584938704028,1.0,1.0,5/23,11.47%,ORC3;CDC45;ORC4;POLA1;ORC2
prerank,SH3 domain binding (GO:0017124),0.29051565987114325,0.9424108025689506,0.5657492354740061,1.0,1.0,16/62,17.02%,CBL;VASP;CABYR;SHANK3;EVL;SGIP1;PTPN12;REPS1;SYNJ2;ELMO1;CYBA;RUFY1;ABI2;ARHGAP27;CD2AP;ADAM9
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.377605420436837,-0.9423613052714,0.5384615384615384,0.7937671574954352,1.0,8/13,27.08%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1;ALDH2;ADH5;ALDH9A1;ALDH1L2
prerank,NAD binding (GO:0051287),-0.3091373301414006,-0.9422565990650392,0.5452322738386308,0.790548564640559,1.0,5/26,7.04%,ALDH1A1;ME1;ZC3HAV1;SIRT2;GLUD1
prerank,calcium channel regulator activity (GO:0005246),-0.2881672134026503,-0.9422052718258042,0.5634146341463414,0.7872720499181202,1.0,8/37,12.21%,ITPR1;STIM2;NRXN1;STIM1;SGK1;CACNG7;NRXN2;SRI
prerank,histone acetyltransferase binding (GO:0035035),-0.32795230073078413,-0.9408513262487955,0.5128205128205128,0.7870342721033127,1.0,6/21,19.51%,GLI3;KANSL1L;SIRT2;TP53;EID1;STAT1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.24390694762891263,-0.9406304668561559,0.5585284280936454,0.7841555134546746,1.0,24/74,23.06%,DGKI;NADK2;PIK3C2B;GK;NADK;DCAKD;PIK3C3;DGKH;PANK3;FAM20C;ADK;PKM;CHKA;AGK;FAM20A;PAPSS2;NT5C3A;IDNK;HYKK;NOL9;DGKQ;HK2;CHKB;RFK
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.3680003597688097,-0.9404312397208745,0.5299145299145299,0.7812465300614125,1.0,6/13,27.39%,GPSM1;GDI1;ARHGDIA;ARHGDIB;ITGB1BP1;SH3BP4
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.23821986727168326,0.9402035258179718,0.6205583756345178,1.0,1.0,50/232,17.71%,RNF7;CBL;ARIH1;RNF149;RNF38;RFFL;BIRC2;NEDD4L;NEURL2;VPS11;NHLRC1;RBBP6;UBE3A;TRIM14;IRF2BPL;RNF130;NFX1;COP1;RNF187;PPP1R11;TRIM25;MDM2;RFWD3;MYCBP2;PIAS2;UBE3D;RNF6;ZNRF1;RNF13;RNF25;ANAPC11;PIAS1;DTX4;RNF11;CUL3;RNF216;RNF180;TRIM27;FANCL;TRIM3;NHLRC3;RNF114;PELI1;RNF128;RNF125;VPS18;UBR3;MSL2;KCMF1;RNF215
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.30552272462556135,0.9400928585789751,0.5504885993485342,1.0,1.0,5/42,9.02%,CKS2;CCNC;CCNH;CDKN1A;CCNG2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.22140597568124884,0.9388311701941943,0.6955161626694474,1.0,1.0,84/831,10.86%,TBX4;SOX30;LRRFIP1;ATF3;IRX1;MAZ;ZBTB42;CTCFL;FOXQ1;DACH1;MECOM;SIM1;ONECUT1;KLF8;TFCP2;NR4A2;TAL1;ATF6;ZFAT;LEF1;HES6;RUVBL2;GTF2IRD1;KLF2;ELK3;STOX1;PAX8;ZBTB24;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;SMAD1;ZKSCAN1;PRDM15;HEY1;NR5A1;ZBTB41;IRF9;PRDM4;MYBL2;BBX;SOX2;MEIS1;YY1;GMEB2;ZNF83;ZNF740;USF2;ZSCAN2;VEZF1;RFX3;TBX1;ZNF260;NFX1;CARF;CEBPG;CALCOCO1;FOXF2;PPARD;ZNF205;ACTN4;CLOCK;ZNF3;KDM6A;HEY2;ZBTB14;SOX13;RELA;JUND;HOXA7;TFAP4;ERG;TRPS1;ZKSCAN3;KLF6;WBP2;MGA;HIC2;ESR1;THRB;RBPJ;DACH2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3132261532110876,-0.9378621569472152,0.552863436123348,0.7840294641440676,1.0,10/24,27.64%,CAMK4;PHKA2;CAMK2D;CAMK1;DAPK1;PHKG2;MKNK2;CAMK2B;CAMK2A;MAPKAPK2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.2938223676761265,0.9357606519034076,0.5568,1.0,1.0,14/53,17.97%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC17A6;SLC1A2;SLC25A2;SFXN1;SLC25A12;SLC38A5;SLC66A1;SLC25A38;SLC7A5;SLC43A2
prerank,voltage-gated anion channel activity (GO:0008308),0.3793298414420678,0.9357325451444328,0.5437262357414449,1.0,1.0,3/15,5.58%,CLCN3;GPR89B;GPR89A
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.35178981868270465,-0.9351035379892523,0.5781584582441114,0.787208218592782,1.0,6/16,20.90%,MTMR7;SACM1L;MTMR12;MTMR9;MTMR4;MTMR11
prerank,exopeptidase activity (GO:0008238),-0.25858735011314227,-0.9338944755328423,0.5679347826086957,0.786798862459476,1.0,16/50,21.15%,DPP6;RNPEP;TRHDE;DPP4;ANPEP;FAP;DPP10;CPM;CTSA;NAALAD2;CTSZ;LAP3;ACE;ENPEP;DPP3;GGH
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.2596867491512273,-0.9329966144747223,0.575,0.7856151483960773,1.0,14/51,18.17%,SLCO3A1;MCU;SLC22A8;ANKH;SLC25A3;SLC22A4;SLC20A1;TMEM241;SLC35D2;SLC22A6;SLC16A2;SLC16A10;SLC5A6;SLC5A5
prerank,androgen receptor binding (GO:0050681),-0.3055342054961919,-0.9317781898268962,0.562358276643991,0.7851086719206687,1.0,5/25,8.52%,DDX5;FOXP1;RNF14;WIPI1;SNW1
prerank,lysine-acetylated histone binding (GO:0070577),-0.3218374907895814,-0.9289502192057767,0.5804988662131519,0.7851952690116492,1.0,6/20,12.95%,KMT2A;BRD9;BRD7;PSME4;BRD4;DPF2
prerank,acetylation-dependent protein binding (GO:0140033),-0.3218374907895814,-0.9289502192057767,0.5804988662131519,0.7851952690116492,1.0,6/20,12.95%,KMT2A;BRD9;BRD7;PSME4;BRD4;DPF2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.3723575248556607,0.9284317936091289,0.56672760511883,1.0,1.0,6/16,18.03%,ATP6V1D;ATP6V0D1;ATP6V0E1;ATP6V1B2;ATP5F1B;ATP6V1A
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.3723575248556607,0.9284317936091289,0.56672760511883,1.0,1.0,6/16,18.03%,ATP6V1D;ATP6V0D1;ATP6V0E1;ATP6V1B2;ATP5F1B;ATP6V1A
prerank,histone deacetylase binding (GO:0042826),0.2634254441439893,0.9275482857993126,0.5955882352941176,1.0,1.0,16/88,13.91%,TAL1;LEF1;HDAC9;HDAC3;MAPK8;YWHAB;SFPQ;HEY2;RELA;TFAP4;PKN1;AKAP8L;CIR1;SP1;HDAC5;HES1
prerank,voltage-gated chloride channel activity (GO:0005247),-0.40097992140943295,-0.9271285575484869,0.5725646123260437,0.7859091951297577,1.0,4/10,14.22%,CLCN6;ANO1;CLCN2;ANO6
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.34714946840665384,0.9254433280260486,0.571912013536379,1.0,1.0,5/24,16.52%,PPIP5K2;NME1;IP6K2;DTYMK;ITPKB
prerank,N-methyltransferase activity (GO:0008170),0.34926818363706547,0.9239112325415532,0.5645161290322581,1.0,1.0,4/20,13.14%,TRMO;TRMT11;SETD3;RNMT
prerank,ubiquitin protein ligase activity (GO:0061630),0.23430521192966328,0.9225438511961279,0.6624525916561315,1.0,1.0,48/228,17.71%,RNF7;CBL;ARIH1;RNF149;RNF38;RFFL;BIRC2;NEDD4L;NEURL2;VPS11;NHLRC1;RBBP6;UBE3A;TRIM14;IRF2BPL;RNF130;NFX1;COP1;RNF187;PPP1R11;TRIM25;MDM2;RFWD3;MYCBP2;UBE3D;RNF6;ZNRF1;RNF13;RNF25;ANAPC11;DTX4;RNF11;CUL3;RNF216;RNF180;TRIM27;FANCL;TRIM3;NHLRC3;RNF114;PELI1;RNF128;RNF125;VPS18;UBR3;MSL2;KCMF1;RNF215
prerank,transcription cis-regulatory region binding (GO:0000976),0.2238103195026029,0.9217831547159677,0.7048054919908466,1.0,1.0,58/406,14.27%,ATF3;CTCFL;DACH1;SIM1;ARID5A;FOXN2;TFCP2;MTERF3;TAL1;ATF6;LEF1;ELK3;STOX1;PAX8;GABPA;NR5A1;MMP12;FLI1;BBX;SMARCA2;SOX2;YY1;ZSCAN2;VEZF1;RFX3;NFX1;CALCOCO1;FOXF2;SFPQ;LONP1;ACTN4;DRAP1;ZNF3;ZBTB14;SOX13;RELA;XRN2;JUND;TFAP4;PARK7;TRPS1;CARM1;RPS3;ZBED4;E2F3;SP1;MZF1;IRF2;CHD3;TBP;HDAC5;EPAS1;DDIT3;THRA;CREBRF;DR1;GRHL1;PURG
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.38645677274378065,0.9213396038680458,0.5631067961165048,1.0,1.0,4/12,14.36%,BCL2L13;BAD;NOD1;APAF1
prerank,sterol binding (GO:0032934),-0.25055378050151994,-0.9198843850301649,0.6137071651090342,0.7986965904405702,1.0,15/56,15.12%,OSBPL9;GRAMD1B;OSBPL11;OSBPL6;SIDT1;VDAC1;GRAMD1C;OSBP;INSIG2;OSBPL5;ABCA1;RORA;OSBP2;STARD5;GRAMD1A
prerank,nuclear localization sequence binding (GO:0008139),0.35368628631622134,0.9185297525817974,0.5727272727272728,1.0,1.0,7/18,20.50%,KPNA3;KPNA1;NFKBIA;KPNB1;POM121;BRAP;RANBP6
prerank,lipoprotein particle receptor binding (GO:0070325),-0.2948740419219886,-0.9182567950819637,0.5654205607476636,0.7987769504049164,1.0,5/27,12.26%,LRP1;RELN;HSPG2;AP2A1;MESD
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.3932253983634149,-0.9175288853272904,0.5840163934426229,0.7972788187811308,1.0,8/10,38.80%,FAN1;DNAJC2;DNAJB2;ANKRD13D;ANKRD13B;LAPTM5;FAAP20;IDE
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3954556126752634,-0.9170712032252151,0.5733855185909981,0.7950260257902951,1.0,3/10,4.57%,PRKAG2;PKIG;PRKAG1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.3901558824696888,-0.9168656940848857,0.5883534136546185,0.792230410916765,1.0,2/10,14.26%,SLCO3A1;SLC22A6
prerank,palmitoyltransferase activity (GO:0016409),0.32249481108912614,0.9152212480742182,0.5797598627787307,1.0,1.0,6/28,14.04%,ZDHHC17;ZDHHC13;ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,carboxylic acid binding (GO:0031406),0.3122718464665692,0.9151361967309978,0.5980392156862745,1.0,1.0,2/38,0.78%,PCK1;GCLC
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.327221703906606,-0.9131020858295341,0.591324200913242,0.7974908501013004,1.0,4/20,5.78%,LPGAT1;AGPAT4;ABHD5;AGPAT5
prerank,metalloaminopeptidase activity (GO:0070006),0.3642783860375307,0.9108717291505243,0.5760456273764258,1.0,1.0,1/16,0.22%,LVRN
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.3873496733040596,-0.9108466470450889,0.579175704989154,0.7993842253164021,1.0,2/11,14.15%,SLC22A4;SLC25A47
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.35393167268564024,-0.9099811422755332,0.56,0.79807654238701,1.0,3/14,5.65%,SLC7A11;SLC1A3;SLC25A13
prerank,cytokine receptor binding (GO:0005126),-0.2281364314728831,-0.9095787956249479,0.6616314199395771,0.795781773448743,1.0,11/83,13.88%,TGFBR3;SMAD3;JAK1;OSMR;IL6R;PIBF1;IL34;IL13RA1;SOCS2;IL18;IL6ST
prerank,lipoprotein particle binding (GO:0071813),-0.3292215492399665,-0.9095125349991529,0.5714285714285714,0.7928350953245149,1.0,6/20,18.47%,MAPT;SORL1;LDLR;THBS1;HSPD1;SCARF1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2919332182259402,-0.909081312312619,0.5841346153846154,0.7906388679589109,1.0,17/28,43.08%,PRORP;AGO3;DICER1;ELAC1;RPP30;RPP14;DROSHA;RPP21;DBR1;EDC3;RNASEH2A;ELAC2;POP4;RPP38;NUDT16;NUDT16L1;MRPL44
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.33452790720873427,0.9075701890686717,0.5618181818181818,1.0,1.0,4/21,9.15%,CDK19;CDK11B;CDK4;CDKL4
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.33452790720873427,0.9075701890686717,0.5618181818181818,1.0,1.0,4/21,9.15%,CDK19;CDK11B;CDK4;CDKL4
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.30271048005569884,0.9072588754600068,0.606473594548552,1.0,1.0,6/35,10.61%,SRC;FYN;SYK;PEAK1;LYN;YES1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.3421871139966663,-0.9042529855461596,0.5726141078838174,0.7980374894857124,1.0,3/15,27.00%,CCR9;CMKLR1;CX3CR1
prerank,calcium ion binding (GO:0005509),0.226525151436494,0.9023023406099713,0.7166276346604216,1.0,1.0,43/323,12.62%,SPOCK2;EFHD2;LCP1;EML1;SLC25A24;CABYR;ASTN2;CETN3;PPP3CB;ADGRL3;NUCB2;LTBP4;MEX3B;ATP2A2;CDH2;ITSN1;ESYT2;MMP12;EFHD1;SDF4;RASGRP3;CIB1;RET;SELP;MCTP2;CALM3;CDH12;RCN2;AIF1L;S100A16;TRPM4;MCTP1;ACER3;PAM;PPP3CA;PRNP;PPP3R1;AGRN;MICU3;LETM1;IDS;SLC25A12;CDH5
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.32690485554890664,0.9011195601352121,0.6038062283737025,1.0,1.0,5/24,14.04%,ZDHHC17;ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.39094143662416214,-0.9009268969000205,0.584051724137931,0.8020901561410552,1.0,1/10,1.62%,DPYSL3
prerank,gamma-tubulin binding (GO:0043015),0.33743389872795765,0.9004672002268389,0.5950704225352113,1.0,1.0,5/21,10.80%,TUBGCP5;ARHGEF7;RAB11FIP5;PAK1;DDX3X
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3208256456382669,0.8996217768623557,0.601063829787234,1.0,1.0,6/26,15.43%,SAG;BOD1;PPP1R11;MGAT5;CABIN1;PPP1R8
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.288454876051357,-0.8993501717491516,0.6346604215456675,0.8025857247467085,1.0,6/28,19.51%,EDA;CASP8AP2;MADD;TRAF2;TMBIM1;STAT1
prerank,NF-kappaB binding (GO:0051059),0.3234181382604195,0.8965732187489164,0.6075949367088608,1.0,1.0,9/24,18.37%,HDAC3;EP300;RELA;RNF25;TAF4B;FAF1;NFKBIA;NPM1;HDAC2
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3761175999351587,-0.8948052346968337,0.6164383561643836,0.8094124568561059,1.0,5/11,10.94%,RAD50;HNRNPA2B1;STN1;RPA1;HNRNPA1
prerank,neuropeptide receptor activity (GO:0008188),0.31076765400018214,0.8945760374680587,0.6212361331220285,1.0,1.0,2/29,2.10%,NPFFR1;TACR1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.39356151624632624,0.8944601502863923,0.5992217898832685,1.0,1.0,1/11,0.80%,MAP3K11
prerank,translation initiation factor activity (GO:0003743),0.29751749918934944,0.892413349936281,0.6103448275862069,1.0,1.0,13/36,20.22%,EIF2S1;EIF2A;EIF3B;EIF2B3;EIF4G2;EIF5;EIF3M;EIF2S2;EIF3A;EIF4G1;EIF3E;EIF4E;EIF1
prerank,anion transmembrane transporter activity (GO:0008509),-0.36726282963125334,-0.891658240424658,0.6103896103896104,0.8126655675938356,1.0,5/12,15.92%,SLC39A8;SLC22A6;SLC26A11;SLC4A2;SLC19A1
prerank,protein kinase regulator activity (GO:0019887),-0.22146720329825179,-0.8905407814474935,0.7435064935064936,0.8116983082416538,1.0,20/95,15.07%,PRKAG2;CCNL2;PARVA;DNAJC3;ELP4;WNK1;PRKAG1;GMFB;TAOK3;CAB39;CDKN1B;CCND3;STRADA;STK11;PRKAR1B;CCNT1;DUS2;MADD;RPLP1;CCNK
prerank,mechanosensitive ion channel activity (GO:0008381),-0.35537541705061426,-0.8898280222654344,0.6129032258064516,0.8100441551945005,1.0,5/12,28.80%,PIEZO2;TMEM63A;TMEM63B;TMC4;TMC6
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.38444512186019664,0.8895917086385925,0.5806451612903226,1.0,1.0,2/11,11.52%,APLF;RPS3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3391380029289994,-0.8885560294967124,0.6242544731610338,0.8095003536771483,1.0,8/15,38.36%,PLA2G4A;SNX3;SAP30L;SH3PXD2B;PLEKHF1;JPH2;PLA2G4E;PHLDA3
prerank,mannosyltransferase activity (GO:0000030),0.3354374811075314,0.8881384838610605,0.6179577464788732,1.0,1.0,5/21,11.29%,TMTC2;DPY19L4;ALG8;DPY19L1;PIGB
prerank,sodium channel regulator activity (GO:0017080),0.2955582857927338,0.8876186120746625,0.6344262295081967,1.0,1.0,4/37,6.33%,RSC1A1;NEDD4L;FXYD6;FGF13
prerank,transcription coactivator binding (GO:0001223),0.3253187130955789,0.8872533653447933,0.6,1.0,1.0,6/20,10.75%,RPL23;PPARD;RELA;ESR1;TERT;THRB
prerank,kinase activity (GO:0016301),0.2441937473956277,0.8861625716720425,0.6772413793103448,1.0,1.0,26/109,18.04%,PIK3CG;PPIP5K2;TRIB3;DGKB;PIK3C2G;PANK2;CERKL;LYN;ETNK1;PI4KA;PIK3CD;IP6K2;MAP4K4;TRRAP;PAPSS1;PIK3C2A;PGM2L1;CDKL5;TAF1;CERK;ITPKB;PANK1;PANK4;SEPHS1;DGKK;ADPGK
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.3489094537102207,-0.8859085507049262,0.6244343891402715,0.8119790648643168,1.0,4/15,12.10%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1
prerank,serine-type endopeptidase activity (GO:0004252),0.2602135187411595,0.8844393032561673,0.6807580174927114,1.0,1.0,2/80,0.59%,PCSK1;CELA1
prerank,calcium:sodium antiporter activity (GO:0005432),-0.37480218308321533,-0.8841272951134638,0.6244725738396625,0.8125347476326791,1.0,2/10,9.99%,SLC24A3;SLC24A2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.22863370880643216,0.8825201025771253,0.7439490445859872,1.0,1.0,30/188,14.06%,ATF3;CTCFL;ARID5A;MTERF3;TAL1;ATF6;PAX8;GABPA;FLI1;SMARCA2;SOX2;YY1;RFX3;CALCOCO1;SFPQ;ZBTB14;SOX13;RELA;JUND;TFAP4;CARM1;ZBED4;SP1;MZF1;CHD3;TBP;HDAC5;DDIT3;THRA;GRHL1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.31581260989701077,-0.8813854991893143,0.6234718826405868,0.8149215361331911,1.0,17/18,68.45%,DHRS11;HSD17B7;HSD17B8;HSD11B1;HSD17B10;HSD17B2;HSD3B7;HSD17B14;HSD17B1;SRD5A2;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.2316322260220391,-0.8813322921639466,0.723404255319149,0.8119634059477329,1.0,6/73,6.20%,SORCS1;CALCRL;LGR4;SORCS3;NPR3;EDNRA
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.37627535302541704,0.8795975150414056,0.6206261510128913,1.0,1.0,3/12,17.16%,PDE4D;PDE8B;PDE8A
prerank,phosphotyrosine residue binding (GO:0001784),0.2928846940407734,0.8794253343686302,0.6420168067226891,1.0,1.0,10/37,18.41%,BCAR3;PFN1;SAMSN1;SYK;YES1;CRKL;LDLRAP1;SHC1;PTPN11;IRS1
prerank,ribonuclease activity (GO:0004540),0.27159894557171055,0.8794120465146348,0.6494522691705791,1.0,1.0,18/56,20.97%,ZC3H12D;RNASE6;CNOT7;EXOSC9;RNASE12;CNOT6;EXOSC1;PPP1R8;ANG;RNASE4;N4BP1;SMG6;TSNAX;DIS3L2;EXOSC7;AGO1;ERN1;RNASE1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.35246571291569223,0.8784103197020199,0.6307129798903108,1.0,1.0,4/15,12.49%,SLC1A1;SLC17A6;SLC1A2;SLC25A12
prerank,manganese ion binding (GO:0030145),0.28084858015127245,0.8771696814382958,0.664576802507837,1.0,1.0,9/48,15.49%,PCK1;GYG1;PIM1;SOD2;EXD2;PAPOLA;MGAT5;IMPA1;DYRK2
prerank,MAP kinase activity (GO:0004707),0.3695024917559527,0.8766048481882985,0.6206225680933852,1.0,1.0,5/14,12.69%,MAPK3;MAPK8;NLK;MAPK6;MAPK12
prerank,cholesterol binding (GO:0015485),0.2764199775752206,0.8764050720384049,0.6741741741741741,1.0,1.0,11/47,13.79%,PROM1;OSBPL10;TSPO;SOAT1;OSBPL1A;CD81;ERLIN2;STARD3NL;NPC2;NPC1;OSBPL2
prerank,Notch binding (GO:0005112),-0.3025958506194525,-0.8761206296004032,0.6587112171837709,0.8194444345527334,1.0,5/22,16.37%,SNED1;DNER;SNW1;MEGF10;CCN3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3024981121826684,0.8754610192251214,0.6284779050736498,1.0,1.0,9/32,18.00%,JMJD4;ALKBH2;KDM2A;TET3;EGLN2;PHF8;FTO;TET2;KDM4C
prerank,single-stranded DNA binding (GO:0003697),0.2481949620378554,0.8751646980189558,0.7050147492625368,1.0,1.0,17/93,12.85%,CTC1;PCBP1;ERCC4;SSBP1;PMS2;CDC45;LONP1;MLH1;SPRTN;POLA1;RAD23A;MSH3;PARK7;RAD51B;APTX;TOP3A;NUP35
prerank,cytokine activity (GO:0005125),-0.20655812354680914,-0.874017443530696,0.8274509803921568,0.8205965145642405,1.0,22/131,24.21%,BMP6;WNT5B;BMP5;BMP7;BMP4;IL34;WNT4;AIMP1;IL16;WNT9A;CCL14;IL18;IL33;TNFRSF11B;TGFB1;SCG2;CX3CL1;CCL13;VEGFA;IL17D;CKLF;TGFB3
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.26796182665355867,0.8727949141162294,0.6797488226059655,1.0,1.0,14/57,14.40%,NDUFB6;NDUFB4;COX6B1;NDUFA10;NDUFA1;NDUFS2;COX5A;NDUFB7;COX15;NDUFV3;NDUFA8;NDUFC2;NDUFA13;COX10
prerank,tau-protein kinase activity (GO:0050321),0.3274690501556675,0.8647232486612141,0.6236363636363637,1.0,1.0,3/20,6.68%,GSK3A;FYN;SIK3
prerank,phospholipid transfer activity (GO:0120014),0.3263335270580827,0.8644898938902463,0.6523297491039427,1.0,1.0,8/21,19.03%,PRELID3B;PRELID2;PITPNA;OSBPL2;CERT1;PLEKHA3;PITPNB;PLTP
prerank,histone deacetylase activity (GO:0004407),0.33197428028260106,0.8629598130171489,0.6678966789667896,1.0,1.0,4/19,7.30%,HDAC9;HDAC3;SIRT3;SIRT1
prerank,aminopeptidase activity (GO:0004177),0.3121873771096503,0.8617605539826307,0.6762075134168157,1.0,1.0,2/26,5.07%,LVRN;METAP2
prerank,protein phosphatase activator activity (GO:0072542),0.37195269629880656,0.8615968273308461,0.656,1.0,1.0,6/13,21.17%,CALM3;PTPA;PPP2R5A;CALM1;PPP2R5C;PHACTR4
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.32029809395889336,0.8605277907044393,0.6528301886792452,1.0,1.0,5/22,14.38%,APOE;SNX17;PICALM;LDLRAP1;AP2M1
prerank,SUMO binding (GO:0032183),-0.33962959804671167,-0.8604576418353964,0.6565874730021598,0.8447052184446543,1.0,4/13,9.20%,CASP8AP2;PML;RNF4;USPL1
prerank,protein kinase C binding (GO:0005080),0.2756865760223201,0.8596814125219554,0.6819727891156463,1.0,1.0,8/43,13.31%,TIRAP;HDAC7;HDAC9;PRKD2;TRPV4;PKN1;HDAC5;PLEK
prerank,chemokine activity (GO:0008009),0.30106131330825964,0.8580355552785444,0.6890756302521008,1.0,1.0,2/31,8.51%,CXCL12;CCL25
prerank,RNA stem-loop binding (GO:0035613),0.3624950576611471,0.8556976274376071,0.6284046692607004,1.0,1.0,7/12,24.36%,DDX3X;RC3H1;DHX9;RC3H2;FMR1;MYH10;CPEB3
prerank,channel activity (GO:0015267),-0.24781851425745094,-0.8555262338081959,0.7098445595854922,0.8512890460237753,1.0,11/41,26.66%,PDPN;AQP4;MPV17;TMEM120B;BCL2;MCUB;TMEM120A;PANX1;AQP11;CHRNA7;TRPV2
prerank,diacylglycerol kinase activity (GO:0004143),-0.3625512938949087,-0.8546693497614231,0.6905263157894737,0.8498173147549473,1.0,3/11,12.50%,DGKI;DGKH;AGK
prerank,MHC protein binding (GO:0042287),0.3251552258203903,0.8541272418021814,0.6583629893238434,1.0,1.0,5/20,20.09%,TUBB;CD81;ATP5F1B;DERL1;TAP2
prerank,phosphatidylinositol binding (GO:0035091),0.2454150032923776,0.8531132292998562,0.7422096317280453,1.0,1.0,23/91,16.72%,EXOC8;MCF2L;SNX8;ESYT2;PLEKHF2;DENND1A;SNX17;EPB41;WDFY1;SNX1;PITPNA;ING2;ZFYVE9;SCARB1;PICALM;MYO1E;SNX24;AIDA;PARD3;DENND1B;PIGU;SNX16;ZFYVE1
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.24330198830090516,-0.8519378137999818,0.7432432432432432,0.8519884173323242,1.0,13/49,20.57%,ATP1A2;MPPED2;PLCXD3;SACM1L;DUSP16;FRA10AC1;ENPP6;PTPN22;ACP2;PTPRO;GDPD3;LHPP;SBF1
prerank,signal sequence binding (GO:0005048),0.2858365726218994,0.8513844843359802,0.6766169154228856,1.0,1.0,9/35,17.45%,TOMM20;KPNA3;KDELR2;KPNA1;SEC61A2;NFKBIA;AP2M1;KPNB1;POM121
prerank,tumor necrosis factor receptor binding (GO:0005164),0.3598221360243569,0.8506402883797292,0.626953125,1.0,1.0,2/12,9.00%,TRAF5;TRAF3
prerank,exoribonuclease activity (GO:0004532),0.36778367884746055,0.8498537599217373,0.6679245283018868,1.0,1.0,4/12,13.15%,CNOT7;EXOSC9;CNOT6;EXOSC1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.30333512806081103,0.8486823691002648,0.6761565836298933,1.0,1.0,8/27,16.97%,ARIH1;DCUN1D4;AUP1;UBE3D;RNF180;RNF125;DCUN1D2;DCUN1D1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.29163177439088395,-0.8466306302118188,0.6809954751131222,0.8589314437314606,1.0,2/21,4.75%,GLRB;P2RX4
prerank,gated channel activity (GO:0022836),0.3468294897296288,0.844823597137227,0.6907020872865275,1.0,1.0,2/14,8.37%,TMEM266;TMC7
prerank,heme binding (GO:0020037),0.2556799640613309,0.8434095719210861,0.7236842105263158,1.0,1.0,9/65,11.55%,HMOX2;CYCS;PTGES2;SRC;THAP4;CYB5R4;CYP1B1;NOS3;COX15
prerank,ankyrin binding (GO:0030506),0.32661686430014975,0.8421354200159687,0.6827458256029685,1.0,1.0,2/19,2.03%,SPTB;PTPRC
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.32713913318318144,-0.841519966171607,0.6728395061728395,0.8656573833555955,1.0,5/14,20.90%,MTMR7;MTMR12;MTMR9;MTMR4;MTMR11
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.34491742778855133,0.8407264395087962,0.7017543859649122,1.0,1.0,3/15,8.69%,NDST3;HS6ST1;HS3ST2
prerank,mitogen-activated protein kinase binding (GO:0051019),0.29849823899267924,0.838044383311945,0.6970740103270223,1.0,1.0,5/29,14.25%,DUSP7;PTPRJ;SIRT1;NBR1;GCH1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.26413604969223525,-0.8379579484951096,0.7580246913580246,0.8690523652293392,1.0,10/31,26.78%,UBE2N;UBE2E1;UBE2J2;UBE2J1;UBE2K;UBE2Q1;UBE2B;UBE2E2;UBE2S;UBE2G2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.2807908150178143,0.8375099646587781,0.7232597623089984,1.0,1.0,11/35,17.31%,RUVBL2;MMP12;DRAP1;RELA;PARK7;TBP;DR1;BAZ2A;TAF1;SMARCA4;NPM1
prerank,telomerase RNA binding (GO:0070034),0.3065048432375721,0.837388795587343,0.6690391459074733,1.0,1.0,9/22,19.90%,HNRNPC;TERT;DKC1;PARN;SMG6;SMG5;SNRPD3;DHX36;SMG7
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.34323359697613054,0.8363921889530244,0.6653992395437263,1.0,1.0,3/14,15.70%,RDH11;RDH10;AKR1A1
prerank,methyl-CpG binding (GO:0008327),0.31192518362108385,0.8323401511648075,0.6860670194003528,1.0,1.0,4/22,11.13%,ZBTB33;CHTOP;TET3;ERH
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.25744722211875903,-0.8311886930880181,0.7493670886075949,0.8785606316479474,1.0,12/34,21.33%,IQGAP1;CAB39;MAP2K2;STRADA;CCNT1;TAOK1;FAM20A;IGF2;CCNK;IRGM;PARP16;ETAA1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.323833077384447,0.8310205943111131,0.6924398625429553,1.0,1.0,2/18,3.83%,RPS6KA1;BIRC2
prerank,hexosyltransferase activity (GO:0016758),0.23543427674078216,0.8309598729802995,0.7916063675832128,1.0,1.0,8/101,4.62%,CSGALNACT1;GYG1;TMTC2;CHSY3;POMGNT2;EXT2;ALG6;DPY19L4
prerank,protein phosphatase regulator activity (GO:0019888),0.2560199924855102,0.8301345072285413,0.7589424572317263,1.0,1.0,18/53,20.27%,SAG;PPP2R2D;BOD1;PPP1R16B;CALM3;RCAN2;ANKLE2;MGAT5;CABIN1;PTPA;PPP6R1;PPP2R3A;PPP2R5A;CALM1;IGBP1;PPP2R5C;PPP1R2;RCAN3
prerank,DNA-binding transcription factor binding (GO:0140297),0.2155907302007754,0.8254091107451162,0.8567708333333334,1.0,1.0,39/189,16.20%,CHCHD2;TAL1;HES6;DMAP1;HIPK2;HDAC7;HDAC9;GABPA;USF2;EP300;PPARD;SIRT1;HEY2;RELA;PIAS2;PARK7;LMO2;RBPJ;CREBBP;CTBP1;TLE4;PIAS1;IFI27;SP1;NBN;TBP;RERE;HDAC5;DDIT3;NEK6;HES1;HCFC1;CRTC3;MAP3K10;TCERG1;TAF1;ID2;TCF3;PURB
prerank,DNA polymerase binding (GO:0070182),0.32171732631024585,0.8235709544052354,0.6920222634508348,1.0,1.0,7/18,20.74%,LONP1;ACD;CDK2AP1;SMARCA4;SMG6;PTGES3;HSP90AB1
prerank,alpha-tubulin binding (GO:0043014),0.28554242332295177,0.8229536086495443,0.7142857142857143,1.0,1.0,9/31,16.70%,FYN;DIP2B;DNAL1;TRPV4;TBCEL;TTLL7;EFHC2;INO80;SETD2
prerank,iron ion binding (GO:0005506),-0.23184450034731882,-0.8212093192284455,0.7965116279069767,0.8935546267913529,1.0,20/48,31.03%,AGMO;AOX1;DNAJC24;TET1;KDM7A;FTL;NFU1;PHYH;FDX1;EGLN3;PHF2;CDO1;JMJD6;ABCE1;EGLN1;HIF1AN;SNCA;ETHE1;FXN;SCD
prerank,sulfotransferase activity (GO:0008146),-0.24904925083388452,-0.8187464817277426,0.772020725388601,0.8947603522117968,1.0,4/33,10.38%,UST;HS3ST3A1;CHST15;CHST11
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.3306504858972818,0.8184523637153766,0.6907407407407408,1.0,1.0,3/14,14.46%,CYB5R4;AIFM1;CYBA
prerank,protein phosphatase 2A binding (GO:0051721),0.3020243377133244,0.8180445275155507,0.7074074074074074,1.0,1.0,10/23,20.20%,BOD1;MFHAS1;ANKLE2;CTTNBP2NL;STRN4;PTPA;SMG5;IGBP1;SMG7;STRN3
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.35905587528483374,-0.8176523435415044,0.7012195121951219,0.8934934802577843,1.0,5/10,15.51%,DPP6;DPP4;FAP;DPP10;NAALAD2
prerank,histone demethylase activity (GO:0032452),0.2903762674015279,0.8163607937682241,0.7293729372937293,1.0,1.0,7/27,14.24%,KDM3A;KDM2A;KDM6A;KDM4D;JMJD1C;KDM5C;PHF8
prerank,RNA cap binding (GO:0000339),0.3226848281469614,0.8139832537855349,0.7165775401069518,1.0,1.0,7/16,20.15%,NCBP1;GEMIN5;NCBP3;CYFIP1;LSM1;LARP1;EIF4E
prerank,lysine N-methyltransferase activity (GO:0016278),-0.28617393088165544,-0.8111991714851386,0.7614678899082569,0.9019936432812259,1.0,7/20,23.28%,SETD7;EHMT2;ATPSCKMT;EEF1AKMT1;SMYD2;SETD4;METTL21A
prerank,O-methyltransferase activity (GO:0008171),0.35766000041128776,0.8062151701698941,0.6982591876208898,1.0,1.0,1/10,2.25%,BCDIN3D
prerank,H4 histone acetyltransferase activity (GO:0010485),0.35792800565383137,0.8057009605297691,0.7046332046332047,1.0,1.0,5/10,18.84%,EP300;USP22;NAA50;MSL3;HAT1
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.2291354476220662,-0.8040930623632029,0.8328690807799443,0.9112529398774339,1.0,9/46,19.35%,MGAT4C;OGT;HEXA;HEXB;LARGE1;B3GALT5;B3GALNT1;B3GALT1;PIGA
prerank,nucleotide diphosphatase activity (GO:0004551),0.33014274068428767,0.8035794827834722,0.7189922480620154,1.0,1.0,2/14,3.90%,NUDT11;NUDT12
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.31033833798502675,-0.8033668385828409,0.7274678111587983,0.9092155425077124,1.0,7/14,45.90%,KCNJ2;KCNQ1;KCNJ3;KCNJ8;KCNIP2;KCNE4;KCNH2
prerank,protein phosphatase 1 binding (GO:0008157),0.3031701406533406,0.8015304147439773,0.7293497363796133,1.0,1.0,3/21,12.34%,PPP1R16B;PPP1R11;AKAP11
prerank,cytokine receptor activity (GO:0004896),0.2290406924479193,0.8011941618578285,0.8420289855072464,1.0,1.0,4/83,3.16%,GFRA3;IL1R1;IFNLR1;CRLF1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.3243599115588539,-0.8004251493492781,0.7414187643020596,0.9110097448079219,1.0,6/12,19.53%,CDK6;BRD4;CDK7;CCNK;CDK9;CDK12
prerank,phosphatase inhibitor activity (GO:0019212),0.3068431311870986,0.8002972113611557,0.7314974182444062,1.0,1.0,4/20,13.52%,SAG;BOD1;MGAT5;CABIN1
prerank,ADP binding (GO:0043531),-0.26511225043561065,-0.7999555449016906,0.7831050228310502,0.9085841225099263,1.0,4/25,7.04%,PRKAG2;ME1;PRKAG1;GLUD1
prerank,ligand-gated cation channel activity (GO:0099094),-0.20839660928747344,-0.7992138998595256,0.8599348534201955,0.9066390683901256,1.0,19/75,29.72%,GRIA4;GRIA2;GRIN2B;P2RX4;KCNJ2;KCNJ6;GRIK4;KCNJ13;KCNJ10;GRIK1;GRIK3;GRIN2D;GRIN1;MCOLN1;CHRNA7;GRIA1;KCNK1;KCNJ12;CCDC51
prerank,nuclear export signal receptor activity (GO:0005049),0.33793455485281654,0.7958748658852617,0.7150943396226415,1.0,1.0,4/11,18.37%,XPO5;RANBP17;XPO1;NUP42
prerank,pentosyltransferase activity (GO:0016763),0.26933377294174055,0.7957702678347796,0.7752808988764045,1.0,1.0,7/36,11.69%,UPP1;SIRT3;SIRT1;PARP11;UPP2;PNP;TNKS
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.34144851253160435,0.7953769081081682,0.7230215827338129,1.0,1.0,6/12,19.49%,KDM3A;KDM4D;JMJD1C;PHF8;KDM4C;KDM3B
prerank,acetyltransferase activity (GO:0016407),0.275263527986334,0.7949470512365103,0.7541254125412541,1.0,1.0,8/31,18.77%,ACAT1;EP300;ESCO1;CREBBP;NAA80;NAA15;ELP3;NAA50
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.3302366455338648,-0.7931471799237002,0.7494646680942184,0.9132879839634683,1.0,9/11,66.99%,CHRNA7;CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,bHLH transcription factor binding (GO:0043425),0.30614251649507856,0.7905029587852873,0.7509157509157509,1.0,1.0,7/19,16.10%,USF2;SIRT1;LMO2;CREBBP;SP1;MAP3K10;TCF3
prerank,methyltransferase activity (GO:0008168),0.2536326988631482,0.7903454229749672,0.8060200668896321,1.0,1.0,12/46,19.59%,BCDIN3D;PRMT3;TRMT11;METTL27;CARNMT1;RRP8;NTMT1;COQ5;LCMT1;COQ3;NSUN2;FTSJ1
prerank,MAP kinase kinase kinase activity (GO:0004709),0.3573421022882938,0.7898670623363543,0.722,1.0,1.0,2/11,5.23%,MAP3K7;MAP3K4
prerank,phosphate ion binding (GO:0042301),0.34543455300179504,0.7880555383910632,0.7071713147410359,1.0,1.0,2/10,10.60%,RELA;PNP
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.27373839010923584,-0.7856444940599092,0.7733644859813084,0.9217684918840658,1.0,8/20,25.24%,SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC39A8;SLC39A7;SLC39A6;SLC30A5
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3128563320518884,-0.7838243967308052,0.7536842105263157,0.9214216990131334,1.0,4/12,16.42%,BACE2;BACE1;DDI2;HM13
prerank,chemokine receptor binding (GO:0042379),0.2678856211970473,0.7835297173803949,0.7940199335548173,1.0,1.0,2/35,8.51%,CXCL12;CCL25
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.26537299261059444,0.7826896031986543,0.800658978583196,1.0,1.0,7/34,14.43%,EZH2;TTLL12;SMYD3;SETD3;KMT5B;DOT1L;ETFBKMT
prerank,serine-type peptidase activity (GO:0008236),0.2229524130818588,0.7825581205488762,0.85273492286115,1.0,1.0,2/96,0.59%,PCSK1;CELA1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.2699246567445316,0.778372712100091,0.8056013179571664,1.0,1.0,3/30,6.21%,RPS6KA1;BIRC2;CARD16
prerank,chloride transmembrane transporter activity (GO:0015108),0.309101639154513,0.7778745658986,0.7473309608540926,1.0,1.0,2/16,9.01%,SLC1A1;CLCN7
prerank,telomeric DNA binding (GO:0042162),0.2687447136425149,0.7748855345592937,0.8045375218150087,1.0,1.0,5/32,10.58%,CTC1;SMG1;ACD;UPF2;TERT
prerank,calcium activated cation channel activity (GO:0005227),-0.29404296271537833,-0.7747151166891363,0.778969957081545,0.9320848443579184,1.0,6/17,18.71%,KCNMA1;ANO1;TMEM63A;ANO6;TMEM63B;ANO10
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3327708692195843,0.771149036932374,0.7490636704119851,1.0,1.0,4/12,15.69%,RUVBL2;RELA;TBP;TAF1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2694683319006097,0.7698136820062444,0.8020477815699659,1.0,1.0,4/29,11.63%,ACER2;ENGASE;MGAM;ACER3
prerank,phosphatase activity (GO:0016791),0.22505156201658863,0.7644917828900801,0.8553654743390358,1.0,1.0,12/73,13.32%,PTPRJ;ENOPH1;DUSP12;PLPP6;PXYLP1;PLPP1;PRUNE1;DUSP11;PGP;APTX;PTPMT1;PPP5C
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3035139055811685,-0.7639798478277582,0.7839506172839507,0.9449441583165821,1.0,3/13,5.78%,AGPAT4;ABHD5;AGPAT5
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.3316034464197758,0.7618578845205398,0.7628676470588235,1.0,1.0,3/11,16.56%,SLC25A24;SLC25A42;SLC25A25
prerank,inward rectifier potassium channel activity (GO:0005242),-0.2519045180129599,-0.7615691943844012,0.8294392523364486,0.9452685724555829,1.0,11/24,39.09%,KCNJ2;KCNJ6;ABCC9;KCNJ13;KCNJ10;KCNK1;KCNJ12;KCNJ3;KCNK6;KCNJ8;KCNJ15
prerank,histone methyltransferase binding (GO:1990226),0.32598917720035103,0.7608051806284111,0.7615658362989324,1.0,1.0,3/11,15.78%,PRDM4;LCORL;WIZ
prerank,BMP binding (GO:0036122),-0.31293139047044477,-0.7605440743781987,0.7797619047619048,0.9435367949467881,1.0,3/11,19.93%,NBL1;GREM2;BMPR2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3155621441424696,0.7572797882094984,0.7631578947368421,1.0,1.0,3/12,15.17%,GREM1;CDH5;VEGFC
prerank,RNA methyltransferase activity (GO:0008173),0.29021408750078886,0.7564231115176653,0.8097826086956522,1.0,1.0,1/19,2.25%,BCDIN3D
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.33486972340484356,0.7545278401057253,0.7771535580524345,1.0,1.0,4/10,16.70%,SETD5;SETD3;NSD2;SETD2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.27880264472774174,-0.7503784417761191,0.8181818181818182,0.9539270179303777,1.0,3/16,5.65%,SLC13A3;SLC1A5;SLC25A13
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.27567675571478917,0.7468407534722932,0.8222222222222222,1.0,1.0,3/22,8.81%,ILF3;ZFP36L1;EXOSC9
prerank,sodium channel activity (GO:0005272),0.25164668921112615,0.7466186360812246,0.8290322580645161,1.0,1.0,3/37,4.61%,GRIK5;GRIK2;SCN2A
prerank,leucine zipper domain binding (GO:0043522),-0.3247549305313605,-0.7459915194970592,0.814453125,0.9566075058418925,1.0,2/10,5.24%,PAWR;AATF
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3285115946551824,0.7435660606452729,0.8114285714285714,1.0,1.0,2/11,8.79%,LEF1;ZXDC
prerank,acyl-CoA hydrolase activity (GO:0047617),0.2863238984601364,0.7419194796803388,0.8066914498141264,1.0,1.0,4/17,18.29%,PPT1;ACOT8;ACAA2;ACOT13
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3227425215965978,-0.7413064235785937,0.8191056910569106,0.9592579315867185,1.0,2/10,12.80%,CXADR;SIRPA
prerank,MHC class II protein complex binding (GO:0023026),-0.3130749373026557,-0.7408096553903681,0.8106382978723404,0.9566689013592604,1.0,3/11,10.64%,ATP1B1;ANXA11;PKM
prerank,receptor antagonist activity (GO:0048019),-0.26764848187621926,-0.73965985941803,0.8415178571428571,0.954983003494487,1.0,1/17,7.08%,DKK3
prerank,methylated histone binding (GO:0035064),0.22115720259231111,0.7388794747530351,0.9032258064516129,1.0,1.0,18/62,19.14%,TTLL12;ING4;SPIN1;CDYL;ING3;ING2;CHD1;MORC4;TDRD3;RRP8;ING5;PHF8;TAF1;CHD8;MORC3;ATRX;MSL3;ZMYND11
prerank,myosin II binding (GO:0045159),-0.322279171145157,-0.7388730930807413,0.802547770700637,0.9527748617500337,1.0,3/10,14.45%,GSN;STXBP5;TRIOBP
prerank,NADPH binding (GO:0070402),0.31322065175287683,0.7385193525763981,0.8021978021978022,1.0,1.0,2/13,8.84%,HMGCR;KCNAB1
prerank,thioesterase binding (GO:0031996),0.3197277873737358,0.7376677818590636,0.783203125,1.0,1.0,3/11,15.57%,TRAF5;TRAF3;ARF6
prerank,methylation-dependent protein binding (GO:0140034),-0.20150664416497083,-0.7362008060317675,0.9405405405405406,0.953115237621382,1.0,25/57,31.63%,MBTD1;KDM4A;KDM7A;MPHOSPH8;ZCWPW2;PYGO1;RBBP5;GLYR1;MTF2;SGF29;CBX5;SUZ12;BPTF;PHF2;KAT8;PHF1;L3MBTL2;ZMYND8;NCAPG2;WDR5;KDM8;MSH6;ING1;PHF13;LRWD1
prerank,SH2 domain binding (GO:0042169),0.2575605486661745,0.7335543483760746,0.845,1.0,1.0,6/31,14.56%,SRC;DAG1;TRPV4;NLK;PAG1;RUFY1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3091985421126473,0.7320619534186663,0.815018315018315,1.0,1.0,2/14,12.82%,NME1;DTYMK
prerank,phosphatidic acid binding (GO:0070300),-0.26374931964168125,-0.7315141082907682,0.8452914798206278,0.9555928359638558,1.0,13/19,41.05%,GRAMD1B;SMPD3;PITPNC1;COMMD1;RAPGEF2;GSDMD;PLEKHN1;MICALL1;JPH2;MAPKAP1;OPA1;ATP13A2;PITPNM1
prerank,N-acetyltransferase activity (GO:0008080),0.28474088570334,0.7306575651088325,0.8351254480286738,1.0,1.0,3/19,12.78%,EP300;ESCO1;NAA80
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.31537929178469193,0.7290981918682041,0.8174904942965779,1.0,1.0,3/12,10.94%,CIAPIN1;ISCU;CISD2
prerank,ferrous iron binding (GO:0008198),0.2828000723914498,0.7282764156534657,0.8384353741496599,1.0,1.0,6/21,17.72%,ALKBH2;ISCU;EGLN2;FTO;TET2;FECH
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.32959286275760274,0.7279516435902906,0.8253676470588235,1.0,1.0,3/10,17.41%,DCLRE1B;EXD2;DCLRE1C
prerank,protein kinase inhibitor activity (GO:0004860),0.23620965058405669,0.7266356511682399,0.8760611205432938,1.0,1.0,5/42,6.38%,RPTOR;SPRED1;CIB1;CDKN1A;YWHAB
prerank,MHC class I protein binding (GO:0042288),0.3058998498349722,0.7250019262530243,0.8238532110091743,1.0,1.0,4/13,20.09%,TUBB;ATP5F1B;DERL1;TAP2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.2882352645772591,0.7245746166902464,0.7865384615384615,1.0,1.0,4/16,12.22%,TDG;SMUG1;RPS3;ADPRH
prerank,carbohydrate kinase activity (GO:0019200),-0.30239921219976984,-0.7244574775507291,0.8228941684665226,0.9605903043811952,1.0,7/11,48.50%,NAGK;HK2;GALK1;POMK;HK1;XYLB;KHK
prerank,proton transmembrane transporter activity (GO:0015078),-0.21066713180821,-0.7216743045200542,0.9173333333333333,0.9604600962209161,1.0,17/39,33.95%,CYB5A;UQCRH;COX8A;CTNS;UQCRC1;NDUFA4;COX7A2L;COX6A1;SLC11A2;DMAC2L;UQCR10;UQCRQ;UQCR11;SLC9A1;NNT;COX5B;CLCN4
prerank,NADP binding (GO:0050661),0.2545397441865548,0.7215561774692728,0.8763693270735524,1.0,1.0,5/32,11.15%,SPR;ME3;HMGCR;KCNAB1;NOS3
prerank,Hsp70 protein binding (GO:0030544),-0.23142801130316648,-0.7215540654441421,0.9006928406466512,0.9574330248846051,1.0,11/31,29.10%,PACRG;PPID;SACS;GPR37;DNAJC2;STUB1;DNAJB2;METTL21A;DNAJA1;PPEF2;SNCA
prerank,E-box binding (GO:0070888),0.24564682180768438,0.7208546931142273,0.8845500848896435,0.9988085165478625,1.0,5/34,16.10%,TAL1;CLOCK;TFAP4;HES1;TCF3
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.26683210059224305,-0.7206972012236156,0.8623024830699775,0.9551604149823946,1.0,9/17,35.87%,ABCA1;PITPNC1;ATP8B2;ATP8B1;MTTP;ABCA7;ABCB4;ATP10B;PCTP
prerank,snoRNA binding (GO:0030515),-0.23063582089354231,-0.7162657420240197,0.8962025316455696,0.9570770448044944,1.0,20/30,42.79%,NUDT4;BMS1;UTP6;DDX21;NOP56;NUFIP1;NOP14;WDR3;NUDT7;BYSL;IMP3;GAR1;IMP4;TSR1;DHX37;NOP10;NUDT1;TBL3;NUDT16;NUDT16L1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.30712095296899056,0.7154689022222533,0.804,1.0,1.0,5/12,21.52%,TENT4A;PAPOLA;PAPOLG;TENT2;MTPAP
prerank,receptor ligand activity (GO:0048018),0.18166710201403172,0.7149569641386032,0.986335403726708,0.9995561090465089,1.0,15/245,9.12%,GDF1;JAG2;SEMA6A;SEMA6D;SEMA7A;GREM1;CRLF1;GNRH1;SEMA3C;SEMA6B;BDNF;CCL25;WNT5A;NPPC;SEMA4C
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.30354012893575744,0.7135534696002019,0.8137432188065099,0.9980741295025887,1.0,1/12,1.88%,SLC25A24
prerank,NAD+ binding (GO:0070403),-0.29543907795667135,-0.7119488967953005,0.85,0.9586220058533389,1.0,3/12,7.04%,ZC3HAV1;SIRT2;GLUD1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.24127622250191152,0.7108854532184515,0.8768718801996672,0.9981897013763372,1.0,8/34,16.45%,UFC1;UBE2I;AKTIP;UBE2R2;UBE2F;UBE2G1;TAF1;UBE2H
prerank,lipid phosphatase activity (GO:0042577),0.2837634803513879,0.7097271258718423,0.8479087452471483,0.9963541110178887,1.0,4/14,13.88%,PLPP6;PLPP1;SGPP2;SGPP1
prerank,"DNA binding, bending (GO:0008301)",-0.2702287377854813,-0.7056332836219826,0.8698347107438017,0.9621828708500612,1.0,9/14,35.83%,FOXD1;FOXC1;SAP30L;FOXL1;HMGA2;TERF1;HMGB1;HHEX;HMGB2
prerank,cytochrome-c oxidase activity (GO:0004129),0.2904793111690218,0.6985690049661837,0.8674463937621832,1.0,1.0,4/15,14.40%,COX6B1;COX5A;COX15;COX10
prerank,nuclear import signal receptor activity (GO:0061608),-0.26785310045921057,-0.6976027664289312,0.8717391304347826,0.9670529559181338,1.0,3/15,12.92%,IPO9;TNPO3;TNPO2
prerank,DNA secondary structure binding (GO:0000217),-0.21941784479117335,-0.6949550352003201,0.9209302325581395,0.9663977852204574,1.0,16/31,36.90%,KMT2A;MAPT;ERCC5;LIN54;RAD51D;MSH2;XPC;BLM;MSH6;HMGA2;CLSPN;RAD51C;HMGB1;MEN1;HMGB2;XRCC2
prerank,carboxylic ester hydrolase activity (GO:0052689),0.1996630975392964,0.6934818380011398,0.9615384615384616,1.0,1.0,9/85,15.10%,NDST3;CA2;PLAAT3;PNPLA7;PGLS;ABHD12;ABHD4;PNPLA6;DAGLB
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.2963259864534848,-0.6920811746756867,0.876984126984127,0.9660032938044988,1.0,2/10,16.08%,CDADC1;LACC1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.26143637335318826,0.6871843337431623,0.8844884488448845,1.0,1.0,5/20,14.31%,YOD1;DESI2;USP47;OTUD5;USP9X
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.30024306196807893,0.6850868219178253,0.839622641509434,1.0,1.0,4/11,20.86%,SGMS1;PIGN;SAMD8;SGMS2
prerank,hormone activity (GO:0005179),0.21175786185367512,0.6848014623510373,0.9179566563467493,1.0,1.0,4/54,10.59%,GNRH1;CCL25;NPPC;PPY
prerank,endoribonuclease activity (GO:0004521),-0.21577700392033358,-0.6845673655822812,0.9509803921568627,0.9701299360384811,1.0,13/32,31.70%,AGO3;SND1;DICER1;INTS11;ZC3H12B;RCL1;NOB1;CPSF3;LACTB2;RIDA;ZC3H12A;EXOG;RNASEL
prerank,cAMP binding (GO:0030552),0.29705643650128677,0.6833078267934425,0.8568702290076335,1.0,1.0,1/11,1.75%,PDE4D
prerank,endopeptidase activator activity (GO:0061133),0.3031835937581413,0.6831731807879005,0.8538899430740038,1.0,1.0,3/10,15.68%,VSIR;PSMD14;APH1A
prerank,5'-3' exonuclease activity (GO:0008409),0.28131609408178015,0.6823789108211108,0.8703703703703703,0.9992304101533488,1.0,3/14,9.41%,DCLRE1B;XRN2;DXO
prerank,fatty acid synthase activity (GO:0004312),0.3027675537569886,0.6803383513375536,0.8497109826589595,0.9980618729561269,1.0,1/10,5.49%,ELOVL6
prerank,actin monomer binding (GO:0003785),0.2523631668605355,0.6791342828292498,0.8857142857142857,0.9961101824435443,1.0,4/22,14.33%,MRTFA;PFN1;NOS3;TWF1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.2652741061457813,-0.6757221891709416,0.8724279835390947,0.9746760402225338,1.0,3/13,20.12%,SLC7A2;SLC38A7;SLC15A4
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.27276602233039005,0.6672753197064815,0.8782771535580525,1.0,1.0,4/15,13.87%,LPCAT2;GPAT4;AGPAT3;ABHD4
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.2544879654116786,-0.6669905639555926,0.8949671772428884,0.9790773042692497,1.0,4/15,29.78%,P2RX4;P2RY14;P2RY12;P2RY1
prerank,phospholipase A2 activity (GO:0004623),-0.21421278675867084,-0.6650820448160829,0.9384236453201971,0.9775267395745704,1.0,10/26,39.04%,PLA2G4A;ABHD3;PLA2G6;PLA2G7;PLA2G12A;PLA2G15;PRDX6;PLA2G4E;PNPLA3;PLA2G4C
prerank,mRNA methyltransferase activity (GO:0008174),0.2812401910949088,0.6625985241045941,0.8897485493230174,1.0,1.0,4/12,20.12%,TRMT61B;RNMT;NSUN2;METTL14
prerank,low-density lipoprotein particle binding (GO:0030169),-0.2546788584885805,-0.6596837300241712,0.9014989293361885,0.9786694310601428,1.0,3/16,9.33%,SORL1;LDLR;THBS1
prerank,phosphatase activator activity (GO:0019211),0.27976941561606616,0.6573651014979047,0.8866799204771372,1.0,1.0,6/14,21.17%,CALM3;PPP2R5A;FRS2;CALM1;PPP2R5C;PHACTR4
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.19719184364777176,0.6526559869719454,0.9815384615384616,1.0,1.0,10/60,16.13%,CTDSP1;PPP3CB;PPP2CA;PPP2CB;PHLPP1;PPP3CA;PPP3R1;PPP5C;CAMK2G;PPM1L
prerank,lysophospholipase activity (GO:0004622),0.24607458847505523,0.6486282598184763,0.9159212880143113,1.0,1.0,6/20,20.29%,PNPLA7;ABHD12;ABHD4;PNPLA6;LYPLA1;ENPP2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.2761632647771401,-0.6468446026089459,0.9170212765957447,0.9850733348471108,1.0,2/10,5.28%,KDM4A;KDM7A
prerank,P-type ion transporter activity (GO:0015662),-0.2634138468468118,-0.6458942259369062,0.9191489361702128,0.9826333903274879,1.0,2/12,5.67%,ATP6V1E1;ATP7A
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.20725086971112178,0.6388271926040741,0.9466437177280551,1.0,1.0,7/40,13.06%,THUMPD2;CARNMT1;ICMT;SETD3;METTL2B;METTL2A;RRP8
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.2582535107254975,-0.6339749378347221,0.9166666666666666,0.9872051356637176,1.0,6/12,38.58%,GAB2;PIK3R1;SH2B1;BLNK;SH2B2;TRADD
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.2761910740066539,0.6262208787488932,0.9122137404580153,1.0,1.0,11/11,72.40%,KCND3;KCNE1;KCNE3;KCNE2;KCNJ5;KCNE5;KCNH2;KCNE4;KCNJ8;KCNJ3;KCNQ1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.25667400457622364,0.6237707330538768,0.9202898550724637,1.0,1.0,2/14,12.09%,ISCU;ACO1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.275305397229733,0.6216458566576204,0.8714555765595463,1.0,1.0,5/10,22.43%,HSD17B4;ECHDC1;ECHS1;HADHA;AUH
prerank,transaminase activity (GO:0008483),-0.2564896354413484,-0.6201154207355616,0.9356223175965666,0.9922723067962446,1.0,4/11,24.63%,ABAT;BCAT1;GOT1;OAT
prerank,RNA polymerase binding (GO:0070063),0.23999077399866567,0.6190922450078719,0.9364485981308411,1.0,1.0,7/18,21.38%,PPIB;STOM;SCAF8;TCERG1;YTHDC2;PKN2;DHX9
prerank,single-stranded DNA helicase activity (GO:0017116),-0.217108886719248,-0.6089687726808765,0.9439461883408071,0.9952180041130526,1.0,14/19,54.27%,WRNIP1;MCM6;RFC2;HELQ;POLQ;DNA2;RFC3;RAD51;RFC4;MCM7;MCM5;DSCC1;CHTF18;PIF1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.1837284739366305,-0.6023300888407704,0.9852579852579852,0.9951551661293548,1.0,21/35,44.15%,DUS2;ELAC1;TARS2;NT5C3A;MTFMT;QTRT2;DUS4L;QRSL1;PTRH2;QTRT1;TRMT5;LCMT2;DTWD1;DUS3L;ELAC2;DUS1L;MRPL58;GATC;TYW3;TRMT12;TRPT1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.2119500178379865,-0.6005773033344938,0.9624217118997912,0.9929396475672452,1.0,2/21,10.73%,FGF1;KL
prerank,FMN binding (GO:0010181),-0.24181253870239502,-0.5933472211174426,0.9381663113006397,0.9929638829491236,1.0,5/11,36.01%,DUS2;MTRR;POR;NOS1;NDOR1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.26593643144167767,0.5890628308913747,0.9580838323353293,1.0,1.0,1/10,5.65%,CDKN1A
prerank,titin binding (GO:0031432),-0.2302638728744773,-0.5849229945934001,0.9556962025316456,0.9934787109270219,1.0,2/13,10.68%,ACTN2;CAMK2D
prerank,endopeptidase regulator activity (GO:0061135),-0.17238201199789488,-0.5796628604672412,0.9947916666666666,0.9922816552544627,1.0,13/40,36.54%,TFPI;PSMF1;ITIH2;RENBP;CAST;SERPIND1;APH1B;PSME2;PSME3;ABCA2;PSME1;PSENEN;SPINT2
prerank,sequence-specific mRNA binding (GO:1990825),0.26512678885262353,0.5790655309758742,0.9375,1.0,1.0,10/10,73.50%,SSB;DHX9;FMR1;LIN28A;LARP6;ETF1;RBM24;TYMS;DHFR;SHFL
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.24492884271768695,-0.5788120531009011,0.9464285714285714,0.9896036451276257,1.0,2/11,11.82%,PPP1R1A;PPP1R14C
prerank,nucleoside-diphosphatase activity (GO:0017110),0.24605493613830579,0.568592920296342,0.9383177570093458,1.0,1.0,1/12,3.76%,NUDT5
prerank,receptor tyrosine kinase binding (GO:0030971),0.17117908623414785,0.5672924082236382,0.9937694704049844,1.0,1.0,2/56,2.11%,CBL;MAP3K7
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.1841597690005981,0.562268958620849,0.9867330016583747,1.0,1.0,13/38,21.11%,DENND1A;TECPR1;LANCL2;PARD3;PLEKHA5;ZFYVE1;SNX27;KIF16B;ZFYVE19;ZFYVE26;WDR45B;ATG2B;SNX12
prerank,histone acetyltransferase activity (GO:0004402),0.19614115955975775,0.5588566178464703,0.9831932773109243,1.0,1.0,8/30,18.84%,EP300;CLOCK;CREBBP;USP22;TAF1;TADA2A;NAA50;HAT1
prerank,antiporter activity (GO:0015297),0.2140891527062025,0.5542760574763654,0.9771929824561404,1.0,1.0,2/20,8.41%,CLCN3;SLC35A1
prerank,CARD domain binding (GO:0050700),0.23049508985695494,0.5510275170082758,0.9510357815442562,1.0,1.0,2/14,11.38%,CARD16;NOD1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.21630693496879289,0.5443220349598772,0.9543057996485061,1.0,1.0,2/17,12.82%,NME1;DTYMK
prerank,four-way junction DNA binding (GO:0000400),0.21270446819886124,0.5409444475761833,0.971042471042471,1.0,1.0,2/17,10.81%,YY1;RAD51B
prerank,glucose transmembrane transporter activity (GO:0005355),0.21023547880690752,0.5290753991693257,0.984182776801406,1.0,1.0,17/17,79.00%,SLC2A1;SLC2A7;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A6;SLC2A5;PPBP;SLC2A2;SLC2A4;SLC2A8;SLC5A11;SLC5A3;SLC2A10;SLC2A3;MFSD4A
prerank,death domain binding (GO:0070513),0.23258227014865018,0.5258178592040599,0.9698681732580038,1.0,1.0,3/11,17.79%,CRADD;DAPL1;BAX
prerank,hyaluronic acid binding (GO:0005540),-0.22290997725367895,-0.5254646949618994,0.9736842105263158,1.0,1.0,1/10,4.65%,CEMIP
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.22479598242310125,0.5235318938290986,0.9631782945736435,1.0,1.0,12/12,77.54%,NQO2;CRYZL1;ADH4;AKR1C1;DCXR;NQO1;CBR1;CRYZ;NDUFS7;CBR4;AIFM2;DHRS4
prerank,lipase activity (GO:0016298),0.16535538960894652,0.5129419084642161,0.9983792544570502,1.0,1.0,5/43,15.10%,SEC23IP;DDHD1;PNPLA8;ABHD12;DAGLB
prerank,5'-nucleotidase activity (GO:0008253),0.2135589678157206,0.5071931025898013,0.9790076335877863,1.0,1.0,3/13,18.67%,NT5C3B;NT5C2;NT5DC1
prerank,ribonuclease P activity (GO:0004526),-0.21159029102508004,-0.5065883578309001,0.9781659388646288,1.0,1.0,6/11,41.09%,PRORP;RPP30;RPP14;RPP21;POP4;RPP38
prerank,hexose transmembrane transporter activity (GO:0015149),0.21016949152542383,0.48835133931950825,0.9803220035778175,1.0,1.0,12/12,79.00%,SLC2A1;SLC2A7;SLC5A1;SLC2A6;SLC2A5;PPBP;SLC2A2;SLC2A4;SLC2A8;SLC5A3;SLC2A3;MFSD4A
prerank,ribonuclease P RNA binding (GO:0033204),0.208950539794125,0.4703787148101463,0.9925233644859813,1.0,1.0,10/10,79.12%,POP5;POP1;RPP25;RPP40;POP7;RPP38;POP4;RPP21;RPP14;RPP30
prerank,neuropeptide receptor binding (GO:0071855),0.1980160723254643,0.4701289095514332,0.9857904085257548,1.0,1.0,14/14,80.22%,PPY;AGRP;APELA;UCN3;QRFP;GHRH;NPPA;UCN2;GAL;APLN;NPY;NTS;NMU;SHANK1
prerank,peptidoglycan binding (GO:0042834),0.1962088877730353,0.4440527245691315,0.991869918699187,1.0,1.0,10/10,80.39%,NOD1;PGLYRP2;PGLYRP3;TLR2;NLRP3;JCHAIN;NOD2;HK1;PGLYRP1;RNASE7
prerank,growth factor activity (GO:0008083),0.12576390157954415,0.42801552212279304,1.0,1.0,1.0,1/74,0.86%,JAG2
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.16412735228556674,-0.4245282851499829,0.9977477477477478,1.0,1.0,7/14,41.09%,PRORP;RPP30;RPP14;RPP21;ELAC2;POP4;RPP38
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.17714082155566324,-0.4076812297844802,1.0,1.0,1.0,1/10,11.53%,NOX4
prerank,nucleotidase activity (GO:0008252),0.16007638620454745,0.39313078516530836,0.996309963099631,1.0,1.0,2/15,12.02%,NT5C3B;NT5C2
prerank,CoA hydrolase activity (GO:0016289),-0.14581293426370212,-0.38644852739021907,1.0,1.0,1.0,3/16,24.07%,ACOT11;ACOT7;NUDT7
prerank,pseudouridine synthase activity (GO:0009982),-0.15193337547565045,-0.37786961298445154,1.0,0.9996055976955637,1.0,10/13,51.67%,PUS7;TRUB1;PUS3;RPUSD4;PUS1;PUS7L;RPUSD1;PUSL1;RPUSD2;RPUSD3
prerank,acylglycerol lipase activity (GO:0047372),0.16332935785575303,0.3729268455502411,1.0,0.9995479404264102,1.0,11/11,83.68%,ABHD12;ABHD16A;PNLIPRP2;ABHD12B;ABHD6;ABHD2;ABHD15;MGLL;FAAH;LIPE;ABHD3
